data_6nu4_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6nu4 _Structure_validation_residue.Date_analyzed 2019-05-03 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.41 32.24 10.93 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.036 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.4 t -63.34 138.65 58.6 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.773 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 p -149.59 139.74 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.046 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 61.3 ttm-85 -145.48 139.99 27.22 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.713 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -130.21 148.82 52.09 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.076 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.1 tp -135.22 136.91 50.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.226 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 89.7 m -121.54 130.07 53.3 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.628 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -71.21 155.24 93.31 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.132 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.51 147.21 70.28 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.01 1.807 . . . . 0.0 112.347 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.68 156.2 34.52 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.22 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 87.5 mt -65.82 -66.16 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.164 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -176.62 48.41 0.01 OUTLIER 'General case' 0 C--O 1.245 0.84 0 CA-C-O 121.075 0.464 . . . . 0.0 110.85 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -93.18 119.51 32.45 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.228 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -97.52 -175.71 34.13 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -132.94 -71.75 0.52 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.28 0.086 . . . . 0.0 111.124 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -71.83 -49.59 37.09 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -174.41 154.78 2.18 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.058 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.0 m -132.56 152.58 36.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.759 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 66.2 t-80 -71.87 136.87 47.11 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.409 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.7 m -96.64 132.87 41.84 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.68 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.52 137.98 52.95 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.39 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -68.37 -27.48 66.28 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.273 0.358 . . . . 0.0 110.643 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.75 -30.09 15.05 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.917 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -127.29 54.19 11.95 Favored Pre-proline 0 CA--C 1.557 1.219 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.191 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.4 -23.3 20.62 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.004 1.803 . . . . 0.0 111.747 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 43.1 p30 -72.04 -16.96 62.05 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.08 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.7 m -84.51 -38.05 20.54 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.9 t -62.59 128.98 38.54 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.128 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -138.58 136.8 36.37 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.514 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -65.36 -39.8 92.78 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.157 177.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -138.86 150.8 46.4 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.376 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -152.85 172.14 17.2 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.383 0.611 . . . . 0.0 112.478 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.27 -170.49 2.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.242 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -59.64 148.63 74.28 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.9 -24.37 21.07 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 122.314 2.009 . . . . 0.0 112.21 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -81.48 128.02 33.44 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.53 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -120.92 146.63 46.43 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.664 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -151.4 133.47 15.15 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.178 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -110.27 148.57 17.5 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 53.5 t -89.1 114.18 25.41 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -123.72 18.23 7.64 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.752 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.6 m -63.39 -31.62 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 116.85 0.325 . . . . 0.0 111.208 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.0 mt 66.88 -2.33 1.15 Allowed 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -66.42 -36.28 82.43 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.94 0.4 . . . . 0.0 110.844 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.05 -40.9 0.34 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 52.49 98.82 0.01 OUTLIER 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.754 0.312 . . . . 0.0 111.357 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -125.46 141.13 52.22 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.868 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -125.2 139.93 53.31 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.226 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -125.65 157.97 35.92 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.259 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.8 m -61.51 -42.51 98.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.157 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -166.78 179.12 40.81 Favored Glycine 0 CA--C 1.538 1.489 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.17 -32.72 10.29 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 121.815 1.677 . . . . 0.0 112.436 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -139.0 58.69 13.55 Favored Pre-proline 0 CA--C 1.562 1.439 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.132 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -62.52 -27.0 76.43 Favored 'Trans proline' 0 N--CA 1.507 2.294 0 C-N-CA 122.627 2.218 . . . . 0.0 111.839 176.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.7 m . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.034 -0.984 . . . . 0.0 111.164 -178.804 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 . . . . . 0 N--CA 1.497 1.898 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 75.34 -51.81 0.65 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.883 0.473 . . . . 0.0 111.472 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.3 p 63.13 138.89 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.739 0.304 . . . . 0.0 111.132 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.21 158.98 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.319 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -120.18 129.04 53.94 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.668 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -108.36 -47.74 3.47 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.708 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.6 mm -119.34 128.4 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.567 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 t -75.89 -29.93 58.64 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -122.19 139.69 31.04 Favored Pre-proline 0 CA--C 1.558 1.287 0 N-CA-C 111.636 0.236 . . . . 0.0 111.636 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.18 -26.55 8.99 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.158 1.905 . . . . 0.0 112.594 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.06 159.8 36.71 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.023 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 79.9 mt -72.63 -62.37 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.921 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -175.4 62.36 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.512 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -70.37 143.12 52.02 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.988 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.92 45.42 0.03 OUTLIER Glycine 0 C--N 1.343 0.932 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.9 t70 52.01 47.12 25.39 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.206 0.527 . . . . 0.0 111.439 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -72.49 146.29 46.95 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.078 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.21 153.0 34.08 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.638 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.1 m -105.42 -18.9 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.114 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -69.19 142.45 54.29 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.705 0.288 . . . . 0.0 110.881 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 82.0 m -92.97 135.9 33.74 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.011 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -66.11 134.41 52.74 Favored 'General case' 0 CA--C 1.512 -0.519 0 O-C-N 123.277 0.361 . . . . 0.0 110.097 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -71.13 -21.46 62.19 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.736 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.88 -28.61 13.75 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.434 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -128.4 54.96 15.03 Favored Pre-proline 0 CA--C 1.56 1.351 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.29 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.95 -24.45 24.2 Favored 'Trans proline' 0 N--CA 1.5 1.857 0 C-N-CA 121.931 1.754 . . . . 0.0 111.744 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -64.39 -34.58 78.5 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.105 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 68.4 p -89.13 -0.75 57.69 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.685 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.4 t -60.4 136.05 57.93 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 120.787 0.327 . . . . 0.0 110.649 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -65.73 130.97 45.14 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.862 -177.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.9 mmmm -137.02 153.61 50.6 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.835 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -125.08 -76.57 0.59 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 15.71 -79.68 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.437 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.04 165.49 1.86 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.763 0.316 . . . . 0.0 111.071 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -63.03 151.2 86.67 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.818 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -75.16 -22.98 13.97 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.536 2.157 . . . . 0.0 112.155 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -60.97 131.27 50.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.36 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -117.16 141.49 48.21 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.309 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -137.8 125.0 21.62 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.086 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.7 178.96 51.36 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.3 p -75.43 152.59 37.95 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.64 0.257 . . . . 0.0 110.924 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.7 5.2 50.85 Favored Glycine 0 CA--C 1.54 1.628 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.898 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.8 m -64.35 -30.49 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 116.965 0.383 . . . . 0.0 111.338 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.4 mt 62.69 6.05 1.94 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -65.74 -36.08 82.55 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.936 0.398 . . . . 0.0 110.982 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.73 -21.93 0.91 Allowed Glycine 0 CA--C 1.535 1.302 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.253 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 56.56 46.24 20.85 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.475 0.655 . . . . 0.0 110.648 178.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -60.62 -44.74 95.97 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.808 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -151.36 163.79 38.14 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.125 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -151.37 -60.97 0.17 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.68 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.1 t -150.59 150.56 31.35 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.378 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.87 163.82 36.34 Favored Glycine 0 CA--C 1.546 1.998 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.16 146.79 46.94 Favored 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 122.006 1.804 . . . . 0.0 112.181 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -142.13 82.71 13.06 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.207 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -66.14 -16.31 51.63 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 121.972 1.781 . . . . 0.0 111.825 178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.7 m . . . . . 0 C--N 1.349 0.567 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.832 -178.818 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.04 151.99 35.46 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.695 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 51.85 -175.68 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.543 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.8 t -120.38 67.72 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-O 121.172 0.51 . . . . 0.0 110.47 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 48.03 -179.24 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.114 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -145.18 -54.37 0.3 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.213 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 92.4 mt -61.75 -45.52 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.768 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 81.8 p -129.76 159.76 35.51 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.043 -178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -134.69 156.34 78.73 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.005 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -71.4 150.03 57.58 Favored 'Trans proline' 0 N--CA 1.503 2.064 0 C-N-CA 122.153 1.902 . . . . 0.0 112.088 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -152.75 148.33 27.12 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.76 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.9 mp -123.46 108.66 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.998 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.4 p30 29.32 40.56 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.921 0.888 . . . . 0.0 112.864 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -70.88 143.66 50.93 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.685 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.25 -179.46 16.69 Favored Glycine 0 N--CA 1.465 0.57 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -99.17 105.98 18.1 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.681 0.277 . . . . 0.0 110.956 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -163.57 175.44 10.66 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.311 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.18 -38.42 83.21 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.164 -177.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.9 t 73.1 133.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.507 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -134.49 160.54 37.69 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.651 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 68.5 m -87.54 158.91 18.8 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.888 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.31 137.31 57.85 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.319 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -68.19 -26.03 65.53 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.87 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -95.59 -28.24 14.94 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.839 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -128.35 54.31 13.28 Favored Pre-proline 0 CA--C 1.558 1.269 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.838 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.68 -25.43 24.36 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.194 1.929 . . . . 0.0 112.505 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -86.89 -11.49 50.57 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.125 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 67.9 p -127.35 17.84 7.03 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 30.3 p -60.32 160.41 8.6 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-O 120.828 0.347 . . . . 0.0 111.107 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -61.77 -41.69 98.03 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.961 -176.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -139.07 150.5 45.81 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.156 0.503 . . . . 0.0 111.67 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt 69.79 172.79 0.3 Allowed 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.479 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -152.9 -44.62 0.1 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.692 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.59 137.77 58.26 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.507 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -74.73 155.38 87.08 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.278 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.89 -24.11 18.09 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.219 1.946 . . . . 0.0 111.586 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -90.54 122.99 33.84 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.26 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -91.97 -63.63 1.22 Allowed 'General case' 0 CA--C 1.513 -0.468 0 O-C-N 123.277 0.36 . . . . 0.0 111.304 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -170.98 151.87 3.4 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.603 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.84 -176.32 47.79 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 21.9 p -66.84 156.87 34.47 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.751 0.31 . . . . 0.0 111.214 -178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.34 1.39 46.66 Favored Glycine 0 CA--C 1.54 1.628 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.644 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.3 m -66.88 -28.96 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.952 0.376 . . . . 0.0 111.193 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.5 mt 57.96 12.36 1.75 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.364 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -64.74 -36.68 85.08 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.861 0.362 . . . . 0.0 110.723 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.49 -51.88 0.11 Allowed Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 55.63 41.06 30.95 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.096 0.474 . . . . 0.0 110.436 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -149.35 158.7 44.4 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.65 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -62.48 -48.62 78.81 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.349 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -148.53 162.8 38.92 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.034 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.1 m -62.69 -42.96 99.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.872 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -175.13 -177.25 44.07 Favored Glycine 0 CA--C 1.541 1.691 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -70.47 151.25 64.88 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.849 1.699 . . . . 0.0 112.081 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -129.85 71.53 82.14 Favored Pre-proline 0 CA--C 1.56 1.363 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.713 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -66.33 -24.57 50.22 Favored 'Trans proline' 0 N--CA 1.506 2.259 0 C-N-CA 122.231 1.954 . . . . 0.0 112.084 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 m . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.006 -0.997 . . . . 0.0 111.046 -179.054 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.41 -39.9 92.45 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.868 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.3 t -154.55 172.71 17.37 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.746 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.5 m -63.78 -27.98 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.122 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -112.38 158.41 19.84 Favored 'General case' 0 C--N 1.343 0.326 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.011 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -114.77 19.83 15.65 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.654 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.0 pt -125.6 157.88 34.69 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.658 -176.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.0 m -124.94 138.42 54.24 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.594 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -60.67 143.5 90.56 Favored Pre-proline 0 CA--C 1.551 0.996 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.25 -177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.79 161.13 27.51 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.432 2.088 . . . . 0.0 112.377 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 60.87 99.14 0.03 OUTLIER 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.227 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.2 mm -63.55 -44.88 98.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -149.74 -57.72 0.19 Allowed 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.995 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 45.82 -174.29 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.817 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.91 164.8 30.8 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -89.35 -40.43 12.77 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.524 0.202 . . . . 0.0 110.976 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -151.84 93.46 1.85 Allowed 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.27 -6.27 59.37 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.2 m 44.96 176.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -70.14 148.23 48.96 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.576 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 18.3 m -63.05 153.8 32.84 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.027 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.58 133.34 42.23 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.936 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -70.97 -26.72 63.28 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.147 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.21 -26.31 15.49 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.719 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -128.79 53.07 10.34 Favored Pre-proline 0 CA--C 1.559 1.311 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.515 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.0 -26.63 18.25 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.915 1.743 . . . . 0.0 111.435 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -65.29 -35.46 81.07 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.139 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 75.2 p -107.04 10.38 30.32 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 116.211 -0.449 . . . . 0.0 112.085 -178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.6 p -69.59 170.24 11.12 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 123.191 0.307 . . . . 0.0 110.489 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -70.18 143.03 52.39 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.964 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -128.66 152.26 48.58 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.022 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -133.36 152.2 51.9 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.698 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -151.06 170.36 19.57 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.149 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.24 157.17 33.8 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.794 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.2 p30 -70.78 157.43 90.25 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.465 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.92 -23.71 6.49 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.368 2.045 . . . . 0.0 112.638 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -67.4 133.7 50.07 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.049 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -112.64 142.43 45.24 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.157 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 61.1 ttt85 -125.85 119.31 27.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.45 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.6 178.0 48.66 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.954 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 41.0 t -91.13 115.2 27.83 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.335 -0.433 . . . . 0.0 110.441 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -136.71 11.16 3.99 Favored Glycine 0 CA--C 1.54 1.611 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.762 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.3 m -65.38 -32.74 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 117.101 0.45 . . . . 0.0 111.112 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.6 mt 63.31 3.66 1.44 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -64.89 -36.61 84.92 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.07 0.462 . . . . 0.0 110.275 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -163.58 -72.88 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.8 t 65.48 -73.17 0.07 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 122.833 0.453 . . . . 0.0 111.741 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -85.01 132.25 34.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 123.305 0.378 . . . . 0.0 110.135 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 20.2 tpp85 -60.17 -39.19 85.57 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.781 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 71.72 24.87 3.35 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.862 0.465 . . . . 0.0 111.058 -176.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.5 m -163.28 88.85 0.6 Allowed 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.965 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -172.04 63.29 0.15 Allowed Glycine 0 CA--C 1.539 1.552 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.8 -26.77 74.95 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.072 1.848 . . . . 0.0 112.158 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm 58.9 63.9 3.57 Favored Pre-proline 0 C--O 1.243 0.751 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -64.4 -23.25 65.36 Favored 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 121.713 1.609 . . . . 0.0 112.19 -176.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 CA--C 1.537 0.462 0 CA-C-O 117.961 -1.019 . . . . 0.0 111.917 -179.011 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 39.1 mp0 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.37 -42.15 98.24 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.599 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.6 t 47.43 -172.35 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.019 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.3 p -144.63 126.18 9.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -161.21 136.19 7.48 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.994 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -132.34 142.38 49.31 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.677 177.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.3 tp -124.13 79.67 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 121.402 0.62 . . . . 0.0 110.679 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.5 p -118.27 -4.93 10.9 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.235 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -70.76 148.94 95.12 Favored Pre-proline 0 CA--C 1.55 0.973 0 CA-C-O 119.695 -0.193 . . . . 0.0 110.906 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -75.31 148.6 34.34 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.239 1.96 . . . . 0.0 111.943 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.7 139.93 16.59 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.509 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 24.0 mt -139.75 -124.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.573 1.845 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -65.73 -44.06 87.15 Favored 'General case' 0 C--N 1.36 1.062 0 CA-C-N 118.74 0.7 . . . . 0.0 110.65 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 47.89 -89.44 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.013 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.54 179.95 53.15 Favored Glycine 0 C--N 1.353 1.487 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -87.41 108.79 19.16 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.629 0.252 . . . . 0.0 110.847 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -110.77 130.89 55.45 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.444 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -109.3 130.33 55.5 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.079 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 79.3 t -63.75 -42.48 96.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.089 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -65.12 146.46 54.95 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.287 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 98.9 m -71.67 151.49 43.62 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.76 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -67.56 134.09 50.62 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 121.223 0.535 . . . . 0.0 110.471 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.8 ptmm? -71.23 -28.46 64.2 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.497 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.87 -24.01 16.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.64 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -129.9 52.53 9.55 Favored Pre-proline 0 CA--C 1.558 1.268 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.362 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -72.77 -23.41 19.23 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.814 1.676 . . . . 0.0 111.563 177.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.7 p-10 -75.35 -16.42 60.4 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.447 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.4 p -105.92 -6.52 18.8 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 120.456 0.169 . . . . 0.0 111.336 177.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 38.3 t -61.21 138.0 58.23 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.33 0.586 . . . . 0.0 111.042 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -73.61 147.56 43.71 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.92 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -101.81 -33.16 9.92 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt 76.4 166.09 0.26 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.773 0.429 . . . . 0.0 111.13 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -158.78 172.4 18.32 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.132 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.9 139.43 38.05 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.474 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.2 p30 -74.94 157.38 85.6 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.88 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -82.89 -21.4 4.83 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 C-N-CA 122.543 2.162 . . . . 0.0 112.576 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -80.66 129.16 34.36 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.568 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 57.6 ttm-85 -145.54 136.23 24.36 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.504 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.7 tpm_? -163.07 133.66 4.62 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.337 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.52 -179.95 51.47 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 49.7 t -89.74 114.56 26.26 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -136.65 26.39 3.04 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.22 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 36.0 m -62.28 -31.29 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.603 0.24 . . . . 0.0 111.413 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.5 mt 66.12 -1.26 1.2 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -67.37 -36.31 81.09 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.926 0.393 . . . . 0.0 110.684 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.35 49.29 0.01 OUTLIER Glycine 0 C--N 1.332 0.323 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 30.1 t -61.42 -47.56 85.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.98 -0.61 . . . . 0.0 111.011 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -159.5 119.98 3.11 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.574 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -63.54 -39.96 95.78 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.151 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 82.18 -78.66 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.746 0.818 . . . . 0.0 110.956 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.2 t -156.2 151.99 27.28 Favored 'General case' 0 C--N 1.346 0.424 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.29 148.27 17.66 Favored Glycine 0 CA--C 1.55 2.226 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.94 151.9 51.17 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 122.19 1.927 . . . . 0.0 112.2 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -130.95 70.43 82.61 Favored Pre-proline 0 CA--C 1.562 1.412 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.708 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.18 -24.52 32.24 Favored 'Trans proline' 0 N--CA 1.507 2.305 0 C-N-CA 122.237 1.958 . . . . 0.0 112.423 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.7 m . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.058 -0.972 . . . . 0.0 111.093 -178.984 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.87 126.16 48.09 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.879 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.0 m -130.86 142.49 50.38 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.752 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.6 m -135.02 159.85 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.545 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.8 tpt85 -71.62 151.62 43.58 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.324 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -150.64 104.91 3.24 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.8 mp -119.38 118.67 58.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.587 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.3 m -131.26 128.05 39.07 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 123.318 0.386 . . . . 0.0 111.18 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -137.45 152.98 74.12 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.994 176.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.77 -17.99 32.59 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 122.298 1.999 . . . . 0.0 112.86 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 59.24 86.46 0.09 Allowed 'General case' 0 C--N 1.346 0.453 0 CA-C-O 120.868 0.366 . . . . 0.0 110.084 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 73.1 mt -84.83 96.01 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.61 -176.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 48.05 35.94 5.78 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.277 177.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -67.13 145.86 54.86 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.888 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.66 158.29 31.46 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -62.62 -43.24 99.31 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.539 0.209 . . . . 0.0 111.118 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -133.39 147.06 51.75 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.073 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.33 152.0 29.73 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.011 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.5 t -122.67 129.34 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.884 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -99.27 145.7 27.0 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.693 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.1 m -65.65 155.21 36.62 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.242 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -70.48 139.03 51.6 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.048 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.93 -26.19 63.09 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.906 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.17 -29.15 15.28 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.796 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -128.0 54.29 12.88 Favored Pre-proline 0 CA--C 1.559 1.319 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.164 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.4 -28.1 18.45 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.965 1.777 . . . . 0.0 111.954 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 42.9 p-10 -81.53 -17.51 48.25 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.822 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.0 p -124.06 17.88 9.23 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 123.111 0.257 . . . . 0.0 111.406 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 21.4 p -66.47 158.16 30.23 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.573 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? 66.27 -170.2 0.2 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.973 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -117.69 150.33 39.25 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.018 0.437 . . . . 0.0 110.804 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt 68.08 179.27 0.23 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.461 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -156.91 168.27 27.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 123.533 0.52 . . . . 0.0 111.197 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.42 169.59 9.81 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.849 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -66.33 152.26 94.66 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.528 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.77 -20.83 17.05 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.419 2.079 . . . . 0.0 112.668 -177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -105.66 -102.27 0.33 Allowed 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.728 -175.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -179.19 161.98 1.16 Allowed 'General case' 0 C--N 1.359 1.02 0 CA-C-N 118.054 0.388 . . . . 0.0 110.087 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -113.45 124.36 52.24 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 176.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.21 151.19 50.92 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.364 -0.446 . . . . 0.0 111.994 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.4 p -75.64 159.36 31.26 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.423 -0.388 . . . . 0.0 111.184 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.59 6.85 1.26 Allowed Glycine 0 CA--C 1.54 1.649 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.639 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.0 m -66.26 -32.02 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 117.054 0.427 . . . . 0.0 110.96 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.0 mt 62.79 4.13 1.36 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -66.2 -36.77 83.94 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.869 0.366 . . . . 0.0 110.678 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 169.66 73.7 0.04 OUTLIER Glycine 0 C--N 1.33 0.24 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.5 t -117.61 118.95 33.53 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.67 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -134.4 -59.73 0.81 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.999 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -143.7 127.47 17.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.144 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.8 mp0 -66.6 -45.68 78.39 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.014 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.5 p -141.79 151.54 42.92 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.58 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 154.86 -173.07 33.26 Favored Glycine 0 CA--C 1.54 1.617 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.05 161.85 42.36 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.025 1.816 . . . . 0.0 111.29 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -126.04 72.96 71.05 Favored Pre-proline 0 CA--C 1.559 1.311 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.305 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -69.94 -24.28 29.01 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.279 1.986 . . . . 0.0 112.196 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.1 m . . . . . 0 C--O 1.219 -0.526 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.869 -179.019 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 . . . . . 0 N--CA 1.497 1.884 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.5 -73.15 0.33 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.278 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.8 t -158.78 147.13 18.3 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-O 120.549 0.214 . . . . 0.0 111.285 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.1 p -140.43 136.62 36.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.404 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -87.6 140.57 29.39 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.259 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -147.4 131.53 17.34 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.6 tt -134.67 141.87 42.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.2 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.3 t -148.26 151.77 36.01 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.05 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -70.73 149.91 95.27 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.983 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.18 148.26 43.89 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 122.169 1.913 . . . . 0.0 112.082 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -118.81 -28.22 5.64 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.384 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 72.6 mt 60.73 -100.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.473 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.322 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -102.06 5.57 40.6 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 90.9 mtt-85 -71.61 140.89 49.95 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.504 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.37 75.81 0.31 Allowed Glycine 0 C--N 1.342 0.868 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -67.56 149.67 49.82 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.476 0.179 . . . . 0.0 110.664 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -149.08 160.97 42.86 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.242 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -99.54 16.42 23.37 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.3 t -109.6 121.34 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -80.81 167.32 20.07 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.305 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 45.8 m -74.94 165.07 25.84 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.972 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -72.98 139.48 46.72 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.229 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -70.22 -26.89 64.08 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.91 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.13 -29.16 15.29 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.878 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -127.54 53.86 11.39 Favored Pre-proline 0 CA--C 1.556 1.205 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.982 177.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.82 -28.29 16.9 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.937 1.758 . . . . 0.0 111.919 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -80.67 -17.72 50.24 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.738 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.4 m -131.65 28.88 4.56 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.814 0.34 . . . . 0.0 110.869 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 24.8 p -67.48 150.69 48.54 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.316 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt 59.07 179.59 0.08 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.916 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -138.58 158.44 44.24 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.812 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -130.72 151.66 50.92 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.531 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.1 pm0 -148.72 167.57 25.19 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.226 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.25 138.58 56.21 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.882 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -73.69 155.12 89.29 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.057 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -72.09 -23.88 21.01 Favored 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 122.224 1.949 . . . . 0.0 111.834 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -90.06 125.09 35.29 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.738 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -94.77 -73.05 0.59 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.688 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.4 ttp-105 -172.84 142.16 1.1 Allowed 'General case' 0 C--N 1.349 0.559 0 O-C-N 123.098 0.248 . . . . 0.0 110.915 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -110.76 157.95 14.68 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 15.0 p -68.7 152.8 44.85 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.685 0.279 . . . . 0.0 111.007 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.52 11.96 54.15 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.032 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.56 -32.44 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.7 mt 64.39 7.01 3.34 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.244 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -66.1 -36.31 82.84 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-O 120.808 0.337 . . . . 0.0 111.1 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.52 -37.28 0.25 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 54.5 41.94 31.65 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 121.063 0.459 . . . . 0.0 110.823 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -85.6 102.97 14.01 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.531 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -100.53 109.83 21.96 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.214 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -168.5 155.6 7.61 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.847 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 t -155.61 152.72 29.08 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.394 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -173.59 166.37 38.65 Favored Glycine 0 CA--C 1.544 1.864 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.65 144.49 44.51 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 121.856 1.704 . . . . 0.0 112.007 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.95 55.21 2.33 Favored Pre-proline 0 CA--C 1.558 1.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.653 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.37 -24.81 42.74 Favored 'Trans proline' 0 N--CA 1.506 2.256 0 C-N-CA 122.287 1.991 . . . . 0.0 112.258 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 C--O 1.218 -0.554 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.895 -179.215 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.03 128.39 54.62 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.835 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.2 t -172.54 -43.73 0.02 OUTLIER 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.948 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.1 p -137.49 149.66 25.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.726 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.4 mmm-85 -64.12 144.84 56.81 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.595 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -157.87 93.34 1.25 Allowed 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.6 pt -133.64 155.65 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.098 -177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 67.0 p -118.67 20.88 12.78 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.615 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 63.04 155.19 0.12 Allowed Pre-proline 0 CA--C 1.544 0.74 0 CA-C-O 119.412 -0.327 . . . . 0.0 110.16 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.74 -61.88 0.22 Allowed 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.806 1.671 . . . . 0.0 112.232 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 47.65 90.71 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.79 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 43.9 pt -97.01 -174.99 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.556 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 59.3 p30 -94.25 61.14 2.82 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 121.538 0.685 . . . . 0.0 110.89 -178.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -61.14 -43.02 99.53 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.123 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.31 -172.72 31.51 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -98.65 -93.89 0.24 Allowed 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -176.43 -98.42 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 122.469 0.308 . . . . 0.0 110.679 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -164.86 149.16 9.09 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.66 159.1 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 120.884 0.373 . . . . 0.0 111.65 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -131.74 150.22 52.22 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.971 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.1 m -72.51 136.24 45.86 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 123.324 0.39 . . . . 0.0 110.36 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -70.3 132.77 46.2 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.56 -22.25 64.5 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 123.2 0.313 . . . . 0.0 111.058 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.2 -27.58 14.1 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.599 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -128.88 54.81 15.17 Favored Pre-proline 0 CA--C 1.557 1.22 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.375 178.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -70.82 -23.38 26.03 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.881 1.721 . . . . 0.0 111.637 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -61.5 -36.66 81.12 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.171 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.9 p -88.74 -0.03 56.92 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.047 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 53.8 t -61.1 131.49 50.72 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.672 0.272 . . . . 0.0 110.748 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 150.12 25.17 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.621 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -129.96 154.45 47.35 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.659 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -130.46 151.23 51.17 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.745 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.0 pm0 -152.54 162.27 41.44 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.491 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.81 156.44 41.82 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.447 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -70.68 152.52 95.23 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.079 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -80.25 -22.05 7.33 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.46 2.107 . . . . 0.0 112.629 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -63.68 129.04 38.49 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.309 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -150.53 140.58 22.05 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.511 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -136.17 -26.24 1.16 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.117 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.74 150.92 49.62 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.7 p -69.11 155.7 39.92 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.725 0.298 . . . . 0.0 111.271 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -122.2 16.67 8.64 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.246 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.1 m -61.54 -34.38 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 116.823 0.312 . . . . 0.0 111.356 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.7 mt 67.98 -6.08 0.77 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -64.96 -35.85 82.48 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.025 0.44 . . . . 0.0 110.763 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.28 -24.16 0.68 Allowed Glycine 0 CA--C 1.535 1.288 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.034 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 58.7 70.5 0.65 Allowed 'General case' 0 C--O 1.243 0.714 0 CA-C-O 121.332 0.587 . . . . 0.0 110.953 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 63.3 t-80 -155.25 139.6 16.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.678 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -69.64 134.39 48.67 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.176 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -127.29 153.77 45.74 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.782 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.9 t -155.8 -30.38 0.1 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.917 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.72 56.72 1.71 Allowed Glycine 0 CA--C 1.54 1.641 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.32 146.54 63.21 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 122.019 1.813 . . . . 0.0 111.551 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -149.05 82.27 7.17 Favored Pre-proline 0 CA--C 1.554 1.114 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.311 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.06 -29.09 56.96 Favored 'Trans proline' 0 N--CA 1.505 2.149 0 C-N-CA 122.005 1.803 . . . . 0.0 111.518 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 CA--C 1.541 0.62 0 CA-C-O 117.841 -1.076 . . . . 0.0 112.167 179.663 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.6 152.1 37.36 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.688 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.3 m -120.13 150.54 40.46 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.764 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.1 p -133.36 138.23 51.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.008 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -69.41 133.86 48.28 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.932 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -141.56 101.04 3.9 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.287 0.367 . . . . 0.0 110.045 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 81.1 mt -123.01 129.5 75.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.314 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.9 m -102.0 126.03 48.83 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -71.67 152.44 93.55 Favored Pre-proline 0 CA--C 1.556 1.203 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.223 -176.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -81.29 164.77 19.19 Favored 'Trans proline' 0 N--CA 1.502 1.992 0 C-N-CA 122.592 2.195 . . . . 0.0 112.56 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -137.29 144.37 42.62 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.35 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -98.67 -158.73 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.2 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -93.57 10.22 33.51 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -60.6 140.62 57.33 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.832 0.348 . . . . 0.0 111.025 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.89 149.19 19.67 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -99.73 120.35 39.58 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.723 0.297 . . . . 0.0 110.989 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -68.82 145.41 53.76 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.941 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.4 140.74 38.85 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.375 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.3 m -90.1 15.33 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -60.12 137.1 58.17 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 74.6 m -87.71 147.15 25.35 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.995 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -73.28 133.41 43.91 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.024 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -70.64 -23.76 62.59 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.059 0.224 . . . . 0.0 110.714 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.62 -28.29 15.45 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.708 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -130.54 53.58 12.17 Favored Pre-proline 0 CA--C 1.559 1.308 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.501 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -73.87 -20.38 19.78 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.016 1.811 . . . . 0.0 111.809 178.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -73.8 -15.84 61.17 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.289 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.7 t -108.1 4.6 25.14 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 111.606 0.225 . . . . 0.0 111.606 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 46.6 t -61.84 137.17 58.22 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.73 128.49 36.69 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.413 -176.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp 55.08 173.45 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.366 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -138.78 -47.48 0.5 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.434 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -74.96 165.88 24.55 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.942 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.95 142.63 24.59 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.188 178.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -74.49 149.69 86.54 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.823 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.77 -21.62 8.28 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.261 1.974 . . . . 0.0 112.226 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -67.29 128.89 38.11 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.064 -178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 68.4 ttp85 -161.26 147.1 14.24 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.934 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -131.9 134.23 45.46 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.445 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.03 174.75 54.84 Favored Glycine 0 CA--C 1.518 0.219 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.118 -177.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 48.0 t -76.37 121.07 22.49 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 114.896 -0.652 . . . . 0.0 111.224 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -134.79 42.23 1.37 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.9 t -61.91 -42.06 93.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.3 mt 77.17 -12.96 1.0 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.03 0.932 . . . . 0.0 112.083 -177.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -65.92 -36.86 84.54 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.943 0.401 . . . . 0.0 111.382 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.6 38.48 0.02 OUTLIER Glycine 0 N--CA 1.464 0.504 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 37.3 t -63.26 -41.86 99.09 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.302 0.641 . . . . 0.0 111.382 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -59.66 -42.32 92.58 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.563 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 64.88 82.29 0.19 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.0 0.429 . . . . 0.0 110.935 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -89.66 -53.66 4.42 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.909 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.2 p 50.35 92.8 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.519 -177.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.57 139.25 12.02 Favored Glycine 0 CA--C 1.543 1.798 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.07 156.96 51.48 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.749 1.633 . . . . 0.0 111.761 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -129.69 70.55 82.0 Favored Pre-proline 0 CA--C 1.56 1.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.773 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.82 -20.22 39.79 Favored 'Trans proline' 0 N--CA 1.505 2.182 0 C-N-CA 122.279 1.986 . . . . 0.0 112.165 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.6 t . . . . . 0 CA--C 1.537 0.463 0 CA-C-O 118.022 -0.99 . . . . 0.0 111.594 -178.884 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 121.36 0.6 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.83 -17.4 64.0 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.932 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.7 m -59.98 -39.6 86.22 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.251 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.6 m 42.24 62.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-O 121.401 0.619 . . . . 0.0 111.568 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -61.89 130.09 44.02 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.327 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -73.2 -29.82 63.08 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.956 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.4 mm -74.87 113.92 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.533 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 76.5 m -132.51 130.23 40.16 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.882 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -94.01 149.22 36.56 Favored Pre-proline 0 CA--C 1.555 1.143 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.452 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.27 160.3 36.05 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.423 2.082 . . . . 0.0 112.178 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.73 134.61 49.61 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.952 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 47.1 mm -120.17 140.18 45.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.2 p30 -63.62 77.58 0.03 OUTLIER 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.557 0.694 . . . . 0.0 110.45 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.7 mmp_? -61.49 -43.49 98.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.045 -177.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.2 173.0 40.95 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.457 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -109.02 108.07 18.65 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.791 -0.205 . . . . 0.0 110.506 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -79.42 66.41 4.87 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.475 0.655 . . . . 0.0 110.489 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -158.49 157.2 31.68 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.88 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.7 t -117.91 126.31 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.724 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -71.11 169.48 14.94 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.522 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 73.9 m -93.96 137.29 33.33 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.138 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -66.58 131.5 46.14 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.89 -23.54 66.01 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.863 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.88 -27.95 14.05 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.658 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -127.92 54.7 13.81 Favored Pre-proline 0 CA--C 1.558 1.27 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.079 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -69.83 -25.23 28.5 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.868 1.712 . . . . 0.0 111.595 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -63.09 -37.57 87.72 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.618 177.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 85.9 m -67.57 -38.57 84.3 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.669 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 53.6 t -49.09 139.08 11.12 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.706 -177.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm -64.86 148.34 51.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.683 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -129.92 155.1 46.6 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.18 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -129.58 149.49 51.32 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.333 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -153.05 -41.51 0.1 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.007 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 64.03 173.34 0.18 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.142 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -71.38 154.75 93.44 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.777 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -89.52 -68.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.441 2.094 . . . . 0.0 111.048 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 51.0 t80 34.78 93.78 0.01 OUTLIER 'General case' 0 C--N 1.353 0.734 0 C-N-CA 123.25 0.62 . . . . 0.0 112.66 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 64.18 162.73 0.12 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.452 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.15 -39.73 1.89 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.495 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -132.45 157.36 22.5 Favored Glycine 0 C--N 1.338 0.653 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 21.6 p -68.79 149.09 49.39 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.116 0.484 . . . . 0.0 111.286 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.89 18.78 0.35 Allowed Glycine 0 CA--C 1.536 1.359 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.098 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.19 -38.77 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.1 mt 69.09 23.37 6.52 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.231 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -102.96 -35.18 8.67 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.396 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.26 78.64 0.06 OUTLIER Glycine 0 C--N 1.334 0.421 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.1 t -136.03 122.31 20.47 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -133.53 148.94 51.69 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.438 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -117.59 123.64 46.7 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.178 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -159.87 164.99 33.12 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.569 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 63.2 p -67.96 -35.4 78.31 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.101 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 169.54 177.69 40.25 Favored Glycine 0 CA--C 1.543 1.827 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.31 149.16 50.54 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.011 1.808 . . . . 0.0 112.151 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -136.32 80.37 40.17 Favored Pre-proline 0 CA--C 1.557 1.234 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.715 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.04 -24.88 44.68 Favored 'Trans proline' 0 N--CA 1.506 2.253 0 C-N-CA 122.188 1.925 . . . . 0.0 112.062 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 117.89 -1.052 . . . . 0.0 110.92 -179.31 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.03 142.26 57.88 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.816 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 t 59.15 62.97 1.7 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.538 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.25 157.94 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.97 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -97.98 118.9 35.59 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.307 178.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -116.78 -36.56 3.85 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.71 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.1 mp -102.57 121.23 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.982 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 70.7 m -106.95 103.72 13.22 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.194 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -171.96 136.26 0.91 Allowed Pre-proline 0 CA--C 1.557 1.242 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.485 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -74.28 150.79 42.49 Favored 'Trans proline' 0 N--CA 1.503 2.067 0 C-N-CA 122.059 1.839 . . . . 0.0 111.916 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.16 94.39 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.627 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 73.9 mt -127.17 162.74 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 57.2 p30 -58.78 -20.58 51.04 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 122.986 0.179 . . . . 0.0 111.467 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 42.63 -167.28 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 122.473 0.309 . . . . 0.0 111.757 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.01 -175.51 54.79 Favored Glycine 0 C--N 1.35 1.33 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -100.16 120.23 39.56 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.678 0.275 . . . . 0.0 110.629 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -65.28 -39.96 93.25 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.072 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.48 144.14 53.31 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.94 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.54 138.27 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.502 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.5 p-80 -134.25 162.6 31.72 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.707 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 96.9 m -72.31 159.9 33.28 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.802 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -61.67 136.68 58.1 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.197 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -69.82 -23.37 63.3 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.601 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.64 -29.12 14.01 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.752 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -128.51 53.8 12.09 Favored Pre-proline 0 CA--C 1.56 1.358 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.208 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.69 -21.86 24.77 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.054 1.836 . . . . 0.0 112.942 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -85.95 -10.3 55.41 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 t -131.6 19.53 4.71 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 30.5 p -62.75 152.14 36.58 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -119.32 -47.06 2.47 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -176.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? 61.18 176.84 0.11 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.669 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -138.49 149.96 45.93 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 123.208 0.317 . . . . 0.0 111.042 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 pm0 -159.21 167.72 28.34 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.16 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 59.64 166.9 0.07 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.556 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -71.67 153.23 93.47 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.665 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.14 -27.9 13.31 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.116 1.877 . . . . 0.0 111.874 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -76.42 135.1 39.43 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.536 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.0 ttt-85 -132.35 142.77 49.46 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.617 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 42.4 ttm105 -139.82 134.39 31.68 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.979 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -107.14 140.59 15.36 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 48.8 t -88.7 114.63 25.53 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -134.76 18.72 4.04 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.702 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.8 m -64.43 -34.66 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.958 0.379 . . . . 0.0 110.959 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 70.0 mt 63.28 2.22 1.09 Allowed 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.377 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -69.08 -36.48 77.66 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-O 121.053 0.454 . . . . 0.0 111.134 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.64 49.47 0.02 OUTLIER Glycine 0 C--O 1.234 0.109 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 18.3 t -60.87 -45.04 96.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.747 -0.726 . . . . 0.0 110.73 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -159.96 40.99 0.19 Allowed 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.434 0.635 . . . . 0.0 110.162 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 75.34 -48.12 0.61 Allowed 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.509 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 80.61 -87.57 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.3 0.64 . . . . 0.0 111.217 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.7 m -163.19 -50.09 0.04 OUTLIER 'General case' 0 C--N 1.346 0.444 0 CA-C-O 120.771 0.32 . . . . 0.0 110.62 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -172.97 171.85 44.71 Favored Glycine 0 CA--C 1.545 1.959 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.18 148.44 56.01 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.025 1.817 . . . . 0.0 112.49 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -140.37 82.39 16.55 Favored Pre-proline 0 CA--C 1.549 0.941 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.028 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -65.52 -16.57 54.47 Favored 'Trans proline' 0 N--CA 1.501 1.968 0 C-N-CA 121.977 1.785 . . . . 0.0 111.794 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.6 m . . . . . 0 C--N 1.349 0.564 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.997 -178.541 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.53 0.681 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.48 -37.64 84.38 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.212 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.0 m -58.9 -38.9 79.94 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.692 -177.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 64.9 t -111.52 126.49 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 121.03 0.443 . . . . 0.0 111.111 -178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -72.03 162.78 28.96 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.71 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -155.65 102.54 2.22 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.3 pt -139.75 170.22 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.53 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 t -108.99 156.9 19.19 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.146 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -68.07 159.09 81.74 Favored Pre-proline 0 CA--C 1.55 0.949 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.632 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.59 124.5 12.91 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.437 1.425 . . . . 0.0 110.942 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.28 -39.77 95.51 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.811 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 33.0 mm -69.78 -2.19 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.73 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.3 t0 61.82 49.21 4.92 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 122.082 0.944 . . . . 0.0 109.018 -177.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -66.2 142.54 57.68 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.694 -177.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.96 165.96 39.15 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 57.16 39.8 28.66 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 120.856 0.36 . . . . 0.0 111.47 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -108.02 116.9 32.8 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.315 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.31 136.13 46.13 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.12 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.7 p -152.13 127.24 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.179 178.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -133.26 143.28 48.99 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.406 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.1 m -95.39 138.56 32.9 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.315 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -66.28 130.64 43.91 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 123.228 0.33 . . . . 0.0 110.111 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -66.31 -24.01 66.47 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.924 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.2 -27.68 14.43 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.761 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -127.48 53.92 11.49 Favored Pre-proline 0 CA--C 1.559 1.297 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.115 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -72.71 -22.48 20.51 Favored 'Trans proline' 0 N--CA 1.5 1.91 0 C-N-CA 122.143 1.896 . . . . 0.0 111.812 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 42.4 p-10 -74.67 -14.12 60.71 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.876 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 68.1 p -107.62 9.85 29.22 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.803 -0.18 . . . . 0.0 111.314 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 53.5 t -70.7 132.57 45.59 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 122.693 0.397 . . . . 0.0 110.545 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -131.0 152.14 50.64 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.309 -175.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -85.44 149.69 25.24 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.37 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -133.91 149.4 51.29 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.623 0.577 . . . . 0.0 111.568 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.0 pm0 -154.84 166.89 32.06 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.942 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.87 138.96 58.4 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.364 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -72.28 153.81 92.17 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.432 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.94 -25.47 11.96 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.365 2.043 . . . . 0.0 111.909 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -66.76 129.53 40.17 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.169 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -160.0 152.91 21.54 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.085 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -125.14 111.02 14.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -133.0 -173.34 13.26 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -178.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.4 p -70.78 152.98 43.19 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.587 0.232 . . . . 0.0 110.856 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -124.54 7.14 8.47 Favored Glycine 0 CA--C 1.54 1.62 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.438 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.1 m -65.72 -30.14 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 116.899 0.35 . . . . 0.0 111.262 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.4 mt 59.38 9.92 1.62 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.364 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.31 -36.17 83.22 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-O 120.9 0.381 . . . . 0.0 110.882 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.27 -34.31 0.2 Allowed Glycine 0 CA--C 1.531 1.058 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 47.24 22.95 0.28 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -149.17 120.74 7.99 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.128 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -170.5 17.12 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -147.93 -71.04 0.22 Allowed 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.0 t -161.93 160.71 28.19 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.313 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -147.69 148.03 19.23 Favored Glycine 0 CA--C 1.545 1.966 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -71.34 147.21 52.45 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 122.047 1.831 . . . . 0.0 112.188 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -136.33 60.39 32.42 Favored Pre-proline 0 CA--C 1.562 1.438 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.5 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -65.15 -22.29 61.59 Favored 'Trans proline' 0 N--CA 1.507 2.311 0 C-N-CA 122.029 1.819 . . . . 0.0 111.931 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.931 -179.179 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.54 152.9 38.76 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.52 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.3 p -70.2 157.48 37.56 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.978 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 81.1 t -65.52 -44.85 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.693 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -76.49 146.78 38.26 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.535 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -109.92 -29.12 8.41 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.846 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mp -123.26 125.8 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.773 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 m -112.83 35.93 3.68 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.931 0.396 . . . . 0.0 111.338 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 59.35 155.03 0.1 OUTLIER Pre-proline 0 CA--C 1.552 1.038 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.34 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.61 152.72 48.59 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 122.305 2.003 . . . . 0.0 112.016 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.88 146.94 26.65 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.674 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 42.0 mm -98.05 -53.21 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.24 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -143.18 -61.17 0.42 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.078 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 50.02 -86.35 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.406 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.99 -174.69 39.24 Favored Glycine 0 C--N 1.351 1.363 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -85.78 100.32 11.96 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.888 0.375 . . . . 0.0 110.793 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -157.39 165.05 36.79 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.635 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.66 154.51 36.52 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.421 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.8 p -136.02 150.5 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.585 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -120.18 152.9 37.01 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.203 0.525 . . . . 0.0 112.074 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.2 m -83.27 162.81 21.04 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.154 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -68.35 136.5 53.48 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.32 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.0 mttm -72.03 -25.4 61.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.142 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.39 -27.55 14.04 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.606 178.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -127.88 54.39 13.0 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.057 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -70.44 -30.57 18.92 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.838 1.692 . . . . 0.0 111.808 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -70.54 -29.34 65.79 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.385 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 63.9 p -116.17 20.96 14.03 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.798 -178.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 19.2 p -67.15 161.92 23.57 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.922 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm 55.01 85.69 0.06 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.188 178.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -121.45 -42.94 2.42 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.807 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.6 mmtt 66.09 35.22 6.36 Favored 'General case' 0 C--O 1.252 1.217 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.42 177.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -143.56 -44.38 0.28 Allowed 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.802 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 59.99 115.38 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.119 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -69.75 156.29 91.98 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.552 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -83.87 -23.77 3.02 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.605 2.204 . . . . 0.0 113.17 -177.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -60.48 -50.4 73.72 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.62 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 62.6 ttt-85 57.62 154.02 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.261 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -162.8 131.27 3.95 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.264 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.66 177.3 45.09 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 178.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 53.5 t -91.24 114.39 26.9 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.781 0.324 . . . . 0.0 110.561 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -141.07 38.23 1.57 Allowed Glycine 0 N--CA 1.466 0.671 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.1 t -63.43 -41.18 91.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 73.2 mt 77.93 -13.14 0.99 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.007 0.923 . . . . 0.0 112.103 -176.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -65.04 -36.84 85.65 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-O 120.826 0.346 . . . . 0.0 111.638 176.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.5 78.55 0.02 OUTLIER Glycine 0 C--O 1.237 0.302 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.5 t -90.23 83.74 6.02 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.163 0.506 . . . . 0.0 110.748 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -127.71 -41.64 1.66 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.439 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 63.2 140.03 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.855 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -67.78 -35.8 79.31 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.79 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 84.0 m -103.17 -67.37 0.89 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.203 -177.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.32 95.24 0.91 Allowed Glycine 0 CA--C 1.546 1.981 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -71.26 151.23 60.26 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.97 1.78 . . . . 0.0 112.081 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -142.5 61.4 11.41 Favored Pre-proline 0 CA--C 1.564 1.499 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.793 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -71.12 -23.17 25.05 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 122.211 1.941 . . . . 0.0 112.043 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.96 -1.019 . . . . 0.0 111.385 -178.549 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.29 75.3 0.35 Allowed 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.099 0.476 . . . . 0.0 110.967 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.6 m -94.26 137.91 32.87 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.977 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.6 p -64.9 -32.44 58.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.389 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.9 tpp180 -62.3 130.22 44.29 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.308 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -148.27 99.95 3.1 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.318 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.0 mm -125.41 125.87 69.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.653 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.2 t -150.0 153.08 35.93 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.956 0.407 . . . . 0.0 111.921 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -133.7 154.08 80.42 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.402 178.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.56 -29.87 70.67 Favored 'Trans proline' 0 N--CA 1.507 2.285 0 C-N-CA 122.081 1.854 . . . . 0.0 113.415 -175.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 48.48 63.43 2.08 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.262 0.553 . . . . 0.0 110.788 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 46.2 mm -61.04 -47.12 95.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.342 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -163.08 39.1 0.1 Allowed 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.154 0.502 . . . . 0.0 110.774 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 70.3 mtp85 -100.97 114.23 27.95 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.499 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -138.99 141.18 11.62 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -137.08 152.15 49.7 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.595 0.236 . . . . 0.0 111.006 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 -155.22 160.09 40.59 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.25 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -156.25 152.92 28.35 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.968 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.1 m -71.3 -18.37 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.775 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -65.63 148.46 51.71 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.698 0.285 . . . . 0.0 110.926 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 77.0 m -80.0 143.77 33.82 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.328 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -71.33 130.29 41.01 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -67.06 -23.65 65.9 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 123.129 0.268 . . . . 0.0 110.949 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.07 -28.55 14.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.762 178.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -128.31 54.81 14.53 Favored Pre-proline 0 CA--C 1.555 1.17 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.3 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.19 -23.24 29.07 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.675 1.584 . . . . 0.0 111.338 177.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -63.35 -35.98 82.2 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.166 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.3 p -85.0 -7.68 59.04 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.601 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 52.4 t -61.61 132.5 53.51 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 123.136 0.272 . . . . 0.0 110.552 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -128.11 151.9 48.65 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.967 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -126.8 153.08 46.07 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.326 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -129.79 151.11 50.72 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.972 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -153.81 171.49 18.84 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.158 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.5 29.02 5.36 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.495 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 61.11 154.46 0.11 Allowed Pre-proline 0 CA--C 1.546 0.795 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.0 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.98 -24.34 15.23 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.376 2.051 . . . . 0.0 112.01 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -63.05 131.7 49.47 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.0 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -136.43 138.23 41.28 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.709 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 73.3 ttt-85 -156.07 140.67 16.92 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.9 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -127.98 162.64 21.78 Favored Glycine 0 N--CA 1.467 0.76 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 53.8 t -90.21 114.36 26.34 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.1 20.44 3.02 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.165 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.8 m -65.22 -32.57 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.777 0.322 . . . . 0.0 111.309 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.4 mt 64.37 2.28 1.5 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -66.59 -36.7 83.25 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.012 0.434 . . . . 0.0 110.84 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.14 55.94 0.02 OUTLIER Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.3 t -75.33 125.2 28.5 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.238 -0.481 . . . . 0.0 110.272 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -155.29 142.47 19.33 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.875 0.369 . . . . 0.0 111.537 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -63.58 -39.32 94.08 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.691 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -103.15 152.17 21.75 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 120.809 0.337 . . . . 0.0 110.685 -176.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.1 m -64.52 -43.8 92.89 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.49 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -164.85 163.67 36.51 Favored Glycine 0 CA--C 1.543 1.811 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -73.01 -30.32 10.99 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 C-N-CA 122.223 1.949 . . . . 0.0 112.588 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -130.62 67.51 80.48 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.989 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -61.56 -20.7 69.71 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 122.599 2.199 . . . . 0.0 111.657 175.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.4 m . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 117.952 -1.023 . . . . 0.0 111.27 -178.629 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.69 140.01 58.69 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.147 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.8 p -70.6 154.4 41.9 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.101 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.1 p -176.9 117.27 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.907 178.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 72.0 mtp85 -139.84 151.25 45.55 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.296 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -132.01 148.89 52.53 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.603 178.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.7 tt -134.28 145.47 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 123.233 0.333 . . . . 0.0 111.416 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.8 p -128.49 160.41 32.4 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.152 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -69.21 148.67 97.55 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.863 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.24 -31.98 21.71 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 122.087 1.858 . . . . 0.0 112.926 -178.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 54.88 82.1 0.1 Allowed 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.095 0.474 . . . . 0.0 110.282 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -121.44 41.21 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.261 -178.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.9 t0 77.69 -14.44 0.85 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.267 -175.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 51.64 31.3 7.65 Favored 'General case' 0 C--N 1.352 0.693 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 174.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.93 -170.78 41.67 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -88.87 104.07 16.59 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -98.44 133.9 42.18 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.628 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.0 137.49 58.23 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.923 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.8 t -126.44 128.01 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.64 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 68.0 m170 -108.92 130.03 55.43 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.061 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.8 m -72.28 156.26 39.3 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.814 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -66.9 131.58 46.19 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.086 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.03 -23.58 65.91 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.948 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.05 -28.63 14.06 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.733 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -128.01 54.76 14.07 Favored Pre-proline 0 CA--C 1.556 1.2 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.149 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.26 -26.01 25.68 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.897 1.731 . . . . 0.0 112.011 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -70.83 -27.42 63.85 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.137 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.7 p -113.1 12.65 19.19 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -175.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 21.9 p -68.19 149.43 49.55 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 121.014 -0.274 . . . . 0.0 110.942 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -142.19 -68.99 0.36 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.841 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -139.94 155.13 47.3 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.804 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -129.28 149.58 51.02 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.453 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -151.5 170.7 18.98 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.165 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.11 175.93 7.85 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.618 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -64.19 152.52 87.98 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.052 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -79.41 -19.88 9.99 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.599 2.199 . . . . 0.0 112.528 -177.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -59.28 -50.13 75.17 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.199 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -62.7 -48.16 80.46 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -172.08 142.05 1.38 Allowed 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.436 -178.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -107.77 141.62 15.73 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 5.7 p -76.14 155.03 35.0 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.856 0.36 . . . . 0.0 111.638 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -145.37 13.09 1.82 Allowed Glycine 0 CA--C 1.541 1.667 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.22 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.6 m -62.59 -27.2 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 116.794 0.297 . . . . 0.0 111.174 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.5 mt 70.06 -4.74 1.44 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.51 0.724 . . . . 0.0 112.823 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -66.19 -36.75 83.89 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.008 0.432 . . . . 0.0 110.539 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -167.66 53.3 0.23 Allowed Glycine 0 C--N 1.332 0.357 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.5 t -132.78 118.24 18.77 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.164 -0.518 . . . . 0.0 111.065 -177.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -160.69 97.86 1.2 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.606 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 67.1 ttt-85 -166.85 142.26 4.27 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.29 178.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -149.27 159.88 43.88 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.813 0.34 . . . . 0.0 111.744 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 t -152.94 150.68 29.51 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.45 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -141.64 64.45 0.51 Allowed Glycine 0 CA--C 1.545 1.925 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -70.54 153.54 65.27 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 122.256 1.97 . . . . 0.0 111.741 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -131.49 83.93 57.28 Favored Pre-proline 0 CA--C 1.554 1.111 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.708 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.62 -22.35 38.09 Favored 'Trans proline' 0 N--CA 1.503 2.047 0 C-N-CA 122.097 1.865 . . . . 0.0 111.947 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.4 m . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.992 -1.004 . . . . 0.0 111.009 -179.101 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.76 142.55 58.12 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.875 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.4 m -64.19 139.52 58.77 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.86 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.97 128.56 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.94 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -105.36 108.22 19.62 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.933 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -175.59 79.88 0.02 OUTLIER 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.383 178.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 mp -124.43 122.15 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.402 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.5 p -134.46 160.04 39.23 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.856 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -62.55 135.37 95.5 Favored Pre-proline 0 CA--C 1.557 1.214 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.46 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -70.7 153.8 64.41 Favored 'Trans proline' 0 N--CA 1.505 2.154 0 C-N-CA 122.174 1.916 . . . . 0.0 112.656 -178.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -114.03 138.4 50.43 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.429 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.6 mt -61.43 -47.21 94.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.106 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.0 p-10 -176.91 -36.34 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.122 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 48.74 -176.13 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.615 179.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.1 158.93 34.58 Favored Glycine 0 C--N 1.344 1.012 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -103.18 138.75 39.57 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.801 -0.2 . . . . 0.0 110.558 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -63.24 -40.68 98.12 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.818 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.32 142.0 50.45 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.854 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.0 p -142.32 145.21 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.16 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -115.94 134.36 55.05 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.205 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 99.0 m -75.59 156.37 35.03 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.075 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -67.64 134.14 50.62 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.268 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -69.07 -23.86 64.09 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.116 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.99 -27.55 14.19 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.672 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -128.5 55.14 15.95 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.895 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -69.91 -27.7 25.44 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.912 1.741 . . . . 0.0 111.951 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -70.67 -27.66 64.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.964 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 75.7 p -115.62 16.43 16.49 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 23.7 p -64.61 159.64 21.44 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.448 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -117.97 138.66 52.02 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.904 -178.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -87.52 -42.0 13.08 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.638 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -139.52 148.07 42.12 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.49 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -159.46 176.2 12.38 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.873 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -113.26 130.41 56.25 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.399 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.4 p30 -72.85 158.16 87.65 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.718 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.67 -19.77 7.18 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.464 2.109 . . . . 0.0 112.743 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -89.34 119.52 29.88 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.314 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -137.09 141.96 42.34 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.788 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 68.9 ttp85 -130.18 -44.71 1.14 Allowed 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.715 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.46 150.81 47.4 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.2 p -74.97 153.43 38.55 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.801 0.334 . . . . 0.0 111.081 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -145.87 4.12 1.18 Allowed Glycine 0 CA--C 1.541 1.702 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.429 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.2 m -64.8 -28.92 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 116.934 0.367 . . . . 0.0 111.279 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.8 mt 58.7 12.6 2.26 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.098 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -64.02 -36.6 84.53 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-O 120.98 0.419 . . . . 0.0 110.321 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.5 43.12 0.02 OUTLIER Glycine 0 C--N 1.333 0.399 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.8 t -62.74 -61.56 2.33 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.429 -0.386 . . . . 0.0 110.339 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 50.37 176.75 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.908 176.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -63.47 -45.2 91.9 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 177.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 173.18 86.8 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.658 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.5 m 62.86 104.49 0.03 OUTLIER 'General case' 0 C--N 1.344 0.365 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.061 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -122.5 140.74 13.6 Favored Glycine 0 CA--C 1.541 1.684 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.06 157.59 46.53 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.762 1.642 . . . . 0.0 112.143 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -130.78 81.25 67.88 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.612 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.35 -13.49 40.09 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 122.224 1.949 . . . . 0.0 111.977 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 C--N 1.35 0.603 0 CA-C-O 117.921 -1.037 . . . . 0.0 111.358 -178.401 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.79 146.15 55.23 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.868 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.1 t 59.63 109.0 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.927 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.2 m -129.09 157.75 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.145 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -76.08 159.55 30.66 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.058 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -126.61 129.76 49.16 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.5 tt -114.74 130.02 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.657 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 73.3 p -79.84 163.7 24.19 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.953 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -132.09 155.81 80.88 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.529 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.6 148.8 66.88 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 121.933 1.755 . . . . 0.0 111.996 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -154.06 156.46 37.35 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.853 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 77.4 mt -86.01 -66.81 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.529 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -127.88 17.07 6.81 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.6 mtt85 -62.24 -38.45 89.27 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.389 0.138 . . . . 0.0 111.363 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.02 20.16 37.97 Favored Glycine 0 N--CA 1.475 1.281 0 CA-C-N 116.361 -0.382 . . . . 0.0 112.614 -178.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 53.79 -178.96 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 122.321 0.248 . . . . 0.0 111.213 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -158.42 165.97 33.36 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.382 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.0 144.1 48.53 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.202 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.3 t -84.73 -70.93 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.712 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -133.83 112.84 11.65 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.208 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.6 m -95.61 157.58 15.83 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.375 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -66.83 138.56 57.43 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 123.256 0.348 . . . . 0.0 110.869 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -73.87 -24.35 59.72 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.736 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.44 -27.01 14.26 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.586 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -129.06 54.31 13.92 Favored Pre-proline 0 CA--C 1.556 1.193 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.154 177.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.42 -30.61 18.94 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.834 1.69 . . . . 0.0 111.694 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -71.11 -28.74 64.52 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.362 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.3 p -117.38 20.2 13.71 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.706 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 19.4 p -62.78 161.26 12.84 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.814 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt 63.72 143.61 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.513 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -135.2 154.53 51.57 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.15 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -129.93 152.05 49.82 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.733 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -148.01 163.93 35.35 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.074 0.464 . . . . 0.0 111.88 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 65.02 -79.39 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.456 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.28 140.92 0.04 OUTLIER Pre-proline 0 CA--C 1.565 1.543 0 C-N-CA 122.918 0.487 . . . . 0.0 112.299 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -79.52 -21.52 8.69 Favored 'Trans proline' 0 N--CA 1.5 1.892 0 C-N-CA 122.245 1.963 . . . . 0.0 112.196 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -60.17 -49.69 76.61 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.103 -178.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 58.7 ttt85 -162.49 140.64 8.62 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.223 0.327 . . . . 0.0 111.178 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.5 ttp-105 -145.32 -10.95 0.55 Allowed 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.289 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -164.33 169.69 39.24 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 25.3 p -78.89 159.91 27.54 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.839 0.352 . . . . 0.0 111.646 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -141.03 14.19 2.83 Favored Glycine 0 CA--C 1.544 1.86 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.139 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.4 m -65.08 -32.58 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 116.809 0.304 . . . . 0.0 111.423 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.5 mt 64.12 2.71 1.51 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -65.27 -36.51 84.32 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.002 0.43 . . . . 0.0 110.562 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.62 -58.5 0.07 OUTLIER Glycine 0 C--N 1.332 0.338 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.9 t 45.39 94.15 0.01 OUTLIER 'General case' 0 C--O 1.239 0.503 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -98.23 114.21 26.39 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.377 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 70.2 ttp85 -138.32 131.69 30.44 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.834 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -129.77 153.69 47.96 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.928 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 t -151.94 150.46 30.06 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 123.34 0.4 . . . . 0.0 111.684 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.75 57.27 0.05 OUTLIER Glycine 0 CA--C 1.545 1.936 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.66 155.46 66.2 Favored 'Trans proline' 0 N--CA 1.504 2.142 0 C-N-CA 122.438 2.092 . . . . 0.0 112.09 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -129.5 69.8 81.53 Favored Pre-proline 0 CA--C 1.561 1.381 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.538 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.21 -22.46 40.42 Favored 'Trans proline' 0 N--CA 1.505 2.179 0 C-N-CA 122.172 1.915 . . . . 0.0 112.001 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.973 -1.013 . . . . 0.0 111.665 -179.178 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.66 146.53 54.69 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.11 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.7 m -66.04 158.19 29.01 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.458 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.8 m 55.73 141.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.476 1.11 . . . . 0.0 112.285 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -59.96 -50.2 74.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.147 -175.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.1 t80 178.37 85.04 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.84 0.352 . . . . 0.0 110.42 178.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.4 pt -138.0 135.02 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.157 0.503 . . . . 0.0 111.524 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 28.8 m -149.89 136.86 19.49 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.006 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -110.96 144.0 29.46 Favored Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.993 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.53 157.72 22.08 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.407 2.071 . . . . 0.0 112.217 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.65 79.41 1.35 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.087 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.9 pp -44.62 -15.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -176.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -65.9 -4.86 7.62 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 121.23 -0.188 . . . . 0.0 110.978 175.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -33.33 128.63 0.3 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.027 0.931 . . . . 0.0 111.779 -178.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.08 -168.16 53.8 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -141.24 89.93 2.27 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 120.918 0.39 . . . . 0.0 110.425 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -82.0 -11.45 58.83 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.94 115.27 23.44 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.741 0.305 . . . . 0.0 111.11 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.0 p -152.07 136.89 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.834 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -86.58 152.44 22.61 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.502 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 82.1 m -67.65 139.34 56.8 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.036 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -69.06 132.83 47.25 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.92 -22.92 64.12 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 123.182 0.301 . . . . 0.0 110.969 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.94 -28.68 14.08 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.636 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -128.58 54.93 15.15 Favored Pre-proline 0 CA--C 1.557 1.247 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.326 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.85 -23.3 25.98 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 121.825 1.684 . . . . 0.0 111.432 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -63.23 -36.35 83.35 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.964 178.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.1 p -91.22 4.49 52.15 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.918 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.7 t -57.32 142.83 42.01 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.074 0.464 . . . . 0.0 110.959 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -55.4 129.24 37.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.722 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -70.23 -39.81 74.88 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.98 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -137.44 150.19 47.43 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.295 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -149.26 -44.02 0.14 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.054 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.74 140.16 58.84 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.983 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -80.89 152.54 71.96 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.735 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.47 -23.91 14.56 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.324 2.016 . . . . 0.0 111.995 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -65.95 131.89 47.31 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.067 -178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 80.2 ttt-85 -138.05 139.76 39.73 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.194 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -153.82 142.88 21.27 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.771 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.01 147.31 16.25 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 51.2 t -64.43 128.01 33.96 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.607 0.241 . . . . 0.0 110.77 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.09 17.34 1.36 Allowed Glycine 0 CA--C 1.539 1.554 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.308 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.5 m -66.01 -30.73 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 116.837 0.319 . . . . 0.0 111.437 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.3 mt 64.45 2.72 1.65 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -66.31 -36.11 82.1 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.921 0.391 . . . . 0.0 110.711 177.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.44 -48.12 0.11 Allowed Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 t 46.84 59.12 4.16 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.43 0.634 . . . . 0.0 111.376 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -154.4 162.37 41.2 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.197 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.0 ttt85 -91.4 -56.5 3.11 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.664 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -146.25 -174.27 4.4 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.97 178.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.9 m -125.05 121.98 35.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 108.26 129.22 5.95 Favored Glycine 0 CA--C 1.552 2.355 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.87 153.7 53.2 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.983 1.789 . . . . 0.0 112.082 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -130.1 70.41 82.16 Favored Pre-proline 0 CA--C 1.56 1.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.5 178.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.75 -23.67 35.57 Favored 'Trans proline' 0 N--CA 1.505 2.182 0 C-N-CA 122.317 2.011 . . . . 0.0 112.4 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.8 m . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.904 -1.046 . . . . 0.0 111.08 -178.967 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 18.0 pm0 . . . . . 0 N--CA 1.495 1.795 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.45 152.05 31.51 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-O 120.591 0.234 . . . . 0.0 110.92 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.2 p -155.8 161.73 40.6 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.127 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.14 157.56 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.917 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -137.36 129.63 29.49 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.202 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -141.87 132.14 24.96 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.3 tt -126.72 134.65 65.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.205 -178.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 5.2 t -157.87 88.27 0.96 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.496 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -72.58 134.19 82.15 Favored Pre-proline 0 CA--C 1.557 1.221 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.893 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -90.5 -76.61 0.0 OUTLIER 'Trans proline' 0 CA--C 1.555 1.544 0 C-N-CA 122.018 1.812 . . . . 0.0 112.056 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 51.62 18.57 0.73 Allowed 'General case' 0 C--N 1.347 0.488 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.2 pt -165.59 -83.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 178.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -60.58 -40.91 93.44 Favored 'General case' 0 C--N 1.345 0.379 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -178.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 70.7 mtp85 49.41 27.88 2.16 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.132 177.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.7 164.21 44.81 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.343 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.47 -33.82 75.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.11 -0.545 . . . . 0.0 111.101 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 78.13 -58.34 0.46 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.384 0.674 . . . . 0.0 110.919 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -104.29 99.03 8.74 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.696 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.6 p -150.63 142.13 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.929 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -132.2 150.26 52.2 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.652 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.3 m -72.03 151.9 42.82 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.913 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -74.17 134.43 42.78 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.035 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -71.36 -26.37 62.78 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.12 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -95.72 -28.37 14.82 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.58 177.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 65.1 m170 -127.83 53.46 10.66 Favored Pre-proline 0 CA--C 1.558 1.266 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.521 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.04 -25.6 19.24 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.903 1.735 . . . . 0.0 111.488 177.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -64.42 -35.57 81.34 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.142 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.8 p -82.59 -19.6 38.11 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.892 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.5 t -62.21 142.13 57.84 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.652 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -61.57 143.94 55.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.566 -177.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -129.82 153.34 48.35 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.718 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -129.7 150.37 51.05 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.741 -177.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -150.96 171.52 17.15 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.495 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.07 131.68 34.21 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 123.444 0.465 . . . . 0.0 110.946 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -73.52 154.17 89.75 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.817 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.1 -25.25 16.24 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.194 1.929 . . . . 0.0 111.686 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -64.57 129.82 41.28 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.35 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 56.3 ttt85 61.63 141.43 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.203 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -159.87 127.52 4.69 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.484 179.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -107.25 150.86 16.86 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 51.2 t -63.67 124.85 22.48 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -143.88 16.59 2.18 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.363 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.9 m -63.6 -30.61 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.832 0.349 . . . . 0.0 111.331 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.2 mt 65.27 1.71 1.68 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -65.1 -36.77 85.36 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.976 0.417 . . . . 0.0 110.702 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.65 -52.09 0.11 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.4 t 45.52 66.25 0.96 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.201 0.524 . . . . 0.0 111.307 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 71.6 t60 58.76 99.88 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.198 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 40.0 ptt85 -53.86 149.81 8.36 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.784 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -146.54 149.03 32.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.593 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.2 t -158.26 159.38 35.94 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.551 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -149.68 162.65 29.16 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -71.42 149.75 56.97 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.057 1.838 . . . . 0.0 112.593 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -130.45 74.81 79.88 Favored Pre-proline 0 CA--C 1.558 1.254 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.904 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -66.17 -22.97 53.35 Favored 'Trans proline' 0 N--CA 1.506 2.211 0 C-N-CA 122.306 2.004 . . . . 0.0 112.113 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.1 m . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.077 -0.963 . . . . 0.0 111.055 -179.194 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.72 140.69 50.79 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.123 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 96.3 p -149.94 160.56 43.51 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.027 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 92.7 t -66.31 -41.68 89.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.193 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -125.89 151.43 46.92 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.1 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -130.29 148.19 52.09 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.594 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.8 tp -131.44 129.6 62.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.11 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.6 m -122.32 129.09 51.82 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.733 -178.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -72.71 155.73 90.6 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.309 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.85 140.18 45.5 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 121.815 1.676 . . . . 0.0 111.749 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -162.82 153.53 16.85 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.861 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.4 -48.28 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.325 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -169.79 -53.41 0.02 OUTLIER 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.78 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 54.22 177.64 0.03 OUTLIER 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.708 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -106.46 117.11 5.29 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.12 -40.51 97.82 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.59 0.233 . . . . 0.0 111.298 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -155.68 -91.81 0.04 OUTLIER 'General case' 0 CA--C 1.561 1.385 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.607 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -162.57 147.75 12.26 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 120.598 0.237 . . . . 0.0 111.072 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.0 m -136.11 157.53 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.174 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -127.96 161.96 27.89 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.372 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 84.8 m -85.02 138.89 32.17 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.739 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.63 128.78 37.57 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -66.05 -23.02 66.46 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 123.108 0.255 . . . . 0.0 110.945 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.31 -25.12 14.95 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.893 178.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -129.48 54.27 13.93 Favored Pre-proline 0 CA--C 1.558 1.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.92 178.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.9 -19.84 26.53 Favored 'Trans proline' 0 N--CA 1.5 1.898 0 C-N-CA 121.946 1.764 . . . . 0.0 111.632 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -62.32 -35.96 80.7 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.777 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.1 t -82.25 -25.88 33.69 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.125 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 51.3 t -62.28 138.78 58.49 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.006 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -97.57 129.0 44.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.1 -176.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm -138.22 153.13 49.14 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.197 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -123.67 -33.04 3.25 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.266 -177.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -139.26 167.14 22.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.125 -177.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -161.77 162.4 29.56 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.858 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -125.71 152.65 72.55 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.358 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.18 -24.29 12.68 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.224 1.949 . . . . 0.0 112.384 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -82.76 -67.0 0.82 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.377 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 56.72 160.91 0.02 OUTLIER 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.298 178.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -150.19 140.12 21.92 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.902 179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.08 117.52 4.86 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.706 -0.558 . . . . 0.0 111.706 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 38.8 t -91.59 161.67 14.84 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.677 -0.262 . . . . 0.0 110.563 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.78 -9.85 57.07 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 111.461 -0.655 . . . . 0.0 111.461 -176.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.0 m -63.01 -24.17 35.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 120.805 0.336 . . . . 0.0 110.353 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.9 mt 67.83 1.28 2.61 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.452 0.701 . . . . 0.0 112.633 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -66.46 -36.6 83.18 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-O 120.915 0.388 . . . . 0.0 110.505 175.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 169.68 88.95 0.07 OUTLIER Glycine 0 C--N 1.336 0.577 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.7 t -138.25 129.7 27.68 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.747 0.308 . . . . 0.0 110.825 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -154.96 163.53 40.18 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.232 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 57.1 ttt85 56.6 100.41 0.02 OUTLIER 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.206 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -116.68 173.23 6.74 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.363 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.5 m -114.26 127.7 56.01 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.206 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -160.53 73.77 0.21 Allowed Glycine 0 CA--C 1.544 1.899 0 CA-C-O 119.649 -0.528 . . . . 0.0 111.952 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -71.12 151.23 61.1 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.054 1.836 . . . . 0.0 111.754 179.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -130.22 69.92 82.08 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.688 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.11 -24.68 38.32 Favored 'Trans proline' 0 N--CA 1.505 2.169 0 C-N-CA 122.352 2.035 . . . . 0.0 112.351 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.2 m . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.74 -179.04 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.41 32.24 10.93 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.036 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.4 t -63.34 138.65 58.6 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.773 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 p -149.59 139.74 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.046 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 61.3 ttm-85 -145.48 139.99 27.22 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.713 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -130.21 148.82 52.09 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.076 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.1 tp -135.22 136.91 50.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.226 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 89.7 m -121.54 130.07 53.3 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.628 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -71.21 155.24 93.31 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.132 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.51 147.21 70.28 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.01 1.807 . . . . 0.0 112.347 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.68 156.2 34.52 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.22 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 87.5 mt -65.82 -66.16 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.164 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -176.62 48.41 0.01 OUTLIER 'General case' 0 C--O 1.245 0.84 0 CA-C-O 121.075 0.464 . . . . 0.0 110.85 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -93.18 119.51 32.45 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.228 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -97.52 -175.71 34.13 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -132.94 -71.75 0.52 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.28 0.086 . . . . 0.0 111.124 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -71.83 -49.59 37.09 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -174.41 154.78 2.18 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.058 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.0 m -132.56 152.58 36.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.759 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -71.87 136.87 47.11 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.409 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.7 m -96.64 132.87 41.84 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.68 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.52 137.98 52.95 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.39 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -68.37 -27.48 66.28 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.273 0.358 . . . . 0.0 110.643 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.75 -30.09 15.05 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.917 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -127.29 54.19 11.95 Favored Pre-proline 0 CA--C 1.557 1.219 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.191 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.4 -23.3 20.62 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.004 1.803 . . . . 0.0 111.747 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 43.1 p30 -72.04 -16.96 62.05 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.08 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.7 m -84.51 -38.05 20.54 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.9 t -62.59 128.98 38.54 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.128 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -138.58 136.8 36.37 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.514 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -65.36 -39.8 92.78 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.157 177.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -138.86 150.8 46.4 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.376 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -152.85 172.14 17.2 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.383 0.611 . . . . 0.0 112.478 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.27 -170.49 2.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.242 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -59.64 148.63 74.28 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.9 -24.37 21.07 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 122.314 2.009 . . . . 0.0 112.21 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -81.48 128.02 33.44 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.53 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -120.92 146.63 46.43 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.664 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -151.4 133.47 15.15 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.178 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -110.27 148.57 17.5 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.47 ' SG ' HG22 ' A' ' 43' ' ' VAL . 53.5 t -89.1 114.18 25.41 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -123.72 18.23 7.64 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.752 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.47 HG22 ' SG ' ' A' ' 41' ' ' CYS . 35.6 m -63.39 -31.62 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 116.85 0.325 . . . . 0.0 111.208 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.0 mt 66.88 -2.33 1.15 Allowed 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -66.42 -36.28 82.43 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.94 0.4 . . . . 0.0 110.844 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.05 -40.9 0.34 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 52.49 98.82 0.01 OUTLIER 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.754 0.312 . . . . 0.0 111.357 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -125.46 141.13 52.22 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.868 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -125.2 139.93 53.31 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.226 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -125.65 157.97 35.92 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.259 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.8 m -61.51 -42.51 98.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.157 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -166.78 179.12 40.81 Favored Glycine 0 CA--C 1.538 1.489 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.17 -32.72 10.29 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 121.815 1.677 . . . . 0.0 112.436 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -139.0 58.69 13.55 Favored Pre-proline 0 CA--C 1.562 1.439 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.132 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -62.52 -27.0 76.43 Favored 'Trans proline' 0 N--CA 1.507 2.294 0 C-N-CA 122.627 2.218 . . . . 0.0 111.839 176.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.7 m . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.034 -0.984 . . . . 0.0 111.164 -178.804 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 16.3 pt-20 . . . . . 0 N--CA 1.497 1.898 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 1' ' ' GLU . . . 75.34 -51.81 0.65 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.883 0.473 . . . . 0.0 111.472 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.3 p 63.13 138.89 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.739 0.304 . . . . 0.0 111.132 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.21 158.98 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.319 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -120.18 129.04 53.94 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.668 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -108.36 -47.74 3.47 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.708 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.6 mm -119.34 128.4 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.567 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 t -75.89 -29.93 58.64 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -122.19 139.69 31.04 Favored Pre-proline 0 CA--C 1.558 1.287 0 N-CA-C 111.636 0.236 . . . . 0.0 111.636 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.18 -26.55 8.99 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.158 1.905 . . . . 0.0 112.594 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.06 159.8 36.71 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.023 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 79.9 mt -72.63 -62.37 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.921 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -175.4 62.36 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.512 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -70.37 143.12 52.02 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.988 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.92 45.42 0.03 OUTLIER Glycine 0 C--N 1.343 0.932 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.9 t70 52.01 47.12 25.39 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.206 0.527 . . . . 0.0 111.439 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -72.49 146.29 46.95 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.078 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.21 153.0 34.08 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.638 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.1 m -105.42 -18.9 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.114 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -69.19 142.45 54.29 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.705 0.288 . . . . 0.0 110.881 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 82.0 m -92.97 135.9 33.74 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.011 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -66.11 134.41 52.74 Favored 'General case' 0 CA--C 1.512 -0.519 0 O-C-N 123.277 0.361 . . . . 0.0 110.097 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -71.13 -21.46 62.19 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.736 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.88 -28.61 13.75 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.434 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -128.4 54.96 15.03 Favored Pre-proline 0 CA--C 1.56 1.351 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.29 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.95 -24.45 24.2 Favored 'Trans proline' 0 N--CA 1.5 1.857 0 C-N-CA 121.931 1.754 . . . . 0.0 111.744 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -64.39 -34.58 78.5 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.105 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 68.4 p -89.13 -0.75 57.69 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.685 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.4 t -60.4 136.05 57.93 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 120.787 0.327 . . . . 0.0 110.649 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -65.73 130.97 45.14 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.862 -177.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.9 mmmm -137.02 153.61 50.6 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.835 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -125.08 -76.57 0.59 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 15.71 -79.68 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.437 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.04 165.49 1.86 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.763 0.316 . . . . 0.0 111.071 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -63.03 151.2 86.67 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.818 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -75.16 -22.98 13.97 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.536 2.157 . . . . 0.0 112.155 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -60.97 131.27 50.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.36 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -117.16 141.49 48.21 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.309 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -137.8 125.0 21.62 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.086 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.7 178.96 51.36 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.3 p -75.43 152.59 37.95 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.64 0.257 . . . . 0.0 110.924 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.7 5.2 50.85 Favored Glycine 0 CA--C 1.54 1.628 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.898 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.8 m -64.35 -30.49 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 116.965 0.383 . . . . 0.0 111.338 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.4 mt 62.69 6.05 1.94 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -65.74 -36.08 82.55 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.936 0.398 . . . . 0.0 110.982 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.73 -21.93 0.91 Allowed Glycine 0 CA--C 1.535 1.302 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.253 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 56.56 46.24 20.85 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.475 0.655 . . . . 0.0 110.648 178.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -60.62 -44.74 95.97 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.808 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -151.36 163.79 38.14 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.125 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -151.37 -60.97 0.17 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.68 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.1 t -150.59 150.56 31.35 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.378 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.87 163.82 36.34 Favored Glycine 0 CA--C 1.546 1.998 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.16 146.79 46.94 Favored 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 122.006 1.804 . . . . 0.0 112.181 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -142.13 82.71 13.06 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.207 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -66.14 -16.31 51.63 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 121.972 1.781 . . . . 0.0 111.825 178.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.7 m . . . . . 0 C--N 1.349 0.567 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.832 -178.818 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.04 151.99 35.46 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.695 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 51.85 -175.68 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.543 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.8 t -120.38 67.72 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-O 121.172 0.51 . . . . 0.0 110.47 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 48.03 -179.24 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.114 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -145.18 -54.37 0.3 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.213 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.468 HG22 HG23 ' A' ' 8' ' ' THR . 92.4 mt -61.75 -45.52 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.768 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.468 HG23 HG22 ' A' ' 7' ' ' ILE . 81.8 p -129.76 159.76 35.51 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.043 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -134.69 156.34 78.73 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.005 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -71.4 150.03 57.58 Favored 'Trans proline' 0 N--CA 1.503 2.064 0 C-N-CA 122.153 1.902 . . . . 0.0 112.088 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -152.75 148.33 27.12 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.76 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.555 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.9 mp -123.46 108.66 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.998 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.4 p30 29.32 40.56 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.921 0.888 . . . . 0.0 112.864 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -70.88 143.66 50.93 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.685 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.25 -179.46 16.69 Favored Glycine 0 N--CA 1.465 0.57 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -99.17 105.98 18.1 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.681 0.277 . . . . 0.0 110.956 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.598 ' CE1' HG22 ' A' ' 19' ' ' VAL . 31.2 p80 -163.57 175.44 10.66 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.311 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.18 -38.42 83.21 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.164 -177.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.598 HG22 ' CE1' ' A' ' 17' ' ' HIS . 21.9 t 73.1 133.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.507 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -134.49 160.54 37.69 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.651 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 68.5 m -87.54 158.91 18.8 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.888 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.31 137.31 57.85 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.319 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -68.19 -26.03 65.53 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.87 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -95.59 -28.24 14.94 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.839 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -128.35 54.31 13.28 Favored Pre-proline 0 CA--C 1.558 1.269 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.838 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.68 -25.43 24.36 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.194 1.929 . . . . 0.0 112.505 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -86.89 -11.49 50.57 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.125 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 67.9 p -127.35 17.84 7.03 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 30.3 p -60.32 160.41 8.6 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-O 120.828 0.347 . . . . 0.0 111.107 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -61.77 -41.69 98.03 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.961 -176.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -139.07 150.5 45.81 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.156 0.503 . . . . 0.0 111.67 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt 69.79 172.79 0.3 Allowed 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.479 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -152.9 -44.62 0.1 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.692 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.59 137.77 58.26 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.507 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -74.73 155.38 87.08 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.278 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.89 -24.11 18.09 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.219 1.946 . . . . 0.0 111.586 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -90.54 122.99 33.84 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.26 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -91.97 -63.63 1.22 Allowed 'General case' 0 CA--C 1.513 -0.468 0 O-C-N 123.277 0.36 . . . . 0.0 111.304 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -170.98 151.87 3.4 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.603 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.84 -176.32 47.79 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.431 ' SG ' HG22 ' A' ' 43' ' ' VAL . 21.9 p -66.84 156.87 34.47 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.751 0.31 . . . . 0.0 111.214 -178.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.34 1.39 46.66 Favored Glycine 0 CA--C 1.54 1.628 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.644 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.431 HG22 ' SG ' ' A' ' 41' ' ' CYS . 28.3 m -66.88 -28.96 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.952 0.376 . . . . 0.0 111.193 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.5 mt 57.96 12.36 1.75 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.364 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -64.74 -36.68 85.08 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.861 0.362 . . . . 0.0 110.723 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.49 -51.88 0.11 Allowed Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 55.63 41.06 30.95 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.096 0.474 . . . . 0.0 110.436 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -149.35 158.7 44.4 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.65 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -62.48 -48.62 78.81 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.349 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -148.53 162.8 38.92 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.034 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.1 m -62.69 -42.96 99.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.872 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -175.13 -177.25 44.07 Favored Glycine 0 CA--C 1.541 1.691 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -70.47 151.25 64.88 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.849 1.699 . . . . 0.0 112.081 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -129.85 71.53 82.14 Favored Pre-proline 0 CA--C 1.56 1.363 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.713 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -66.33 -24.57 50.22 Favored 'Trans proline' 0 N--CA 1.506 2.259 0 C-N-CA 122.231 1.954 . . . . 0.0 112.084 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 m . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.006 -0.997 . . . . 0.0 111.046 -179.054 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.41 -39.9 92.45 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.868 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.3 t -154.55 172.71 17.37 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.746 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.41 HG23 ' HD3' ' A' ' 5' ' ' ARG . 28.5 m -63.78 -27.98 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.122 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.41 ' HD3' HG23 ' A' ' 4' ' ' VAL . 0.5 OUTLIER -112.38 158.41 19.84 Favored 'General case' 0 C--N 1.343 0.326 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.011 177.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -114.77 19.83 15.65 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.654 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.0 pt -125.6 157.88 34.69 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.658 -176.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.0 m -124.94 138.42 54.24 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.594 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -60.67 143.5 90.56 Favored Pre-proline 0 CA--C 1.551 0.996 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.25 -177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.79 161.13 27.51 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.432 2.088 . . . . 0.0 112.377 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 60.87 99.14 0.03 OUTLIER 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.227 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.2 mm -63.55 -44.88 98.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -149.74 -57.72 0.19 Allowed 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.995 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 45.82 -174.29 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.817 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.91 164.8 30.8 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -89.35 -40.43 12.77 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.524 0.202 . . . . 0.0 110.976 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -151.84 93.46 1.85 Allowed 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.27 -6.27 59.37 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.2 m 44.96 176.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -70.14 148.23 48.96 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.576 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 18.3 m -63.05 153.8 32.84 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.027 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.58 133.34 42.23 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.936 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -70.97 -26.72 63.28 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.147 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.21 -26.31 15.49 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.719 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -128.79 53.07 10.34 Favored Pre-proline 0 CA--C 1.559 1.311 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.515 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.0 -26.63 18.25 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.915 1.743 . . . . 0.0 111.435 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -65.29 -35.46 81.07 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.139 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 75.2 p -107.04 10.38 30.32 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 116.211 -0.449 . . . . 0.0 112.085 -178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.6 p -69.59 170.24 11.12 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 123.191 0.307 . . . . 0.0 110.489 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -70.18 143.03 52.39 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.964 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -128.66 152.26 48.58 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.022 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -133.36 152.2 51.9 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.698 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -151.06 170.36 19.57 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.149 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.24 157.17 33.8 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.794 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.2 p30 -70.78 157.43 90.25 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.465 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.92 -23.71 6.49 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.368 2.045 . . . . 0.0 112.638 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -67.4 133.7 50.07 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.049 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -112.64 142.43 45.24 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.157 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 61.1 ttt85 -125.85 119.31 27.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.45 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.6 178.0 48.66 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.954 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 41.0 t -91.13 115.2 27.83 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.335 -0.433 . . . . 0.0 110.441 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -136.71 11.16 3.99 Favored Glycine 0 CA--C 1.54 1.611 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.762 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.3 m -65.38 -32.74 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 117.101 0.45 . . . . 0.0 111.112 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.6 mt 63.31 3.66 1.44 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -64.89 -36.61 84.92 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.07 0.462 . . . . 0.0 110.275 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -163.58 -72.88 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.8 t 65.48 -73.17 0.07 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 122.833 0.453 . . . . 0.0 111.741 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -85.01 132.25 34.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 123.305 0.378 . . . . 0.0 110.135 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 20.2 tpp85 -60.17 -39.19 85.57 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.781 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 71.72 24.87 3.35 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.862 0.465 . . . . 0.0 111.058 -176.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.5 m -163.28 88.85 0.6 Allowed 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.965 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -172.04 63.29 0.15 Allowed Glycine 0 CA--C 1.539 1.552 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.8 -26.77 74.95 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.072 1.848 . . . . 0.0 112.158 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm 58.9 63.9 3.57 Favored Pre-proline 0 C--O 1.243 0.751 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -64.4 -23.25 65.36 Favored 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 121.713 1.609 . . . . 0.0 112.19 -176.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 CA--C 1.537 0.462 0 CA-C-O 117.961 -1.019 . . . . 0.0 111.917 -179.011 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 39.1 mp0 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.37 -42.15 98.24 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.599 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.6 t 47.43 -172.35 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.019 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.3 p -144.63 126.18 9.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -161.21 136.19 7.48 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.994 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -132.34 142.38 49.31 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.677 177.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' ' 7' ' ' ILE . 6.3 tp -124.13 79.67 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 121.402 0.62 . . . . 0.0 110.679 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.5 p -118.27 -4.93 10.9 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.235 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -70.76 148.94 95.12 Favored Pre-proline 0 CA--C 1.55 0.973 0 CA-C-O 119.695 -0.193 . . . . 0.0 110.906 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -75.31 148.6 34.34 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.239 1.96 . . . . 0.0 111.943 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.7 139.93 16.59 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.509 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 24.0 mt -139.75 -124.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.573 1.845 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -65.73 -44.06 87.15 Favored 'General case' 0 C--N 1.36 1.062 0 CA-C-N 118.74 0.7 . . . . 0.0 110.65 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 47.89 -89.44 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.013 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.54 179.95 53.15 Favored Glycine 0 C--N 1.353 1.487 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -87.41 108.79 19.16 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.629 0.252 . . . . 0.0 110.847 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -110.77 130.89 55.45 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.444 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -109.3 130.33 55.5 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.079 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 79.3 t -63.75 -42.48 96.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.089 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -65.12 146.46 54.95 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.287 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 98.9 m -71.67 151.49 43.62 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.76 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -67.56 134.09 50.62 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 121.223 0.535 . . . . 0.0 110.471 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.8 ptmm? -71.23 -28.46 64.2 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.497 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.87 -24.01 16.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.64 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -129.9 52.53 9.55 Favored Pre-proline 0 CA--C 1.558 1.268 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.362 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -72.77 -23.41 19.23 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.814 1.676 . . . . 0.0 111.563 177.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.7 p-10 -75.35 -16.42 60.4 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.447 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.4 p -105.92 -6.52 18.8 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 120.456 0.169 . . . . 0.0 111.336 177.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 38.3 t -61.21 138.0 58.23 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.33 0.586 . . . . 0.0 111.042 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -73.61 147.56 43.71 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.92 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -101.81 -33.16 9.92 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt 76.4 166.09 0.26 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.773 0.429 . . . . 0.0 111.13 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -158.78 172.4 18.32 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.132 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.9 139.43 38.05 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.474 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.2 p30 -74.94 157.38 85.6 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.88 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -82.89 -21.4 4.83 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 C-N-CA 122.543 2.162 . . . . 0.0 112.576 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -80.66 129.16 34.36 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.568 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 57.6 ttm-85 -145.54 136.23 24.36 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.504 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.7 tpm_? -163.07 133.66 4.62 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.337 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.52 -179.95 51.47 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 49.7 t -89.74 114.56 26.26 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -136.65 26.39 3.04 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.22 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 36.0 m -62.28 -31.29 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.603 0.24 . . . . 0.0 111.413 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.5 mt 66.12 -1.26 1.2 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -67.37 -36.31 81.09 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.926 0.393 . . . . 0.0 110.684 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.35 49.29 0.01 OUTLIER Glycine 0 C--N 1.332 0.323 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 30.1 t -61.42 -47.56 85.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.98 -0.61 . . . . 0.0 111.011 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -159.5 119.98 3.11 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.574 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -63.54 -39.96 95.78 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.151 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 82.18 -78.66 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.746 0.818 . . . . 0.0 110.956 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.2 t -156.2 151.99 27.28 Favored 'General case' 0 C--N 1.346 0.424 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.29 148.27 17.66 Favored Glycine 0 CA--C 1.55 2.226 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.94 151.9 51.17 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 122.19 1.927 . . . . 0.0 112.2 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -130.95 70.43 82.61 Favored Pre-proline 0 CA--C 1.562 1.412 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.708 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.18 -24.52 32.24 Favored 'Trans proline' 0 N--CA 1.507 2.305 0 C-N-CA 122.237 1.958 . . . . 0.0 112.423 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.7 m . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.058 -0.972 . . . . 0.0 111.093 -178.984 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.87 126.16 48.09 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.879 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.0 m -130.86 142.49 50.38 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.752 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.6 m -135.02 159.85 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.545 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.56 ' CG ' HD11 ' A' ' 7' ' ' ILE . 18.8 tpt85 -71.62 151.62 43.58 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.324 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -150.64 104.91 3.24 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.56 HD11 ' CG ' ' A' ' 5' ' ' ARG . 4.8 mp -119.38 118.67 58.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.587 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.3 m -131.26 128.05 39.07 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 123.318 0.386 . . . . 0.0 111.18 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -137.45 152.98 74.12 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.994 176.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.77 -17.99 32.59 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 122.298 1.999 . . . . 0.0 112.86 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 59.24 86.46 0.09 Allowed 'General case' 0 C--N 1.346 0.453 0 CA-C-O 120.868 0.366 . . . . 0.0 110.084 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 73.1 mt -84.83 96.01 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.61 -176.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 48.05 35.94 5.78 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.277 177.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -67.13 145.86 54.86 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.888 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.66 158.29 31.46 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -62.62 -43.24 99.31 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.539 0.209 . . . . 0.0 111.118 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -133.39 147.06 51.75 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.073 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.33 152.0 29.73 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.011 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.5 t -122.67 129.34 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.884 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -99.27 145.7 27.0 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.693 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.1 m -65.65 155.21 36.62 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.242 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -70.48 139.03 51.6 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.048 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.93 -26.19 63.09 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.906 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.17 -29.15 15.28 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.796 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -128.0 54.29 12.88 Favored Pre-proline 0 CA--C 1.559 1.319 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.164 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.4 -28.1 18.45 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.965 1.777 . . . . 0.0 111.954 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 42.9 p-10 -81.53 -17.51 48.25 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.822 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.0 p -124.06 17.88 9.23 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 123.111 0.257 . . . . 0.0 111.406 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 21.4 p -66.47 158.16 30.23 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.573 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? 66.27 -170.2 0.2 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.973 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -117.69 150.33 39.25 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.018 0.437 . . . . 0.0 110.804 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt 68.08 179.27 0.23 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.461 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -156.91 168.27 27.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 123.533 0.52 . . . . 0.0 111.197 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.42 169.59 9.81 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.849 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -66.33 152.26 94.66 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.528 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.77 -20.83 17.05 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.419 2.079 . . . . 0.0 112.668 -177.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -105.66 -102.27 0.33 Allowed 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.728 -175.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -179.19 161.98 1.16 Allowed 'General case' 0 C--N 1.359 1.02 0 CA-C-N 118.054 0.388 . . . . 0.0 110.087 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -113.45 124.36 52.24 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 176.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.21 151.19 50.92 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.364 -0.446 . . . . 0.0 111.994 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.4 p -75.64 159.36 31.26 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.423 -0.388 . . . . 0.0 111.184 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.59 6.85 1.26 Allowed Glycine 0 CA--C 1.54 1.649 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.639 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.0 m -66.26 -32.02 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 117.054 0.427 . . . . 0.0 110.96 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.0 mt 62.79 4.13 1.36 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -66.2 -36.77 83.94 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.869 0.366 . . . . 0.0 110.678 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 169.66 73.7 0.04 OUTLIER Glycine 0 C--N 1.33 0.24 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.5 t -117.61 118.95 33.53 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.67 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -134.4 -59.73 0.81 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.999 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -143.7 127.47 17.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.144 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.8 mp0 -66.6 -45.68 78.39 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.014 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.5 p -141.79 151.54 42.92 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.58 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 154.86 -173.07 33.26 Favored Glycine 0 CA--C 1.54 1.617 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.05 161.85 42.36 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.025 1.816 . . . . 0.0 111.29 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -126.04 72.96 71.05 Favored Pre-proline 0 CA--C 1.559 1.311 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.305 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -69.94 -24.28 29.01 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.279 1.986 . . . . 0.0 112.196 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.1 m . . . . . 0 C--O 1.219 -0.526 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.869 -179.019 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 . . . . . 0 N--CA 1.497 1.884 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.5 -73.15 0.33 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.278 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.8 t -158.78 147.13 18.3 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-O 120.549 0.214 . . . . 0.0 111.285 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.1 p -140.43 136.62 36.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.404 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -87.6 140.57 29.39 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.259 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -147.4 131.53 17.34 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.6 tt -134.67 141.87 42.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.2 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.3 t -148.26 151.77 36.01 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.05 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -70.73 149.91 95.27 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.983 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.18 148.26 43.89 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 122.169 1.913 . . . . 0.0 112.082 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.581 ' HB1' ' HB2' ' A' ' 14' ' ' ARG . . . -118.81 -28.22 5.64 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.384 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 72.6 mt 60.73 -100.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.473 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.322 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -102.06 5.57 40.6 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.581 ' HB2' ' HB1' ' A' ' 11' ' ' ALA . 90.9 mtt-85 -71.61 140.89 49.95 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.504 -178.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.37 75.81 0.31 Allowed Glycine 0 C--N 1.342 0.868 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -67.56 149.67 49.82 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.476 0.179 . . . . 0.0 110.664 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -149.08 160.97 42.86 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.242 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -99.54 16.42 23.37 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.49 HG12 ' NZ ' ' A' ' 30' ' ' LYS . 47.3 t -109.6 121.34 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -80.81 167.32 20.07 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.305 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 45.8 m -74.94 165.07 25.84 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.972 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -72.98 139.48 46.72 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.229 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -70.22 -26.89 64.08 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.91 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.13 -29.16 15.29 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.878 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -127.54 53.86 11.39 Favored Pre-proline 0 CA--C 1.556 1.205 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.982 177.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.82 -28.29 16.9 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.937 1.758 . . . . 0.0 111.919 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -80.67 -17.72 50.24 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.738 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.4 m -131.65 28.88 4.56 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.814 0.34 . . . . 0.0 110.869 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 24.8 p -67.48 150.69 48.54 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.316 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.49 ' NZ ' HG12 ' A' ' 19' ' ' VAL . 59.0 mmtt 59.07 179.59 0.08 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.916 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -138.58 158.44 44.24 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.812 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -130.72 151.66 50.92 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.531 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.1 pm0 -148.72 167.57 25.19 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.226 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.25 138.58 56.21 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.882 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -73.69 155.12 89.29 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.057 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -72.09 -23.88 21.01 Favored 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 122.224 1.949 . . . . 0.0 111.834 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -90.06 125.09 35.29 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.738 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -94.77 -73.05 0.59 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.688 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.4 ttp-105 -172.84 142.16 1.1 Allowed 'General case' 0 C--N 1.349 0.559 0 O-C-N 123.098 0.248 . . . . 0.0 110.915 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -110.76 157.95 14.68 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 15.0 p -68.7 152.8 44.85 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.685 0.279 . . . . 0.0 111.007 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.52 11.96 54.15 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.032 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.56 -32.44 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.7 mt 64.39 7.01 3.34 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.244 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -66.1 -36.31 82.84 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-O 120.808 0.337 . . . . 0.0 111.1 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.52 -37.28 0.25 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 54.5 41.94 31.65 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 121.063 0.459 . . . . 0.0 110.823 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -85.6 102.97 14.01 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.531 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -100.53 109.83 21.96 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.214 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -168.5 155.6 7.61 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.847 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 t -155.61 152.72 29.08 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.394 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -173.59 166.37 38.65 Favored Glycine 0 CA--C 1.544 1.864 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.65 144.49 44.51 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 121.856 1.704 . . . . 0.0 112.007 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.95 55.21 2.33 Favored Pre-proline 0 CA--C 1.558 1.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.653 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.37 -24.81 42.74 Favored 'Trans proline' 0 N--CA 1.506 2.256 0 C-N-CA 122.287 1.991 . . . . 0.0 112.258 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 C--O 1.218 -0.554 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.895 -179.215 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.03 128.39 54.62 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.835 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.2 t -172.54 -43.73 0.02 OUTLIER 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.948 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.1 p -137.49 149.66 25.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.726 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.4 mmm-85 -64.12 144.84 56.81 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.595 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -157.87 93.34 1.25 Allowed 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.6 pt -133.64 155.65 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.098 -177.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 67.0 p -118.67 20.88 12.78 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.615 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 63.04 155.19 0.12 Allowed Pre-proline 0 CA--C 1.544 0.74 0 CA-C-O 119.412 -0.327 . . . . 0.0 110.16 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.74 -61.88 0.22 Allowed 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.806 1.671 . . . . 0.0 112.232 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 47.65 90.71 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.79 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 43.9 pt -97.01 -174.99 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.556 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 59.3 p30 -94.25 61.14 2.82 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 121.538 0.685 . . . . 0.0 110.89 -178.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -61.14 -43.02 99.53 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.123 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.31 -172.72 31.51 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -98.65 -93.89 0.24 Allowed 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -176.43 -98.42 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 122.469 0.308 . . . . 0.0 110.679 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -164.86 149.16 9.09 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.66 159.1 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 120.884 0.373 . . . . 0.0 111.65 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -131.74 150.22 52.22 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.971 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.1 m -72.51 136.24 45.86 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 123.324 0.39 . . . . 0.0 110.36 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -70.3 132.77 46.2 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.56 -22.25 64.5 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 123.2 0.313 . . . . 0.0 111.058 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.2 -27.58 14.1 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.599 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -128.88 54.81 15.17 Favored Pre-proline 0 CA--C 1.557 1.22 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.375 178.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -70.82 -23.38 26.03 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.881 1.721 . . . . 0.0 111.637 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -61.5 -36.66 81.12 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.171 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.9 p -88.74 -0.03 56.92 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.047 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 53.8 t -61.1 131.49 50.72 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.672 0.272 . . . . 0.0 110.748 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 150.12 25.17 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.621 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -129.96 154.45 47.35 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.659 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -130.46 151.23 51.17 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.745 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.0 pm0 -152.54 162.27 41.44 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.491 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.81 156.44 41.82 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.447 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -70.68 152.52 95.23 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.079 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -80.25 -22.05 7.33 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.46 2.107 . . . . 0.0 112.629 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -63.68 129.04 38.49 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.309 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -150.53 140.58 22.05 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.511 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -136.17 -26.24 1.16 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.117 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.74 150.92 49.62 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.7 p -69.11 155.7 39.92 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.725 0.298 . . . . 0.0 111.271 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -122.2 16.67 8.64 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.246 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.1 m -61.54 -34.38 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 116.823 0.312 . . . . 0.0 111.356 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.7 mt 67.98 -6.08 0.77 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -64.96 -35.85 82.48 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.025 0.44 . . . . 0.0 110.763 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.28 -24.16 0.68 Allowed Glycine 0 CA--C 1.535 1.288 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.034 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 58.7 70.5 0.65 Allowed 'General case' 0 C--O 1.243 0.714 0 CA-C-O 121.332 0.587 . . . . 0.0 110.953 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 63.3 t-80 -155.25 139.6 16.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.678 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -69.64 134.39 48.67 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.176 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -127.29 153.77 45.74 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.782 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.9 t -155.8 -30.38 0.1 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.917 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.72 56.72 1.71 Allowed Glycine 0 CA--C 1.54 1.641 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.32 146.54 63.21 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 122.019 1.813 . . . . 0.0 111.551 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -149.05 82.27 7.17 Favored Pre-proline 0 CA--C 1.554 1.114 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.311 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.06 -29.09 56.96 Favored 'Trans proline' 0 N--CA 1.505 2.149 0 C-N-CA 122.005 1.803 . . . . 0.0 111.518 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 CA--C 1.541 0.62 0 CA-C-O 117.841 -1.076 . . . . 0.0 112.167 179.663 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.6 152.1 37.36 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.688 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.3 m -120.13 150.54 40.46 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.764 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.1 p -133.36 138.23 51.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.008 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.526 ' NE ' HD11 ' A' ' 7' ' ' ILE . 12.6 tpt180 -69.41 133.86 48.28 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.932 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -141.56 101.04 3.9 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.287 0.367 . . . . 0.0 110.045 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.526 HD11 ' NE ' ' A' ' 5' ' ' ARG . 81.1 mt -123.01 129.5 75.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.314 -178.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.9 m -102.0 126.03 48.83 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -71.67 152.44 93.55 Favored Pre-proline 0 CA--C 1.556 1.203 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.223 -176.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -81.29 164.77 19.19 Favored 'Trans proline' 0 N--CA 1.502 1.992 0 C-N-CA 122.592 2.195 . . . . 0.0 112.56 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -137.29 144.37 42.62 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.35 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.476 HG22 ' H ' ' A' ' 13' ' ' ASP . 0.3 OUTLIER -98.67 -158.73 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.2 -178.687 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.476 ' H ' HG22 ' A' ' 12' ' ' ILE . 69.2 m-20 -93.57 10.22 33.51 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -60.6 140.62 57.33 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.832 0.348 . . . . 0.0 111.025 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.89 149.19 19.67 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -99.73 120.35 39.58 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.723 0.297 . . . . 0.0 110.989 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -68.82 145.41 53.76 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.941 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.4 140.74 38.85 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.375 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.3 m -90.1 15.33 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -60.12 137.1 58.17 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 74.6 m -87.71 147.15 25.35 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.995 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -73.28 133.41 43.91 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.024 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -70.64 -23.76 62.59 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.059 0.224 . . . . 0.0 110.714 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.62 -28.29 15.45 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.708 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -130.54 53.58 12.17 Favored Pre-proline 0 CA--C 1.559 1.308 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.501 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -73.87 -20.38 19.78 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.016 1.811 . . . . 0.0 111.809 178.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -73.8 -15.84 61.17 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.289 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.7 t -108.1 4.6 25.14 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 111.606 0.225 . . . . 0.0 111.606 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 46.6 t -61.84 137.17 58.22 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.73 128.49 36.69 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.413 -176.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp 55.08 173.45 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.366 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -138.78 -47.48 0.5 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.434 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -74.96 165.88 24.55 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.942 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.95 142.63 24.59 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.188 178.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -74.49 149.69 86.54 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.823 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.77 -21.62 8.28 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.261 1.974 . . . . 0.0 112.226 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -67.29 128.89 38.11 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.064 -178.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 68.4 ttp85 -161.26 147.1 14.24 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.934 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -131.9 134.23 45.46 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.445 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.03 174.75 54.84 Favored Glycine 0 CA--C 1.518 0.219 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.118 -177.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.436 ' SG ' HG23 ' A' ' 43' ' ' VAL . 48.0 t -76.37 121.07 22.49 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 114.896 -0.652 . . . . 0.0 111.224 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -134.79 42.23 1.37 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.436 HG23 ' SG ' ' A' ' 41' ' ' CYS . 62.9 t -61.91 -42.06 93.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.3 mt 77.17 -12.96 1.0 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.03 0.932 . . . . 0.0 112.083 -177.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.418 ' H ' HG12 ' A' ' 43' ' ' VAL . 95.4 mt-10 -65.92 -36.86 84.54 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.943 0.401 . . . . 0.0 111.382 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.6 38.48 0.02 OUTLIER Glycine 0 N--CA 1.464 0.504 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 37.3 t -63.26 -41.86 99.09 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.302 0.641 . . . . 0.0 111.382 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -59.66 -42.32 92.58 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.563 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 64.88 82.29 0.19 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.0 0.429 . . . . 0.0 110.935 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -89.66 -53.66 4.42 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.909 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.2 p 50.35 92.8 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.519 -177.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.57 139.25 12.02 Favored Glycine 0 CA--C 1.543 1.798 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.07 156.96 51.48 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.749 1.633 . . . . 0.0 111.761 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -129.69 70.55 82.0 Favored Pre-proline 0 CA--C 1.56 1.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.773 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.82 -20.22 39.79 Favored 'Trans proline' 0 N--CA 1.505 2.182 0 C-N-CA 122.279 1.986 . . . . 0.0 112.165 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.6 t . . . . . 0 CA--C 1.537 0.463 0 CA-C-O 118.022 -0.99 . . . . 0.0 111.594 -178.884 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 121.36 0.6 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.83 -17.4 64.0 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.932 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.7 m -59.98 -39.6 86.22 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.251 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.6 m 42.24 62.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-O 121.401 0.619 . . . . 0.0 111.568 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -61.89 130.09 44.02 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.327 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -73.2 -29.82 63.08 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.956 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.4 mm -74.87 113.92 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.533 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 76.5 m -132.51 130.23 40.16 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.882 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -94.01 149.22 36.56 Favored Pre-proline 0 CA--C 1.555 1.143 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.452 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.27 160.3 36.05 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.423 2.082 . . . . 0.0 112.178 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.73 134.61 49.61 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.952 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 47.1 mm -120.17 140.18 45.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.2 p30 -63.62 77.58 0.03 OUTLIER 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.557 0.694 . . . . 0.0 110.45 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.7 mmp_? -61.49 -43.49 98.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.045 -177.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.2 173.0 40.95 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.457 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -109.02 108.07 18.65 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.791 -0.205 . . . . 0.0 110.506 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -79.42 66.41 4.87 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.475 0.655 . . . . 0.0 110.489 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -158.49 157.2 31.68 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.88 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.7 t -117.91 126.31 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.724 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -71.11 169.48 14.94 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.522 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 73.9 m -93.96 137.29 33.33 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.138 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -66.58 131.5 46.14 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.89 -23.54 66.01 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.863 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.88 -27.95 14.05 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.658 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -127.92 54.7 13.81 Favored Pre-proline 0 CA--C 1.558 1.27 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.079 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -69.83 -25.23 28.5 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.868 1.712 . . . . 0.0 111.595 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -63.09 -37.57 87.72 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.618 177.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 85.9 m -67.57 -38.57 84.3 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.669 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 53.6 t -49.09 139.08 11.12 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.706 -177.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm -64.86 148.34 51.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.683 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -129.92 155.1 46.6 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.18 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -129.58 149.49 51.32 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.333 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -153.05 -41.51 0.1 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.007 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 64.03 173.34 0.18 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.142 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -71.38 154.75 93.44 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.777 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -89.52 -68.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.441 2.094 . . . . 0.0 111.048 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 51.0 t80 34.78 93.78 0.01 OUTLIER 'General case' 0 C--N 1.353 0.734 0 C-N-CA 123.25 0.62 . . . . 0.0 112.66 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 64.18 162.73 0.12 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.452 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.15 -39.73 1.89 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.495 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -132.45 157.36 22.5 Favored Glycine 0 C--N 1.338 0.653 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 21.6 p -68.79 149.09 49.39 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.116 0.484 . . . . 0.0 111.286 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.89 18.78 0.35 Allowed Glycine 0 CA--C 1.536 1.359 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.098 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.19 -38.77 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.1 mt 69.09 23.37 6.52 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.231 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -102.96 -35.18 8.67 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.396 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.26 78.64 0.06 OUTLIER Glycine 0 C--N 1.334 0.421 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.1 t -136.03 122.31 20.47 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -133.53 148.94 51.69 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.438 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -117.59 123.64 46.7 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.178 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -159.87 164.99 33.12 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.569 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 63.2 p -67.96 -35.4 78.31 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.101 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 169.54 177.69 40.25 Favored Glycine 0 CA--C 1.543 1.827 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.31 149.16 50.54 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.011 1.808 . . . . 0.0 112.151 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -136.32 80.37 40.17 Favored Pre-proline 0 CA--C 1.557 1.234 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.715 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.04 -24.88 44.68 Favored 'Trans proline' 0 N--CA 1.506 2.253 0 C-N-CA 122.188 1.925 . . . . 0.0 112.062 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 117.89 -1.052 . . . . 0.0 110.92 -179.31 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.464 ' O ' HG22 ' A' ' 4' ' ' VAL . 31.4 mt-10 . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.03 142.26 57.88 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.816 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 t 59.15 62.97 1.7 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.538 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 1' ' ' GLU . 34.9 m -133.25 157.94 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.97 178.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -97.98 118.9 35.59 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.307 178.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -116.78 -36.56 3.85 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.71 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.1 mp -102.57 121.23 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.982 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 70.7 m -106.95 103.72 13.22 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.194 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -171.96 136.26 0.91 Allowed Pre-proline 0 CA--C 1.557 1.242 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.485 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -74.28 150.79 42.49 Favored 'Trans proline' 0 N--CA 1.503 2.067 0 C-N-CA 122.059 1.839 . . . . 0.0 111.916 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.16 94.39 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.627 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 13' ' ' ASP . 73.9 mt -127.17 162.74 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.445 ' N ' HG22 ' A' ' 12' ' ' ILE . 57.2 p30 -58.78 -20.58 51.04 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 122.986 0.179 . . . . 0.0 111.467 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 42.63 -167.28 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 122.473 0.309 . . . . 0.0 111.757 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.01 -175.51 54.79 Favored Glycine 0 C--N 1.35 1.33 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -100.16 120.23 39.56 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.678 0.275 . . . . 0.0 110.629 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -65.28 -39.96 93.25 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.072 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.48 144.14 53.31 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.94 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.54 138.27 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.502 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -134.25 162.6 31.72 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.707 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 96.9 m -72.31 159.9 33.28 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.802 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -61.67 136.68 58.1 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.197 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -69.82 -23.37 63.3 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.601 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.64 -29.12 14.01 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.752 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -128.51 53.8 12.09 Favored Pre-proline 0 CA--C 1.56 1.358 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.208 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.69 -21.86 24.77 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.054 1.836 . . . . 0.0 112.942 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -85.95 -10.3 55.41 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 t -131.6 19.53 4.71 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 30.5 p -62.75 152.14 36.58 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -119.32 -47.06 2.47 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -176.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? 61.18 176.84 0.11 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.669 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -138.49 149.96 45.93 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 123.208 0.317 . . . . 0.0 111.042 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 pm0 -159.21 167.72 28.34 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.16 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 59.64 166.9 0.07 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.556 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -71.67 153.23 93.47 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.665 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.14 -27.9 13.31 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.116 1.877 . . . . 0.0 111.874 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -76.42 135.1 39.43 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.536 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.0 ttt-85 -132.35 142.77 49.46 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.617 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 42.4 ttm105 -139.82 134.39 31.68 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.979 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -107.14 140.59 15.36 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 48.8 t -88.7 114.63 25.53 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -134.76 18.72 4.04 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.702 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.8 m -64.43 -34.66 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.958 0.379 . . . . 0.0 110.959 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 70.0 mt 63.28 2.22 1.09 Allowed 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.377 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -69.08 -36.48 77.66 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-O 121.053 0.454 . . . . 0.0 111.134 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.64 49.47 0.02 OUTLIER Glycine 0 C--O 1.234 0.109 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 18.3 t -60.87 -45.04 96.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.747 -0.726 . . . . 0.0 110.73 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -159.96 40.99 0.19 Allowed 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.434 0.635 . . . . 0.0 110.162 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 75.34 -48.12 0.61 Allowed 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.509 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 80.61 -87.57 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.3 0.64 . . . . 0.0 111.217 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.7 m -163.19 -50.09 0.04 OUTLIER 'General case' 0 C--N 1.346 0.444 0 CA-C-O 120.771 0.32 . . . . 0.0 110.62 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -172.97 171.85 44.71 Favored Glycine 0 CA--C 1.545 1.959 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.18 148.44 56.01 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.025 1.817 . . . . 0.0 112.49 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -140.37 82.39 16.55 Favored Pre-proline 0 CA--C 1.549 0.941 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.028 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -65.52 -16.57 54.47 Favored 'Trans proline' 0 N--CA 1.501 1.968 0 C-N-CA 121.977 1.785 . . . . 0.0 111.794 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.6 m . . . . . 0 C--N 1.349 0.564 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.997 -178.541 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.53 0.681 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.48 -37.64 84.38 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.212 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.0 m -58.9 -38.9 79.94 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.692 -177.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 64.9 t -111.52 126.49 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 121.03 0.443 . . . . 0.0 111.111 -178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -72.03 162.78 28.96 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.71 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -155.65 102.54 2.22 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.3 pt -139.75 170.22 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.53 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 t -108.99 156.9 19.19 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.146 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -68.07 159.09 81.74 Favored Pre-proline 0 CA--C 1.55 0.949 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.632 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.59 124.5 12.91 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.437 1.425 . . . . 0.0 110.942 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.28 -39.77 95.51 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.811 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 12' ' ' ILE . 33.0 mm -69.78 -2.19 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.73 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.3 t0 61.82 49.21 4.92 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 122.082 0.944 . . . . 0.0 109.018 -177.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -66.2 142.54 57.68 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.694 -177.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.96 165.96 39.15 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 57.16 39.8 28.66 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 120.856 0.36 . . . . 0.0 111.47 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -108.02 116.9 32.8 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.315 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.31 136.13 46.13 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.12 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.7 p -152.13 127.24 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.179 178.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -133.26 143.28 48.99 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.406 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.1 m -95.39 138.56 32.9 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.315 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -66.28 130.64 43.91 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 123.228 0.33 . . . . 0.0 110.111 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -66.31 -24.01 66.47 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.924 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.2 -27.68 14.43 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.761 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -127.48 53.92 11.49 Favored Pre-proline 0 CA--C 1.559 1.297 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.115 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -72.71 -22.48 20.51 Favored 'Trans proline' 0 N--CA 1.5 1.91 0 C-N-CA 122.143 1.896 . . . . 0.0 111.812 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 42.4 p-10 -74.67 -14.12 60.71 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.876 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 68.1 p -107.62 9.85 29.22 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.803 -0.18 . . . . 0.0 111.314 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 53.5 t -70.7 132.57 45.59 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 122.693 0.397 . . . . 0.0 110.545 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -131.0 152.14 50.64 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.309 -175.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -85.44 149.69 25.24 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.37 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -133.91 149.4 51.29 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.623 0.577 . . . . 0.0 111.568 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.0 pm0 -154.84 166.89 32.06 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.942 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.87 138.96 58.4 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.364 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -72.28 153.81 92.17 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.432 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.94 -25.47 11.96 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.365 2.043 . . . . 0.0 111.909 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -66.76 129.53 40.17 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.169 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -160.0 152.91 21.54 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.085 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -125.14 111.02 14.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -133.0 -173.34 13.26 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -178.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.4 p -70.78 152.98 43.19 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.587 0.232 . . . . 0.0 110.856 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -124.54 7.14 8.47 Favored Glycine 0 CA--C 1.54 1.62 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.438 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.1 m -65.72 -30.14 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 116.899 0.35 . . . . 0.0 111.262 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.4 mt 59.38 9.92 1.62 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.364 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.31 -36.17 83.22 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-O 120.9 0.381 . . . . 0.0 110.882 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.27 -34.31 0.2 Allowed Glycine 0 CA--C 1.531 1.058 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 47.24 22.95 0.28 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -149.17 120.74 7.99 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.128 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -170.5 17.12 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -147.93 -71.04 0.22 Allowed 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.0 t -161.93 160.71 28.19 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.313 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -147.69 148.03 19.23 Favored Glycine 0 CA--C 1.545 1.966 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -71.34 147.21 52.45 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 122.047 1.831 . . . . 0.0 112.188 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -136.33 60.39 32.42 Favored Pre-proline 0 CA--C 1.562 1.438 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.5 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -65.15 -22.29 61.59 Favored 'Trans proline' 0 N--CA 1.507 2.311 0 C-N-CA 122.029 1.819 . . . . 0.0 111.931 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.931 -179.179 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.54 152.9 38.76 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.52 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.3 p -70.2 157.48 37.56 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.978 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 81.1 t -65.52 -44.85 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.693 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -76.49 146.78 38.26 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.535 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -109.92 -29.12 8.41 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.846 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mp -123.26 125.8 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.773 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 m -112.83 35.93 3.68 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.931 0.396 . . . . 0.0 111.338 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 59.35 155.03 0.1 OUTLIER Pre-proline 0 CA--C 1.552 1.038 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.34 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.61 152.72 48.59 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 122.305 2.003 . . . . 0.0 112.016 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.88 146.94 26.65 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.674 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 42.0 mm -98.05 -53.21 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.24 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -143.18 -61.17 0.42 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.078 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 50.02 -86.35 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.406 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.99 -174.69 39.24 Favored Glycine 0 C--N 1.351 1.363 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -85.78 100.32 11.96 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.888 0.375 . . . . 0.0 110.793 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -157.39 165.05 36.79 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.635 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.66 154.51 36.52 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.421 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.8 p -136.02 150.5 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.585 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -120.18 152.9 37.01 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.203 0.525 . . . . 0.0 112.074 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.2 m -83.27 162.81 21.04 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.154 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -68.35 136.5 53.48 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.32 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.0 mttm -72.03 -25.4 61.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.142 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.39 -27.55 14.04 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.606 178.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -127.88 54.39 13.0 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.057 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -70.44 -30.57 18.92 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.838 1.692 . . . . 0.0 111.808 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -70.54 -29.34 65.79 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.385 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 63.9 p -116.17 20.96 14.03 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.798 -178.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 19.2 p -67.15 161.92 23.57 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.922 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm 55.01 85.69 0.06 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.188 178.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -121.45 -42.94 2.42 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.807 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.6 mmtt 66.09 35.22 6.36 Favored 'General case' 0 C--O 1.252 1.217 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.42 177.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -143.56 -44.38 0.28 Allowed 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.802 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 59.99 115.38 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.119 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -69.75 156.29 91.98 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.552 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -83.87 -23.77 3.02 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.605 2.204 . . . . 0.0 113.17 -177.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -60.48 -50.4 73.72 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.62 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 62.6 ttt-85 57.62 154.02 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.261 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -162.8 131.27 3.95 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.264 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.66 177.3 45.09 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 178.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 53.5 t -91.24 114.39 26.9 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.781 0.324 . . . . 0.0 110.561 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -141.07 38.23 1.57 Allowed Glycine 0 N--CA 1.466 0.671 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.424 HG12 ' H ' ' A' ' 45' ' ' GLU . 67.1 t -63.43 -41.18 91.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 73.2 mt 77.93 -13.14 0.99 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.007 0.923 . . . . 0.0 112.103 -176.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.424 ' H ' HG12 ' A' ' 43' ' ' VAL . 71.2 mm-40 -65.04 -36.84 85.65 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-O 120.826 0.346 . . . . 0.0 111.638 176.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.5 78.55 0.02 OUTLIER Glycine 0 C--O 1.237 0.302 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.5 t -90.23 83.74 6.02 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.163 0.506 . . . . 0.0 110.748 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -127.71 -41.64 1.66 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.439 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 63.2 140.03 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.855 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -67.78 -35.8 79.31 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.79 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 84.0 m -103.17 -67.37 0.89 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.203 -177.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.32 95.24 0.91 Allowed Glycine 0 CA--C 1.546 1.981 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -71.26 151.23 60.26 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.97 1.78 . . . . 0.0 112.081 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.426 ' HD2' HG22 ' A' ' 56' ' ' THR . 1.0 OUTLIER -142.5 61.4 11.41 Favored Pre-proline 0 CA--C 1.564 1.499 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.793 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -71.12 -23.17 25.05 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 122.211 1.941 . . . . 0.0 112.043 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.426 HG22 ' HD2' ' A' ' 54' ' ' LYS . 8.9 t . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.96 -1.019 . . . . 0.0 111.385 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.29 75.3 0.35 Allowed 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.099 0.476 . . . . 0.0 110.967 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.6 m -94.26 137.91 32.87 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.977 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.6 p -64.9 -32.44 58.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.389 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.9 tpp180 -62.3 130.22 44.29 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.308 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -148.27 99.95 3.1 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.318 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.0 mm -125.41 125.87 69.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.653 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.2 t -150.0 153.08 35.93 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.956 0.407 . . . . 0.0 111.921 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.807 ' CE1' ' HB2' ' A' ' 11' ' ' ALA . 46.1 p90 -133.7 154.08 80.42 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.402 178.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.56 -29.87 70.67 Favored 'Trans proline' 0 N--CA 1.507 2.285 0 C-N-CA 122.081 1.854 . . . . 0.0 113.415 -175.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.807 ' HB2' ' CE1' ' A' ' 9' ' ' TYR . . . 48.48 63.43 2.08 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.262 0.553 . . . . 0.0 110.788 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 46.2 mm -61.04 -47.12 95.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.342 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -163.08 39.1 0.1 Allowed 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.154 0.502 . . . . 0.0 110.774 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 70.3 mtp85 -100.97 114.23 27.95 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.499 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -138.99 141.18 11.62 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -137.08 152.15 49.7 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.595 0.236 . . . . 0.0 111.006 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 -155.22 160.09 40.59 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.25 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -156.25 152.92 28.35 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.968 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.1 m -71.3 -18.37 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.775 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -65.63 148.46 51.71 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.698 0.285 . . . . 0.0 110.926 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 77.0 m -80.0 143.77 33.82 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.328 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -71.33 130.29 41.01 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -67.06 -23.65 65.9 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 123.129 0.268 . . . . 0.0 110.949 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.07 -28.55 14.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.762 178.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -128.31 54.81 14.53 Favored Pre-proline 0 CA--C 1.555 1.17 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.3 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.19 -23.24 29.07 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.675 1.584 . . . . 0.0 111.338 177.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -63.35 -35.98 82.2 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.166 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.3 p -85.0 -7.68 59.04 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.601 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 52.4 t -61.61 132.5 53.51 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 123.136 0.272 . . . . 0.0 110.552 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -128.11 151.9 48.65 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.967 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -126.8 153.08 46.07 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.326 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -129.79 151.11 50.72 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.972 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -153.81 171.49 18.84 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.158 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.5 29.02 5.36 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.495 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 61.11 154.46 0.11 Allowed Pre-proline 0 CA--C 1.546 0.795 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.0 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.98 -24.34 15.23 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.376 2.051 . . . . 0.0 112.01 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -63.05 131.7 49.47 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.0 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -136.43 138.23 41.28 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.709 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 73.3 ttt-85 -156.07 140.67 16.92 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.9 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -127.98 162.64 21.78 Favored Glycine 0 N--CA 1.467 0.76 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 53.8 t -90.21 114.36 26.34 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.1 20.44 3.02 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.165 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.8 m -65.22 -32.57 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.777 0.322 . . . . 0.0 111.309 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.4 mt 64.37 2.28 1.5 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -66.59 -36.7 83.25 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.012 0.434 . . . . 0.0 110.84 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.14 55.94 0.02 OUTLIER Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.3 t -75.33 125.2 28.5 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.238 -0.481 . . . . 0.0 110.272 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.8 t-80 -155.29 142.47 19.33 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.875 0.369 . . . . 0.0 111.537 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -63.58 -39.32 94.08 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.691 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -103.15 152.17 21.75 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 120.809 0.337 . . . . 0.0 110.685 -176.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.1 m -64.52 -43.8 92.89 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.49 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -164.85 163.67 36.51 Favored Glycine 0 CA--C 1.543 1.811 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -73.01 -30.32 10.99 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 C-N-CA 122.223 1.949 . . . . 0.0 112.588 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -130.62 67.51 80.48 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.989 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -61.56 -20.7 69.71 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 122.599 2.199 . . . . 0.0 111.657 175.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.4 m . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 117.952 -1.023 . . . . 0.0 111.27 -178.629 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.69 140.01 58.69 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.147 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.8 p -70.6 154.4 41.9 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.101 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 4' ' ' VAL . 11.1 p -176.9 117.27 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.907 178.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 72.0 mtp85 -139.84 151.25 45.55 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.296 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -132.01 148.89 52.53 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.603 178.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.7 tt -134.28 145.47 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 123.233 0.333 . . . . 0.0 111.416 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.8 p -128.49 160.41 32.4 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.152 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -69.21 148.67 97.55 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.863 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.46 ' CG ' HD11 ' A' ' 12' ' ' ILE . 55.8 Cg_endo -69.24 -31.98 21.71 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 122.087 1.858 . . . . 0.0 112.926 -178.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 54.88 82.1 0.1 Allowed 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.095 0.474 . . . . 0.0 110.282 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.46 HD11 ' CG ' ' A' ' 10' ' ' PRO . 0.8 OUTLIER -121.44 41.21 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.261 -178.3 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.9 t0 77.69 -14.44 0.85 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.267 -175.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 51.64 31.3 7.65 Favored 'General case' 0 C--N 1.352 0.693 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 174.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.93 -170.78 41.67 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -88.87 104.07 16.59 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -98.44 133.9 42.18 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.628 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.0 137.49 58.23 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.923 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.8 t -126.44 128.01 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.64 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 68.0 m170 -108.92 130.03 55.43 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.061 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.8 m -72.28 156.26 39.3 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.814 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -66.9 131.58 46.19 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.086 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.03 -23.58 65.91 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.948 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.05 -28.63 14.06 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.733 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -128.01 54.76 14.07 Favored Pre-proline 0 CA--C 1.556 1.2 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.149 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.26 -26.01 25.68 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.897 1.731 . . . . 0.0 112.011 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -70.83 -27.42 63.85 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.137 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.7 p -113.1 12.65 19.19 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -175.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 21.9 p -68.19 149.43 49.55 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 121.014 -0.274 . . . . 0.0 110.942 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -142.19 -68.99 0.36 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.841 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -139.94 155.13 47.3 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.804 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -129.28 149.58 51.02 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.453 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -151.5 170.7 18.98 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.165 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.11 175.93 7.85 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.618 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -64.19 152.52 87.98 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.052 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -79.41 -19.88 9.99 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.599 2.199 . . . . 0.0 112.528 -177.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -59.28 -50.13 75.17 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.199 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -62.7 -48.16 80.46 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -172.08 142.05 1.38 Allowed 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.436 -178.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -107.77 141.62 15.73 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 5.7 p -76.14 155.03 35.0 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.856 0.36 . . . . 0.0 111.638 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -145.37 13.09 1.82 Allowed Glycine 0 CA--C 1.541 1.667 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.22 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.6 m -62.59 -27.2 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 116.794 0.297 . . . . 0.0 111.174 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.5 mt 70.06 -4.74 1.44 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.51 0.724 . . . . 0.0 112.823 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -66.19 -36.75 83.89 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.008 0.432 . . . . 0.0 110.539 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -167.66 53.3 0.23 Allowed Glycine 0 C--N 1.332 0.357 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.5 t -132.78 118.24 18.77 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.164 -0.518 . . . . 0.0 111.065 -177.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -160.69 97.86 1.2 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.606 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 67.1 ttt-85 -166.85 142.26 4.27 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.29 178.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -149.27 159.88 43.88 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.813 0.34 . . . . 0.0 111.744 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 t -152.94 150.68 29.51 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.45 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -141.64 64.45 0.51 Allowed Glycine 0 CA--C 1.545 1.925 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -70.54 153.54 65.27 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 122.256 1.97 . . . . 0.0 111.741 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -131.49 83.93 57.28 Favored Pre-proline 0 CA--C 1.554 1.111 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.708 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.62 -22.35 38.09 Favored 'Trans proline' 0 N--CA 1.503 2.047 0 C-N-CA 122.097 1.865 . . . . 0.0 111.947 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.4 m . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.992 -1.004 . . . . 0.0 111.009 -179.101 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.76 142.55 58.12 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.875 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.4 m -64.19 139.52 58.77 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.86 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.97 128.56 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.94 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -105.36 108.22 19.62 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.933 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -175.59 79.88 0.02 OUTLIER 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.383 178.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 mp -124.43 122.15 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.402 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.5 p -134.46 160.04 39.23 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.856 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -62.55 135.37 95.5 Favored Pre-proline 0 CA--C 1.557 1.214 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.46 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -70.7 153.8 64.41 Favored 'Trans proline' 0 N--CA 1.505 2.154 0 C-N-CA 122.174 1.916 . . . . 0.0 112.656 -178.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -114.03 138.4 50.43 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.429 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.6 mt -61.43 -47.21 94.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.106 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.0 p-10 -176.91 -36.34 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.122 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 48.74 -176.13 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.615 179.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.1 158.93 34.58 Favored Glycine 0 C--N 1.344 1.012 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -103.18 138.75 39.57 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.801 -0.2 . . . . 0.0 110.558 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -63.24 -40.68 98.12 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.818 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.32 142.0 50.45 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.854 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.0 p -142.32 145.21 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.16 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -115.94 134.36 55.05 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.205 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 99.0 m -75.59 156.37 35.03 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.075 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -67.64 134.14 50.62 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.268 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -69.07 -23.86 64.09 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.116 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.99 -27.55 14.19 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.672 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -128.5 55.14 15.95 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.895 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -69.91 -27.7 25.44 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.912 1.741 . . . . 0.0 111.951 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -70.67 -27.66 64.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.964 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 75.7 p -115.62 16.43 16.49 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 23.7 p -64.61 159.64 21.44 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.448 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -117.97 138.66 52.02 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.904 -178.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -87.52 -42.0 13.08 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.638 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -139.52 148.07 42.12 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.49 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -159.46 176.2 12.38 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.873 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -113.26 130.41 56.25 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.399 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.4 p30 -72.85 158.16 87.65 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.718 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.67 -19.77 7.18 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.464 2.109 . . . . 0.0 112.743 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -89.34 119.52 29.88 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.314 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -137.09 141.96 42.34 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.788 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 68.9 ttp85 -130.18 -44.71 1.14 Allowed 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.715 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.46 150.81 47.4 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.2 p -74.97 153.43 38.55 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.801 0.334 . . . . 0.0 111.081 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -145.87 4.12 1.18 Allowed Glycine 0 CA--C 1.541 1.702 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.429 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.2 m -64.8 -28.92 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 116.934 0.367 . . . . 0.0 111.279 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.8 mt 58.7 12.6 2.26 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.098 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -64.02 -36.6 84.53 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-O 120.98 0.419 . . . . 0.0 110.321 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.5 43.12 0.02 OUTLIER Glycine 0 C--N 1.333 0.399 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.8 t -62.74 -61.56 2.33 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.429 -0.386 . . . . 0.0 110.339 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 50.37 176.75 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.908 176.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -63.47 -45.2 91.9 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 177.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 173.18 86.8 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.658 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.5 m 62.86 104.49 0.03 OUTLIER 'General case' 0 C--N 1.344 0.365 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.061 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -122.5 140.74 13.6 Favored Glycine 0 CA--C 1.541 1.684 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.06 157.59 46.53 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.762 1.642 . . . . 0.0 112.143 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -130.78 81.25 67.88 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.612 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.35 -13.49 40.09 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 122.224 1.949 . . . . 0.0 111.977 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 C--N 1.35 0.603 0 CA-C-O 117.921 -1.037 . . . . 0.0 111.358 -178.401 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.79 146.15 55.23 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.868 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.1 t 59.63 109.0 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.927 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.2 m -129.09 157.75 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.145 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -76.08 159.55 30.66 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.058 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -126.61 129.76 49.16 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.5 tt -114.74 130.02 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.657 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 73.3 p -79.84 163.7 24.19 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.953 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -132.09 155.81 80.88 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.529 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.6 148.8 66.88 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 121.933 1.755 . . . . 0.0 111.996 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -154.06 156.46 37.35 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.853 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 77.4 mt -86.01 -66.81 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.529 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -127.88 17.07 6.81 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.6 mtt85 -62.24 -38.45 89.27 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.389 0.138 . . . . 0.0 111.363 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.02 20.16 37.97 Favored Glycine 0 N--CA 1.475 1.281 0 CA-C-N 116.361 -0.382 . . . . 0.0 112.614 -178.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 53.79 -178.96 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 122.321 0.248 . . . . 0.0 111.213 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -158.42 165.97 33.36 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.382 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.0 144.1 48.53 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.202 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.3 t -84.73 -70.93 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.712 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -133.83 112.84 11.65 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.208 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.6 m -95.61 157.58 15.83 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.375 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -66.83 138.56 57.43 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 123.256 0.348 . . . . 0.0 110.869 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -73.87 -24.35 59.72 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.736 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.44 -27.01 14.26 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.586 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -129.06 54.31 13.92 Favored Pre-proline 0 CA--C 1.556 1.193 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.154 177.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.42 -30.61 18.94 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.834 1.69 . . . . 0.0 111.694 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -71.11 -28.74 64.52 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.362 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.3 p -117.38 20.2 13.71 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.706 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 19.4 p -62.78 161.26 12.84 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.814 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt 63.72 143.61 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.513 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -135.2 154.53 51.57 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.15 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -129.93 152.05 49.82 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.733 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -148.01 163.93 35.35 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.074 0.464 . . . . 0.0 111.88 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 65.02 -79.39 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.456 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.28 140.92 0.04 OUTLIER Pre-proline 0 CA--C 1.565 1.543 0 C-N-CA 122.918 0.487 . . . . 0.0 112.299 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -79.52 -21.52 8.69 Favored 'Trans proline' 0 N--CA 1.5 1.892 0 C-N-CA 122.245 1.963 . . . . 0.0 112.196 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -60.17 -49.69 76.61 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.103 -178.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 58.7 ttt85 -162.49 140.64 8.62 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.223 0.327 . . . . 0.0 111.178 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.5 ttp-105 -145.32 -10.95 0.55 Allowed 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.289 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -164.33 169.69 39.24 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 25.3 p -78.89 159.91 27.54 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.839 0.352 . . . . 0.0 111.646 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -141.03 14.19 2.83 Favored Glycine 0 CA--C 1.544 1.86 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.139 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.4 m -65.08 -32.58 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 116.809 0.304 . . . . 0.0 111.423 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.5 mt 64.12 2.71 1.51 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -65.27 -36.51 84.32 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.002 0.43 . . . . 0.0 110.562 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.62 -58.5 0.07 OUTLIER Glycine 0 C--N 1.332 0.338 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.9 t 45.39 94.15 0.01 OUTLIER 'General case' 0 C--O 1.239 0.503 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -98.23 114.21 26.39 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.377 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 70.2 ttp85 -138.32 131.69 30.44 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.834 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -129.77 153.69 47.96 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.928 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 t -151.94 150.46 30.06 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 123.34 0.4 . . . . 0.0 111.684 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.75 57.27 0.05 OUTLIER Glycine 0 CA--C 1.545 1.936 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.66 155.46 66.2 Favored 'Trans proline' 0 N--CA 1.504 2.142 0 C-N-CA 122.438 2.092 . . . . 0.0 112.09 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -129.5 69.8 81.53 Favored Pre-proline 0 CA--C 1.561 1.381 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.538 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.21 -22.46 40.42 Favored 'Trans proline' 0 N--CA 1.505 2.179 0 C-N-CA 122.172 1.915 . . . . 0.0 112.001 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.973 -1.013 . . . . 0.0 111.665 -179.178 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.66 146.53 54.69 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.11 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.561 ' O ' HG22 ' A' ' 4' ' ' VAL . 68.7 m -66.04 158.19 29.01 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.458 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 3' ' ' SER . 12.8 m 55.73 141.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.476 1.11 . . . . 0.0 112.285 -178.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -59.96 -50.2 74.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.147 -175.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.1 t80 178.37 85.04 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.84 0.352 . . . . 0.0 110.42 178.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.4 pt -138.0 135.02 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.157 0.503 . . . . 0.0 111.524 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 28.8 m -149.89 136.86 19.49 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.006 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -110.96 144.0 29.46 Favored Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.993 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.53 157.72 22.08 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.407 2.071 . . . . 0.0 112.217 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -106.65 79.41 1.35 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.087 178.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.445 ' C ' HD12 ' A' ' 12' ' ' ILE . 2.9 pp -44.62 -15.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -176.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -65.9 -4.86 7.62 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 121.23 -0.188 . . . . 0.0 110.978 175.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 11' ' ' ALA . 63.0 mtp180 -33.33 128.63 0.3 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.027 0.931 . . . . 0.0 111.779 -178.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.08 -168.16 53.8 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -141.24 89.93 2.27 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 120.918 0.39 . . . . 0.0 110.425 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -82.0 -11.45 58.83 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.94 115.27 23.44 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.741 0.305 . . . . 0.0 111.11 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.0 p -152.07 136.89 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.834 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -86.58 152.44 22.61 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.502 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 82.1 m -67.65 139.34 56.8 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.036 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -69.06 132.83 47.25 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.92 -22.92 64.12 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 123.182 0.301 . . . . 0.0 110.969 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.94 -28.68 14.08 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.636 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -128.58 54.93 15.15 Favored Pre-proline 0 CA--C 1.557 1.247 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.326 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.85 -23.3 25.98 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 121.825 1.684 . . . . 0.0 111.432 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -63.23 -36.35 83.35 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.964 178.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.1 p -91.22 4.49 52.15 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.918 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.7 t -57.32 142.83 42.01 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.074 0.464 . . . . 0.0 110.959 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -55.4 129.24 37.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.722 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -70.23 -39.81 74.88 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.98 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -137.44 150.19 47.43 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.295 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -149.26 -44.02 0.14 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.054 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.74 140.16 58.84 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.983 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -80.89 152.54 71.96 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.735 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.47 -23.91 14.56 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.324 2.016 . . . . 0.0 111.995 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -65.95 131.89 47.31 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.067 -178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 80.2 ttt-85 -138.05 139.76 39.73 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.194 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -153.82 142.88 21.27 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.771 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.01 147.31 16.25 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 51.2 t -64.43 128.01 33.96 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.607 0.241 . . . . 0.0 110.77 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.09 17.34 1.36 Allowed Glycine 0 CA--C 1.539 1.554 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.308 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.5 m -66.01 -30.73 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 116.837 0.319 . . . . 0.0 111.437 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.3 mt 64.45 2.72 1.65 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -66.31 -36.11 82.1 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.921 0.391 . . . . 0.0 110.711 177.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.44 -48.12 0.11 Allowed Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 t 46.84 59.12 4.16 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.43 0.634 . . . . 0.0 111.376 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -154.4 162.37 41.2 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.197 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.0 ttt85 -91.4 -56.5 3.11 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.664 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -146.25 -174.27 4.4 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.97 178.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.9 m -125.05 121.98 35.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 108.26 129.22 5.95 Favored Glycine 0 CA--C 1.552 2.355 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.87 153.7 53.2 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.983 1.789 . . . . 0.0 112.082 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -130.1 70.41 82.16 Favored Pre-proline 0 CA--C 1.56 1.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.5 178.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.75 -23.67 35.57 Favored 'Trans proline' 0 N--CA 1.505 2.182 0 C-N-CA 122.317 2.011 . . . . 0.0 112.4 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.8 m . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.904 -1.046 . . . . 0.0 111.08 -178.967 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 18.0 pm0 . . . . . 0 N--CA 1.495 1.795 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.45 152.05 31.51 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-O 120.591 0.234 . . . . 0.0 110.92 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.2 p -155.8 161.73 40.6 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.127 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.14 157.56 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.917 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -137.36 129.63 29.49 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.202 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -141.87 132.14 24.96 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.3 tt -126.72 134.65 65.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.205 -178.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 8' ' ' THR . 5.2 t -157.87 88.27 0.96 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.496 178.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -72.58 134.19 82.15 Favored Pre-proline 0 CA--C 1.557 1.221 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.893 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -90.5 -76.61 0.0 OUTLIER 'Trans proline' 0 CA--C 1.555 1.544 0 C-N-CA 122.018 1.812 . . . . 0.0 112.056 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.606 ' O ' HG23 ' A' ' 12' ' ' ILE . . . 51.62 18.57 0.73 Allowed 'General case' 0 C--N 1.347 0.488 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 11' ' ' ALA . 1.2 pt -165.59 -83.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 178.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -60.58 -40.91 93.44 Favored 'General case' 0 C--N 1.345 0.379 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -178.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 70.7 mtp85 49.41 27.88 2.16 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.132 177.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.7 164.21 44.81 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.343 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.47 -33.82 75.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.11 -0.545 . . . . 0.0 111.101 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 78.13 -58.34 0.46 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.384 0.674 . . . . 0.0 110.919 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -104.29 99.03 8.74 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.696 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.6 p -150.63 142.13 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.929 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -132.2 150.26 52.2 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.652 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.3 m -72.03 151.9 42.82 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.913 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -74.17 134.43 42.78 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.035 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -71.36 -26.37 62.78 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.12 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -95.72 -28.37 14.82 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.58 177.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -127.83 53.46 10.66 Favored Pre-proline 0 CA--C 1.558 1.266 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.521 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.04 -25.6 19.24 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.903 1.735 . . . . 0.0 111.488 177.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -64.42 -35.57 81.34 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.142 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.8 p -82.59 -19.6 38.11 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.892 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.5 t -62.21 142.13 57.84 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.652 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -61.57 143.94 55.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.566 -177.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -129.82 153.34 48.35 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.718 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -129.7 150.37 51.05 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.741 -177.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -150.96 171.52 17.15 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.495 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.07 131.68 34.21 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 123.444 0.465 . . . . 0.0 110.946 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -73.52 154.17 89.75 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.817 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.1 -25.25 16.24 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.194 1.929 . . . . 0.0 111.686 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -64.57 129.82 41.28 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.35 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 56.3 ttt85 61.63 141.43 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.203 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -159.87 127.52 4.69 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.484 179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -107.25 150.86 16.86 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 51.2 t -63.67 124.85 22.48 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -143.88 16.59 2.18 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.363 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.9 m -63.6 -30.61 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.832 0.349 . . . . 0.0 111.331 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.2 mt 65.27 1.71 1.68 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -65.1 -36.77 85.36 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.976 0.417 . . . . 0.0 110.702 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.65 -52.09 0.11 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.4 t 45.52 66.25 0.96 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.201 0.524 . . . . 0.0 111.307 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 71.6 t60 58.76 99.88 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.198 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 40.0 ptt85 -53.86 149.81 8.36 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.784 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -146.54 149.03 32.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.593 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.2 t -158.26 159.38 35.94 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.551 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -149.68 162.65 29.16 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -71.42 149.75 56.97 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.057 1.838 . . . . 0.0 112.593 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -130.45 74.81 79.88 Favored Pre-proline 0 CA--C 1.558 1.254 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.904 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -66.17 -22.97 53.35 Favored 'Trans proline' 0 N--CA 1.506 2.211 0 C-N-CA 122.306 2.004 . . . . 0.0 112.113 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.1 m . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.077 -0.963 . . . . 0.0 111.055 -179.194 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.72 140.69 50.79 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.123 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 96.3 p -149.94 160.56 43.51 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.027 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 92.7 t -66.31 -41.68 89.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.193 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -125.89 151.43 46.92 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.1 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -130.29 148.19 52.09 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.594 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.8 tp -131.44 129.6 62.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.11 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.6 m -122.32 129.09 51.82 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.733 -178.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -72.71 155.73 90.6 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.309 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.85 140.18 45.5 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 121.815 1.676 . . . . 0.0 111.749 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -162.82 153.53 16.85 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.861 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.579 HD12 ' H ' ' A' ' 12' ' ' ILE . 3.7 mp -93.4 -48.28 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.325 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -169.79 -53.41 0.02 OUTLIER 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.78 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 54.22 177.64 0.03 OUTLIER 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.708 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -106.46 117.11 5.29 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.12 -40.51 97.82 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.59 0.233 . . . . 0.0 111.298 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -155.68 -91.81 0.04 OUTLIER 'General case' 0 CA--C 1.561 1.385 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.607 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -162.57 147.75 12.26 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 120.598 0.237 . . . . 0.0 111.072 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.496 HG22 ' HA3' ' A' ' 52' ' ' GLY . 36.0 m -136.11 157.53 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.174 178.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -127.96 161.96 27.89 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.372 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 84.8 m -85.02 138.89 32.17 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.739 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.63 128.78 37.57 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -66.05 -23.02 66.46 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 123.108 0.255 . . . . 0.0 110.945 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.31 -25.12 14.95 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.893 178.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.477 ' O ' HG22 ' A' ' 28' ' ' THR . 69.4 m80 -129.48 54.27 13.93 Favored Pre-proline 0 CA--C 1.558 1.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.92 178.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.9 -19.84 26.53 Favored 'Trans proline' 0 N--CA 1.5 1.898 0 C-N-CA 121.946 1.764 . . . . 0.0 111.632 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -62.32 -35.96 80.7 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.777 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 25' ' ' HIS . 8.1 t -82.25 -25.88 33.69 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.125 -179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 51.3 t -62.28 138.78 58.49 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.006 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -97.57 129.0 44.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.1 -176.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm -138.22 153.13 49.14 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.197 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -123.67 -33.04 3.25 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.266 -177.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -139.26 167.14 22.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.125 -177.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -161.77 162.4 29.56 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.858 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -125.71 152.65 72.55 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.358 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.18 -24.29 12.68 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.224 1.949 . . . . 0.0 112.384 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -82.76 -67.0 0.82 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.377 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 56.72 160.91 0.02 OUTLIER 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.298 178.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -150.19 140.12 21.92 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.902 179.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.08 117.52 4.86 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.706 -0.558 . . . . 0.0 111.706 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 38.8 t -91.59 161.67 14.84 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.677 -0.262 . . . . 0.0 110.563 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.78 -9.85 57.07 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 111.461 -0.655 . . . . 0.0 111.461 -176.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.432 HG23 ' H ' ' A' ' 45' ' ' GLU . 25.0 m -63.01 -24.17 35.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 120.805 0.336 . . . . 0.0 110.353 175.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.9 mt 67.83 1.28 2.61 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.452 0.701 . . . . 0.0 112.633 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.432 ' H ' HG23 ' A' ' 43' ' ' VAL . 95.5 mt-10 -66.46 -36.6 83.18 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-O 120.915 0.388 . . . . 0.0 110.505 175.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 169.68 88.95 0.07 OUTLIER Glycine 0 C--N 1.336 0.577 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.7 t -138.25 129.7 27.68 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.747 0.308 . . . . 0.0 110.825 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -154.96 163.53 40.18 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.232 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 57.1 ttt85 56.6 100.41 0.02 OUTLIER 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.206 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -116.68 173.23 6.74 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.363 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.5 m -114.26 127.7 56.01 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.206 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.496 ' HA3' HG22 ' A' ' 19' ' ' VAL . . . -160.53 73.77 0.21 Allowed Glycine 0 CA--C 1.544 1.899 0 CA-C-O 119.649 -0.528 . . . . 0.0 111.952 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -71.12 151.23 61.1 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.054 1.836 . . . . 0.0 111.754 179.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -130.22 69.92 82.08 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.688 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.11 -24.68 38.32 Favored 'Trans proline' 0 N--CA 1.505 2.169 0 C-N-CA 122.352 2.035 . . . . 0.0 112.351 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.2 m . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.74 -179.04 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 52.41 32.24 10.93 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.036 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.4 t -63.34 138.65 58.6 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.773 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.5 p -149.59 139.74 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.046 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 61.3 ttm-85 -145.48 139.99 27.22 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.713 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -130.21 148.82 52.09 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.076 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.1 tp -135.22 136.91 50.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.226 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 89.7 m -121.54 130.07 53.3 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.628 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -71.21 155.24 93.31 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.132 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.51 147.21 70.28 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.01 1.807 . . . . 0.0 112.347 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.68 156.2 34.52 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.22 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 87.5 mt -65.82 -66.16 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.164 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -176.62 48.41 0.01 OUTLIER 'General case' 0 C--O 1.245 0.84 0 CA-C-O 121.075 0.464 . . . . 0.0 110.85 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -93.18 119.51 32.45 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.228 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -97.52 -175.71 34.13 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -132.94 -71.75 0.52 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.28 0.086 . . . . 0.0 111.124 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -71.83 -49.59 37.09 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -174.41 154.78 2.18 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.058 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.0 m -132.56 152.58 36.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.759 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 66.2 t-80 -71.87 136.87 47.11 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.409 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.7 m -96.64 132.87 41.84 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.68 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -69.52 137.98 52.95 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.39 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -68.37 -27.48 66.28 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 123.273 0.358 . . . . 0.0 110.643 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.75 -30.09 15.05 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.917 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -127.29 54.19 11.95 Favored Pre-proline 0 CA--C 1.557 1.219 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.191 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.4 -23.3 20.62 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.004 1.803 . . . . 0.0 111.747 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 43.1 p30 -72.04 -16.96 62.05 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.934 -0.576 . . . . 0.0 112.08 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.7 m -84.51 -38.05 20.54 Favored 'General case' 0 C--N 1.345 0.384 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.9 t -62.59 128.98 38.54 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.975 -1.012 . . . . 0.0 111.128 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -138.58 136.8 36.37 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.514 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -65.36 -39.8 92.78 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.157 177.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -138.86 150.8 46.4 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.376 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -152.85 172.14 17.2 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.383 0.611 . . . . 0.0 112.478 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.27 -170.49 2.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.242 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -59.64 148.63 74.28 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.9 -24.37 21.07 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 122.314 2.009 . . . . 0.0 112.21 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -81.48 128.02 33.44 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.53 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -120.92 146.63 46.43 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.664 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -151.4 133.47 15.15 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.178 178.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -110.27 148.57 17.5 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.47 ' SG ' HG22 ' A' ' 43' ' ' VAL . 53.5 t -89.1 114.18 25.41 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -123.72 18.23 7.64 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.752 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.47 HG22 ' SG ' ' A' ' 41' ' ' CYS . 35.6 m -63.39 -31.62 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 116.85 0.325 . . . . 0.0 111.208 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.0 mt 66.88 -2.33 1.15 Allowed 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -66.42 -36.28 82.43 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.94 0.4 . . . . 0.0 110.844 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.05 -40.9 0.34 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 52.49 98.82 0.01 OUTLIER 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.754 0.312 . . . . 0.0 111.357 178.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -125.46 141.13 52.22 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.868 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -125.2 139.93 53.31 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.226 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -125.65 157.97 35.92 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.259 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.8 m -61.51 -42.51 98.92 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.157 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -166.78 179.12 40.81 Favored Glycine 0 CA--C 1.538 1.489 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.17 -32.72 10.29 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 121.815 1.677 . . . . 0.0 112.436 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -139.0 58.69 13.55 Favored Pre-proline 0 CA--C 1.562 1.439 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.132 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -62.52 -27.0 76.43 Favored 'Trans proline' 0 N--CA 1.507 2.294 0 C-N-CA 122.627 2.218 . . . . 0.0 111.839 176.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.7 m . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.034 -0.984 . . . . 0.0 111.164 -178.804 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.415 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 16.3 pt-20 . . . . . 0 N--CA 1.497 1.898 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 1' ' ' GLU . . . 75.34 -51.81 0.65 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.883 0.473 . . . . 0.0 111.472 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.3 p 63.13 138.89 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.739 0.304 . . . . 0.0 111.132 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.21 158.98 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.319 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -120.18 129.04 53.94 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.668 178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -108.36 -47.74 3.47 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.708 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.6 mm -119.34 128.4 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.567 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.0 t -75.89 -29.93 58.64 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -122.19 139.69 31.04 Favored Pre-proline 0 CA--C 1.558 1.287 0 N-CA-C 111.636 0.236 . . . . 0.0 111.636 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.18 -26.55 8.99 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.158 1.905 . . . . 0.0 112.594 178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.06 159.8 36.71 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.023 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 79.9 mt -72.63 -62.37 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.921 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -175.4 62.36 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.512 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -70.37 143.12 52.02 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.988 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.92 45.42 0.03 OUTLIER Glycine 0 C--N 1.343 0.932 0 N-CA-C 111.905 -0.478 . . . . 0.0 111.905 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.9 t70 52.01 47.12 25.39 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-O 121.206 0.527 . . . . 0.0 111.439 178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -72.49 146.29 46.95 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.078 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.21 153.0 34.08 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.638 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.1 m -105.42 -18.9 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.114 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -69.19 142.45 54.29 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.705 0.288 . . . . 0.0 110.881 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 82.0 m -92.97 135.9 33.74 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.011 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -66.11 134.41 52.74 Favored 'General case' 0 CA--C 1.512 -0.519 0 O-C-N 123.277 0.361 . . . . 0.0 110.097 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -71.13 -21.46 62.19 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.736 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.88 -28.61 13.75 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.434 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -128.4 54.96 15.03 Favored Pre-proline 0 CA--C 1.56 1.351 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.29 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.95 -24.45 24.2 Favored 'Trans proline' 0 N--CA 1.5 1.857 0 C-N-CA 121.931 1.754 . . . . 0.0 111.744 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -64.39 -34.58 78.5 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.105 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 68.4 p -89.13 -0.75 57.69 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.685 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.4 t -60.4 136.05 57.93 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 120.787 0.327 . . . . 0.0 110.649 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -65.73 130.97 45.14 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.862 -177.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.9 mmmm -137.02 153.61 50.6 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.835 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -125.08 -76.57 0.59 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 15.71 -79.68 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.437 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.04 165.49 1.86 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.763 0.316 . . . . 0.0 111.071 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -63.03 151.2 86.67 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.818 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -75.16 -22.98 13.97 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.536 2.157 . . . . 0.0 112.155 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -60.97 131.27 50.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.36 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -117.16 141.49 48.21 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.309 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -137.8 125.0 21.62 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.086 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.7 178.96 51.36 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.3 p -75.43 152.59 37.95 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.64 0.257 . . . . 0.0 110.924 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -102.7 5.2 50.85 Favored Glycine 0 CA--C 1.54 1.628 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.898 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.8 m -64.35 -30.49 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 116.965 0.383 . . . . 0.0 111.338 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.4 mt 62.69 6.05 1.94 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -65.74 -36.08 82.55 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.936 0.398 . . . . 0.0 110.982 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.73 -21.93 0.91 Allowed Glycine 0 CA--C 1.535 1.302 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.253 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 56.56 46.24 20.85 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.475 0.655 . . . . 0.0 110.648 178.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -60.62 -44.74 95.97 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.808 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -151.36 163.79 38.14 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.125 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -151.37 -60.97 0.17 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.68 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.1 t -150.59 150.56 31.35 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.378 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.87 163.82 36.34 Favored Glycine 0 CA--C 1.546 1.998 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.16 146.79 46.94 Favored 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 122.006 1.804 . . . . 0.0 112.181 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -142.13 82.71 13.06 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.207 178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -66.14 -16.31 51.63 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 121.972 1.781 . . . . 0.0 111.825 178.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.7 m . . . . . 0 C--N 1.349 0.567 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.832 -178.818 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.04 151.99 35.46 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.695 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 51.85 -175.68 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.543 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.8 t -120.38 67.72 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-O 121.172 0.51 . . . . 0.0 110.47 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.6 mmt-85 48.03 -179.24 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.114 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -145.18 -54.37 0.3 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.213 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.468 HG22 HG23 ' A' ' 8' ' ' THR . 92.4 mt -61.75 -45.52 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.768 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.468 HG23 HG22 ' A' ' 7' ' ' ILE . 81.8 p -129.76 159.76 35.51 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.043 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -134.69 156.34 78.73 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.005 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -71.4 150.03 57.58 Favored 'Trans proline' 0 N--CA 1.503 2.064 0 C-N-CA 122.153 1.902 . . . . 0.0 112.088 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -152.75 148.33 27.12 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.76 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.555 HD12 ' N ' ' A' ' 12' ' ' ILE . 3.9 mp -123.46 108.66 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.998 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.4 p30 29.32 40.56 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.921 0.888 . . . . 0.0 112.864 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -70.88 143.66 50.93 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.685 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.25 -179.46 16.69 Favored Glycine 0 N--CA 1.465 0.57 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -99.17 105.98 18.1 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.681 0.277 . . . . 0.0 110.956 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.598 ' CE1' HG22 ' A' ' 19' ' ' VAL . 31.2 p80 -163.57 175.44 10.66 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.311 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.18 -38.42 83.21 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.164 -177.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.598 HG22 ' CE1' ' A' ' 17' ' ' HIS . 21.9 t 73.1 133.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.507 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -134.49 160.54 37.69 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.651 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 68.5 m -87.54 158.91 18.8 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.888 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.31 137.31 57.85 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.319 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -68.19 -26.03 65.53 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.87 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -95.59 -28.24 14.94 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.839 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -128.35 54.31 13.28 Favored Pre-proline 0 CA--C 1.558 1.269 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.838 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.68 -25.43 24.36 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.194 1.929 . . . . 0.0 112.505 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -86.89 -11.49 50.57 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.125 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 67.9 p -127.35 17.84 7.03 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 30.3 p -60.32 160.41 8.6 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-O 120.828 0.347 . . . . 0.0 111.107 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -61.77 -41.69 98.03 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.961 -176.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -139.07 150.5 45.81 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.156 0.503 . . . . 0.0 111.67 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt 69.79 172.79 0.3 Allowed 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.479 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -152.9 -44.62 0.1 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.692 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.59 137.77 58.26 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.507 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -74.73 155.38 87.08 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.278 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.89 -24.11 18.09 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.219 1.946 . . . . 0.0 111.586 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -90.54 122.99 33.84 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.26 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -91.97 -63.63 1.22 Allowed 'General case' 0 CA--C 1.513 -0.468 0 O-C-N 123.277 0.36 . . . . 0.0 111.304 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -170.98 151.87 3.4 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.603 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.84 -176.32 47.79 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.431 ' SG ' HG22 ' A' ' 43' ' ' VAL . 21.9 p -66.84 156.87 34.47 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.751 0.31 . . . . 0.0 111.214 -178.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.34 1.39 46.66 Favored Glycine 0 CA--C 1.54 1.628 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.644 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.431 HG22 ' SG ' ' A' ' 41' ' ' CYS . 28.3 m -66.88 -28.96 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.952 0.376 . . . . 0.0 111.193 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.5 mt 57.96 12.36 1.75 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.364 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -64.74 -36.68 85.08 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.861 0.362 . . . . 0.0 110.723 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.49 -51.88 0.11 Allowed Glycine 0 C--N 1.334 0.461 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 55.63 41.06 30.95 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.096 0.474 . . . . 0.0 110.436 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -149.35 158.7 44.4 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.65 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 60.9 ttt85 -62.48 -48.62 78.81 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.349 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -148.53 162.8 38.92 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.034 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.1 m -62.69 -42.96 99.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.872 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -175.13 -177.25 44.07 Favored Glycine 0 CA--C 1.541 1.691 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -70.47 151.25 64.88 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.849 1.699 . . . . 0.0 112.081 -179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -129.85 71.53 82.14 Favored Pre-proline 0 CA--C 1.56 1.363 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.713 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -66.33 -24.57 50.22 Favored 'Trans proline' 0 N--CA 1.506 2.259 0 C-N-CA 122.231 1.954 . . . . 0.0 112.084 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 m . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 118.006 -0.997 . . . . 0.0 111.046 -179.054 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.41 -39.9 92.45 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.868 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.3 t -154.55 172.71 17.37 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.746 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.41 HG23 ' HD3' ' A' ' 5' ' ' ARG . 28.5 m -63.78 -27.98 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.122 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.41 ' HD3' HG23 ' A' ' 4' ' ' VAL . 0.5 OUTLIER -112.38 158.41 19.84 Favored 'General case' 0 C--N 1.343 0.326 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.011 177.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -114.77 19.83 15.65 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.654 179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.0 pt -125.6 157.88 34.69 Favored 'Isoleucine or valine' 0 C--N 1.344 0.362 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.658 -176.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.0 m -124.94 138.42 54.24 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.594 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -60.67 143.5 90.56 Favored Pre-proline 0 CA--C 1.551 0.996 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.25 -177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -78.79 161.13 27.51 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.432 2.088 . . . . 0.0 112.377 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 60.87 99.14 0.03 OUTLIER 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.227 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.2 mm -63.55 -44.88 98.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -149.74 -57.72 0.19 Allowed 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.995 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 45.82 -174.29 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.817 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.91 164.8 30.8 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -89.35 -40.43 12.77 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 120.524 0.202 . . . . 0.0 110.976 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -151.84 93.46 1.85 Allowed 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.27 -6.27 59.37 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.2 m 44.96 176.19 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -70.14 148.23 48.96 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.576 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 18.3 m -63.05 153.8 32.84 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.027 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -74.58 133.34 42.23 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.936 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -70.97 -26.72 63.28 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.147 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.21 -26.31 15.49 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.719 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -128.79 53.07 10.34 Favored Pre-proline 0 CA--C 1.559 1.311 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.515 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.0 -26.63 18.25 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.915 1.743 . . . . 0.0 111.435 177.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -65.29 -35.46 81.07 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.139 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 75.2 p -107.04 10.38 30.32 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 116.211 -0.449 . . . . 0.0 112.085 -178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 12.6 p -69.59 170.24 11.12 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 123.191 0.307 . . . . 0.0 110.489 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.8 mmmm -70.18 143.03 52.39 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.964 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -128.66 152.26 48.58 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.022 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -133.36 152.2 51.9 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.698 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -151.06 170.36 19.57 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.149 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -157.24 157.17 33.8 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.794 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.2 p30 -70.78 157.43 90.25 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.465 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.92 -23.71 6.49 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.368 2.045 . . . . 0.0 112.638 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -67.4 133.7 50.07 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.049 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -112.64 142.43 45.24 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.157 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 61.1 ttt85 -125.85 119.31 27.49 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.45 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.6 178.0 48.66 Favored Glycine 0 CA--C 1.522 0.469 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.954 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 41.0 t -91.13 115.2 27.83 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.335 -0.433 . . . . 0.0 110.441 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -136.71 11.16 3.99 Favored Glycine 0 CA--C 1.54 1.611 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.762 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 33.3 m -65.38 -32.74 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 117.101 0.45 . . . . 0.0 111.112 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.6 mt 63.31 3.66 1.44 Allowed 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -64.89 -36.61 84.92 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.07 0.462 . . . . 0.0 110.275 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -163.58 -72.88 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.8 t 65.48 -73.17 0.07 Allowed 'General case' 0 C--O 1.236 0.385 0 C-N-CA 122.833 0.453 . . . . 0.0 111.741 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -85.01 132.25 34.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 123.305 0.378 . . . . 0.0 110.135 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 20.2 tpp85 -60.17 -39.19 85.57 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.781 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 71.72 24.87 3.35 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.862 0.465 . . . . 0.0 111.058 -176.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.5 m -163.28 88.85 0.6 Allowed 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.965 177.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -172.04 63.29 0.15 Allowed Glycine 0 CA--C 1.539 1.552 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.8 -26.77 74.95 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.072 1.848 . . . . 0.0 112.158 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm 58.9 63.9 3.57 Favored Pre-proline 0 C--O 1.243 0.751 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -64.4 -23.25 65.36 Favored 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 121.713 1.609 . . . . 0.0 112.19 -176.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 CA--C 1.537 0.462 0 CA-C-O 117.961 -1.019 . . . . 0.0 111.917 -179.011 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 39.1 mp0 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.37 -42.15 98.24 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.599 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.6 t 47.43 -172.35 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.019 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.3 p -144.63 126.18 9.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -161.21 136.19 7.48 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.994 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -132.34 142.38 49.31 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.677 177.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.519 HG23 ' O ' ' A' ' 7' ' ' ILE . 6.3 tp -124.13 79.67 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 121.402 0.62 . . . . 0.0 110.679 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.5 p -118.27 -4.93 10.9 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.235 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -70.76 148.94 95.12 Favored Pre-proline 0 CA--C 1.55 0.973 0 CA-C-O 119.695 -0.193 . . . . 0.0 110.906 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -75.31 148.6 34.34 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.239 1.96 . . . . 0.0 111.943 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.7 139.93 16.59 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.509 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 24.0 mt -139.75 -124.87 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.573 1.845 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -65.73 -44.06 87.15 Favored 'General case' 0 C--N 1.36 1.062 0 CA-C-N 118.74 0.7 . . . . 0.0 110.65 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 47.89 -89.44 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.013 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.54 179.95 53.15 Favored Glycine 0 C--N 1.353 1.487 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -87.41 108.79 19.16 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.629 0.252 . . . . 0.0 110.847 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -110.77 130.89 55.45 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.444 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -109.3 130.33 55.5 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.079 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 79.3 t -63.75 -42.48 96.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.089 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -65.12 146.46 54.95 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.287 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 98.9 m -71.67 151.49 43.62 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.76 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -67.56 134.09 50.62 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 121.223 0.535 . . . . 0.0 110.471 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.8 ptmm? -71.23 -28.46 64.2 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 114.824 -1.08 . . . . 0.0 111.497 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.87 -24.01 16.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.64 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -129.9 52.53 9.55 Favored Pre-proline 0 CA--C 1.558 1.268 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.362 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -72.77 -23.41 19.23 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.814 1.676 . . . . 0.0 111.563 177.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.7 p-10 -75.35 -16.42 60.4 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.447 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.4 p -105.92 -6.52 18.8 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 120.456 0.169 . . . . 0.0 111.336 177.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 38.3 t -61.21 138.0 58.23 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.33 0.586 . . . . 0.0 111.042 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -73.61 147.56 43.71 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.92 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -101.81 -33.16 9.92 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -176.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt 76.4 166.09 0.26 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.773 0.429 . . . . 0.0 111.13 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -158.78 172.4 18.32 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.132 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.9 139.43 38.05 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.474 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.2 p30 -74.94 157.38 85.6 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.88 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -82.89 -21.4 4.83 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 C-N-CA 122.543 2.162 . . . . 0.0 112.576 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -80.66 129.16 34.36 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.568 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 57.6 ttm-85 -145.54 136.23 24.36 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.504 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 7.7 tpm_? -163.07 133.66 4.62 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.337 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.52 -179.95 51.47 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 49.7 t -89.74 114.56 26.26 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -136.65 26.39 3.04 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.22 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 36.0 m -62.28 -31.29 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.603 0.24 . . . . 0.0 111.413 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.5 mt 66.12 -1.26 1.2 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -67.37 -36.31 81.09 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.926 0.393 . . . . 0.0 110.684 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 156.35 49.29 0.01 OUTLIER Glycine 0 C--N 1.332 0.323 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 30.1 t -61.42 -47.56 85.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.98 -0.61 . . . . 0.0 111.011 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -159.5 119.98 3.11 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.574 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -63.54 -39.96 95.78 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.151 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 82.18 -78.66 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.746 0.818 . . . . 0.0 110.956 -178.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.2 t -156.2 151.99 27.28 Favored 'General case' 0 C--N 1.346 0.424 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -157.29 148.27 17.66 Favored Glycine 0 CA--C 1.55 2.226 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.94 151.9 51.17 Favored 'Trans proline' 0 N--CA 1.502 1.979 0 C-N-CA 122.19 1.927 . . . . 0.0 112.2 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -130.95 70.43 82.61 Favored Pre-proline 0 CA--C 1.562 1.412 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.708 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.18 -24.52 32.24 Favored 'Trans proline' 0 N--CA 1.507 2.305 0 C-N-CA 122.237 1.958 . . . . 0.0 112.423 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.7 m . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.058 -0.972 . . . . 0.0 111.093 -178.984 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.87 126.16 48.09 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.879 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.0 m -130.86 142.49 50.38 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.752 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.6 m -135.02 159.85 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.545 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.56 ' CG ' HD11 ' A' ' 7' ' ' ILE . 18.8 tpt85 -71.62 151.62 43.58 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.324 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -150.64 104.91 3.24 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.56 HD11 ' CG ' ' A' ' 5' ' ' ARG . 4.8 mp -119.38 118.67 58.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.587 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.3 m -131.26 128.05 39.07 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 123.318 0.386 . . . . 0.0 111.18 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -137.45 152.98 74.12 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.994 176.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.77 -17.99 32.59 Favored 'Trans proline' 0 N--CA 1.501 1.918 0 C-N-CA 122.298 1.999 . . . . 0.0 112.86 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 59.24 86.46 0.09 Allowed 'General case' 0 C--N 1.346 0.453 0 CA-C-O 120.868 0.366 . . . . 0.0 110.084 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 73.1 mt -84.83 96.01 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.61 -176.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 48.05 35.94 5.78 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.277 177.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -67.13 145.86 54.86 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.888 -178.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.66 158.29 31.46 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -62.62 -43.24 99.31 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 120.539 0.209 . . . . 0.0 111.118 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -133.39 147.06 51.75 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.073 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.33 152.0 29.73 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.011 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.5 t -122.67 129.34 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.884 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -99.27 145.7 27.0 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.693 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.1 m -65.65 155.21 36.62 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.242 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -70.48 139.03 51.6 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.048 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.93 -26.19 63.09 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.906 177.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.17 -29.15 15.28 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.796 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -128.0 54.29 12.88 Favored Pre-proline 0 CA--C 1.559 1.319 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.164 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.4 -28.1 18.45 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.965 1.777 . . . . 0.0 111.954 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 42.9 p-10 -81.53 -17.51 48.25 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.822 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.0 p -124.06 17.88 9.23 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 123.111 0.257 . . . . 0.0 111.406 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 21.4 p -66.47 158.16 30.23 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.573 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? 66.27 -170.2 0.2 Allowed 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.973 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -117.69 150.33 39.25 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.018 0.437 . . . . 0.0 110.804 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt 68.08 179.27 0.23 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.461 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -156.91 168.27 27.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 123.533 0.52 . . . . 0.0 111.197 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.42 169.59 9.81 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.849 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -66.33 152.26 94.66 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.528 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.77 -20.83 17.05 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.419 2.079 . . . . 0.0 112.668 -177.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -105.66 -102.27 0.33 Allowed 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.728 -175.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -179.19 161.98 1.16 Allowed 'General case' 0 C--N 1.359 1.02 0 CA-C-N 118.054 0.388 . . . . 0.0 110.087 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -113.45 124.36 52.24 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 176.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.21 151.19 50.92 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.364 -0.446 . . . . 0.0 111.994 -176.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.4 p -75.64 159.36 31.26 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.423 -0.388 . . . . 0.0 111.184 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.59 6.85 1.26 Allowed Glycine 0 CA--C 1.54 1.649 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.639 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.0 m -66.26 -32.02 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 117.054 0.427 . . . . 0.0 110.96 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.0 mt 62.79 4.13 1.36 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -66.2 -36.77 83.94 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.869 0.366 . . . . 0.0 110.678 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 169.66 73.7 0.04 OUTLIER Glycine 0 C--N 1.33 0.24 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.5 t -117.61 118.95 33.53 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.452 -0.374 . . . . 0.0 110.67 -177.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -134.4 -59.73 0.81 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.999 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 44.0 ttm180 -143.7 127.47 17.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.144 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.8 mp0 -66.6 -45.68 78.39 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.014 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.5 p -141.79 151.54 42.92 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.58 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 154.86 -173.07 33.26 Favored Glycine 0 CA--C 1.54 1.617 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.05 161.85 42.36 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.025 1.816 . . . . 0.0 111.29 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -126.04 72.96 71.05 Favored Pre-proline 0 CA--C 1.559 1.311 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.305 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -69.94 -24.28 29.01 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.279 1.986 . . . . 0.0 112.196 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.1 m . . . . . 0 C--O 1.219 -0.526 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.869 -179.019 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 . . . . . 0 N--CA 1.497 1.884 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.5 -73.15 0.33 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.278 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.8 t -158.78 147.13 18.3 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-O 120.549 0.214 . . . . 0.0 111.285 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.1 p -140.43 136.62 36.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.404 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 90.6 mtm180 -87.6 140.57 29.39 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.259 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -147.4 131.53 17.34 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.6 tt -134.67 141.87 42.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.2 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.3 t -148.26 151.77 36.01 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.05 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -70.73 149.91 95.27 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.983 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.18 148.26 43.89 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 122.169 1.913 . . . . 0.0 112.082 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.581 ' HB1' ' HB2' ' A' ' 14' ' ' ARG . . . -118.81 -28.22 5.64 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.384 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 72.6 mt 60.73 -100.98 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.473 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.322 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -102.06 5.57 40.6 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.581 ' HB2' ' HB1' ' A' ' 11' ' ' ALA . 90.9 mtt-85 -71.61 140.89 49.95 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.504 -178.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -142.37 75.81 0.31 Allowed Glycine 0 C--N 1.342 0.868 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -67.56 149.67 49.82 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 120.476 0.179 . . . . 0.0 110.664 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -149.08 160.97 42.86 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.242 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -99.54 16.42 23.37 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.49 HG12 ' NZ ' ' A' ' 30' ' ' LYS . 47.3 t -109.6 121.34 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.4 p-80 -80.81 167.32 20.07 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.305 -178.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 45.8 m -74.94 165.07 25.84 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.972 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -72.98 139.48 46.72 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.229 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -70.22 -26.89 64.08 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.91 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.13 -29.16 15.29 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.878 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -127.54 53.86 11.39 Favored Pre-proline 0 CA--C 1.556 1.205 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.982 177.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.82 -28.29 16.9 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.937 1.758 . . . . 0.0 111.919 178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -80.67 -17.72 50.24 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.738 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.4 m -131.65 28.88 4.56 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.814 0.34 . . . . 0.0 110.869 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 24.8 p -67.48 150.69 48.54 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.316 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.49 ' NZ ' HG12 ' A' ' 19' ' ' VAL . 59.0 mmtt 59.07 179.59 0.08 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.916 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -138.58 158.44 44.24 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.812 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -130.72 151.66 50.92 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.531 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.1 pm0 -148.72 167.57 25.19 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.226 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -58.25 138.58 56.21 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.882 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -73.69 155.12 89.29 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.057 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -72.09 -23.88 21.01 Favored 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 122.224 1.949 . . . . 0.0 111.834 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -90.06 125.09 35.29 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.738 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -94.77 -73.05 0.59 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.688 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.4 ttp-105 -172.84 142.16 1.1 Allowed 'General case' 0 C--N 1.349 0.559 0 O-C-N 123.098 0.248 . . . . 0.0 110.915 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -110.76 157.95 14.68 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 15.0 p -68.7 152.8 44.85 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.685 0.279 . . . . 0.0 111.007 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -103.52 11.96 54.15 Favored Glycine 0 CA--C 1.536 1.379 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.032 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.56 -32.44 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.7 mt 64.39 7.01 3.34 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.244 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -66.1 -36.31 82.84 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-O 120.808 0.337 . . . . 0.0 111.1 177.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.52 -37.28 0.25 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 54.5 41.94 31.65 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-O 121.063 0.459 . . . . 0.0 110.823 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -85.6 102.97 14.01 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.531 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -100.53 109.83 21.96 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.214 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -168.5 155.6 7.61 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.847 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 t -155.61 152.72 29.08 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.394 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -173.59 166.37 38.65 Favored Glycine 0 CA--C 1.544 1.864 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.65 144.49 44.51 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 121.856 1.704 . . . . 0.0 112.007 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.95 55.21 2.33 Favored Pre-proline 0 CA--C 1.558 1.287 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.653 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -67.37 -24.81 42.74 Favored 'Trans proline' 0 N--CA 1.506 2.256 0 C-N-CA 122.287 1.991 . . . . 0.0 112.258 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 C--O 1.218 -0.554 0 CA-C-O 118.049 -0.977 . . . . 0.0 110.895 -179.215 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.03 128.39 54.62 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.835 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.2 t -172.54 -43.73 0.02 OUTLIER 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.948 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.1 p -137.49 149.66 25.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.726 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 56.4 mmm-85 -64.12 144.84 56.81 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.595 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -157.87 93.34 1.25 Allowed 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.6 pt -133.64 155.65 40.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.098 -177.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 67.0 p -118.67 20.88 12.78 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.615 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 63.04 155.19 0.12 Allowed Pre-proline 0 CA--C 1.544 0.74 0 CA-C-O 119.412 -0.327 . . . . 0.0 110.16 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.74 -61.88 0.22 Allowed 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.806 1.671 . . . . 0.0 112.232 -178.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 47.65 90.71 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.79 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 43.9 pt -97.01 -174.99 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.556 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 59.3 p30 -94.25 61.14 2.82 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 121.538 0.685 . . . . 0.0 110.89 -178.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -61.14 -43.02 99.53 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.142 -0.936 . . . . 0.0 111.123 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.31 -172.72 31.51 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -98.65 -93.89 0.24 Allowed 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 178.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -176.43 -98.42 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 122.469 0.308 . . . . 0.0 110.679 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -164.86 149.16 9.09 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.66 159.1 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 120.884 0.373 . . . . 0.0 111.65 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -131.74 150.22 52.22 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.971 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.1 m -72.51 136.24 45.86 Favored 'General case' 0 C--O 1.238 0.485 0 O-C-N 123.324 0.39 . . . . 0.0 110.36 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -70.3 132.77 46.2 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.56 -22.25 64.5 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 123.2 0.313 . . . . 0.0 111.058 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.2 -27.58 14.1 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.599 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -128.88 54.81 15.17 Favored Pre-proline 0 CA--C 1.557 1.22 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.375 178.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -70.82 -23.38 26.03 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.881 1.721 . . . . 0.0 111.637 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -61.5 -36.66 81.12 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.171 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 69.9 p -88.74 -0.03 56.92 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.047 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 53.8 t -61.1 131.49 50.72 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.672 0.272 . . . . 0.0 110.748 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 150.12 25.17 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.621 -179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -129.96 154.45 47.35 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.659 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -130.46 151.23 51.17 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.745 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.0 pm0 -152.54 162.27 41.44 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.491 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.81 156.44 41.82 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.447 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -70.68 152.52 95.23 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.079 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -80.25 -22.05 7.33 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.46 2.107 . . . . 0.0 112.629 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -63.68 129.04 38.49 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.309 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.4 ttt-85 -150.53 140.58 22.05 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.511 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -136.17 -26.24 1.16 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.117 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.74 150.92 49.62 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.7 p -69.11 155.7 39.92 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.725 0.298 . . . . 0.0 111.271 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -122.2 16.67 8.64 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.246 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.1 m -61.54 -34.38 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 116.823 0.312 . . . . 0.0 111.356 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.7 mt 67.98 -6.08 0.77 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -64.96 -35.85 82.48 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.025 0.44 . . . . 0.0 110.763 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.28 -24.16 0.68 Allowed Glycine 0 CA--C 1.535 1.288 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.034 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 58.7 70.5 0.65 Allowed 'General case' 0 C--O 1.243 0.714 0 CA-C-O 121.332 0.587 . . . . 0.0 110.953 178.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 63.3 t-80 -155.25 139.6 16.72 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.678 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -69.64 134.39 48.67 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.176 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -127.29 153.77 45.74 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.782 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.9 t -155.8 -30.38 0.1 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.917 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.72 56.72 1.71 Allowed Glycine 0 CA--C 1.54 1.641 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.32 146.54 63.21 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 122.019 1.813 . . . . 0.0 111.551 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -149.05 82.27 7.17 Favored Pre-proline 0 CA--C 1.554 1.114 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.311 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.06 -29.09 56.96 Favored 'Trans proline' 0 N--CA 1.505 2.149 0 C-N-CA 122.005 1.803 . . . . 0.0 111.518 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 CA--C 1.541 0.62 0 CA-C-O 117.841 -1.076 . . . . 0.0 112.167 179.663 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.6 152.1 37.36 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.688 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.3 m -120.13 150.54 40.46 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.764 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.1 p -133.36 138.23 51.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.008 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.526 ' NE ' HD11 ' A' ' 7' ' ' ILE . 12.6 tpt180 -69.41 133.86 48.28 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.932 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -141.56 101.04 3.9 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.287 0.367 . . . . 0.0 110.045 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.526 HD11 ' NE ' ' A' ' 5' ' ' ARG . 81.1 mt -123.01 129.5 75.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.314 -178.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.9 m -102.0 126.03 48.83 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -71.67 152.44 93.55 Favored Pre-proline 0 CA--C 1.556 1.203 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.223 -176.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -81.29 164.77 19.19 Favored 'Trans proline' 0 N--CA 1.502 1.992 0 C-N-CA 122.592 2.195 . . . . 0.0 112.56 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -137.29 144.37 42.62 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.35 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.476 HG22 ' H ' ' A' ' 13' ' ' ASP . 0.3 OUTLIER -98.67 -158.73 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.282 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.2 -178.687 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.476 ' H ' HG22 ' A' ' 12' ' ' ILE . 69.2 m-20 -93.57 10.22 33.51 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -178.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -60.6 140.62 57.33 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 120.832 0.348 . . . . 0.0 111.025 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.89 149.19 19.67 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 110.686 -0.965 . . . . 0.0 110.686 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -99.73 120.35 39.58 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.723 0.297 . . . . 0.0 110.989 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -68.82 145.41 53.76 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.941 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.4 140.74 38.85 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.375 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.3 m -90.1 15.33 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -60.12 137.1 58.17 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 74.6 m -87.71 147.15 25.35 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.995 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -73.28 133.41 43.91 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.024 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -70.64 -23.76 62.59 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.059 0.224 . . . . 0.0 110.714 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.62 -28.29 15.45 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.708 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -130.54 53.58 12.17 Favored Pre-proline 0 CA--C 1.559 1.308 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.501 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -73.87 -20.38 19.78 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.016 1.811 . . . . 0.0 111.809 178.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -73.8 -15.84 61.17 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.026 -0.533 . . . . 0.0 112.289 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.7 t -108.1 4.6 25.14 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 111.606 0.225 . . . . 0.0 111.606 177.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 46.6 t -61.84 137.17 58.22 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.73 128.49 36.69 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.413 -176.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp 55.08 173.45 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.366 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -138.78 -47.48 0.5 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.434 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -74.96 165.88 24.55 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.942 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.95 142.63 24.59 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.188 178.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -74.49 149.69 86.54 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.823 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -79.77 -21.62 8.28 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.261 1.974 . . . . 0.0 112.226 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -67.29 128.89 38.11 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.064 -178.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 68.4 ttp85 -161.26 147.1 14.24 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.934 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -131.9 134.23 45.46 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.445 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.03 174.75 54.84 Favored Glycine 0 CA--C 1.518 0.219 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.118 -177.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.436 ' SG ' HG23 ' A' ' 43' ' ' VAL . 48.0 t -76.37 121.07 22.49 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 114.896 -0.652 . . . . 0.0 111.224 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -134.79 42.23 1.37 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.436 HG23 ' SG ' ' A' ' 41' ' ' CYS . 62.9 t -61.91 -42.06 93.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.3 mt 77.17 -12.96 1.0 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.03 0.932 . . . . 0.0 112.083 -177.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.418 ' H ' HG12 ' A' ' 43' ' ' VAL . 95.4 mt-10 -65.92 -36.86 84.54 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.943 0.401 . . . . 0.0 111.382 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.6 38.48 0.02 OUTLIER Glycine 0 N--CA 1.464 0.504 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 37.3 t -63.26 -41.86 99.09 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 123.302 0.641 . . . . 0.0 111.382 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -59.66 -42.32 92.58 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.563 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 64.88 82.29 0.19 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.0 0.429 . . . . 0.0 110.935 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -89.66 -53.66 4.42 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.909 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.2 p 50.35 92.8 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.519 -177.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -123.57 139.25 12.02 Favored Glycine 0 CA--C 1.543 1.798 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.07 156.96 51.48 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.749 1.633 . . . . 0.0 111.761 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -129.69 70.55 82.0 Favored Pre-proline 0 CA--C 1.56 1.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.773 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.82 -20.22 39.79 Favored 'Trans proline' 0 N--CA 1.505 2.182 0 C-N-CA 122.279 1.986 . . . . 0.0 112.165 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.6 t . . . . . 0 CA--C 1.537 0.463 0 CA-C-O 118.022 -0.99 . . . . 0.0 111.594 -178.884 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 121.36 0.6 . . . . 0.0 109.704 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.83 -17.4 64.0 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.932 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.7 m -59.98 -39.6 86.22 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.251 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.6 m 42.24 62.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-O 121.401 0.619 . . . . 0.0 111.568 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -61.89 130.09 44.02 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.327 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -73.2 -29.82 63.08 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.956 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.4 mm -74.87 113.92 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.533 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 76.5 m -132.51 130.23 40.16 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.882 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -94.01 149.22 36.56 Favored Pre-proline 0 CA--C 1.555 1.143 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.452 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.27 160.3 36.05 Favored 'Trans proline' 0 N--CA 1.5 1.86 0 C-N-CA 122.423 2.082 . . . . 0.0 112.178 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.73 134.61 49.61 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.952 178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 47.1 mm -120.17 140.18 45.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.2 p30 -63.62 77.58 0.03 OUTLIER 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.557 0.694 . . . . 0.0 110.45 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.7 mmp_? -61.49 -43.49 98.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.045 -177.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.2 173.0 40.95 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.457 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -109.02 108.07 18.65 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.791 -0.205 . . . . 0.0 110.506 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -79.42 66.41 4.87 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.475 0.655 . . . . 0.0 110.489 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -158.49 157.2 31.68 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.88 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.7 t -117.91 126.31 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.724 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -71.11 169.48 14.94 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.522 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 73.9 m -93.96 137.29 33.33 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.138 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -66.58 131.5 46.14 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.89 -23.54 66.01 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.863 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.88 -27.95 14.05 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.658 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -127.92 54.7 13.81 Favored Pre-proline 0 CA--C 1.558 1.27 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.079 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -69.83 -25.23 28.5 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.868 1.712 . . . . 0.0 111.595 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -63.09 -37.57 87.72 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.618 177.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 85.9 m -67.57 -38.57 84.3 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.669 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 53.6 t -49.09 139.08 11.12 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.706 -177.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm -64.86 148.34 51.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.683 -177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -129.92 155.1 46.6 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.18 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -129.58 149.49 51.32 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.333 -176.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -153.05 -41.51 0.1 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.007 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 64.03 173.34 0.18 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.142 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -71.38 154.75 93.44 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.777 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -89.52 -68.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.441 2.094 . . . . 0.0 111.048 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 51.0 t80 34.78 93.78 0.01 OUTLIER 'General case' 0 C--N 1.353 0.734 0 C-N-CA 123.25 0.62 . . . . 0.0 112.66 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.8 mtt180 64.18 162.73 0.12 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.452 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.15 -39.73 1.89 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.495 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -132.45 157.36 22.5 Favored Glycine 0 C--N 1.338 0.653 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 21.6 p -68.79 149.09 49.39 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.116 0.484 . . . . 0.0 111.286 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.89 18.78 0.35 Allowed Glycine 0 CA--C 1.536 1.359 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.098 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.3 t -66.19 -38.77 82.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.1 mt 69.09 23.37 6.52 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.231 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -102.96 -35.18 8.67 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.396 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 179.26 78.64 0.06 OUTLIER Glycine 0 C--N 1.334 0.421 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.1 t -136.03 122.31 20.47 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -133.53 148.94 51.69 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.438 -177.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -117.59 123.64 46.7 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.178 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -159.87 164.99 33.12 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.569 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 63.2 p -67.96 -35.4 78.31 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.101 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 169.54 177.69 40.25 Favored Glycine 0 CA--C 1.543 1.827 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.31 149.16 50.54 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.011 1.808 . . . . 0.0 112.151 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -136.32 80.37 40.17 Favored Pre-proline 0 CA--C 1.557 1.234 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.715 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.04 -24.88 44.68 Favored 'Trans proline' 0 N--CA 1.506 2.253 0 C-N-CA 122.188 1.925 . . . . 0.0 112.062 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 117.89 -1.052 . . . . 0.0 110.92 -179.31 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.464 ' O ' HG22 ' A' ' 4' ' ' VAL . 31.4 mt-10 . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.03 142.26 57.88 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.816 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 t 59.15 62.97 1.7 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.538 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 1' ' ' GLU . 34.9 m -133.25 157.94 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.97 178.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.9 tmm_? -97.98 118.9 35.59 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.307 178.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -116.78 -36.56 3.85 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.71 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.1 mp -102.57 121.23 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.982 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 70.7 m -106.95 103.72 13.22 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.194 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -171.96 136.26 0.91 Allowed Pre-proline 0 CA--C 1.557 1.242 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.485 178.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -74.28 150.79 42.49 Favored 'Trans proline' 0 N--CA 1.503 2.067 0 C-N-CA 122.059 1.839 . . . . 0.0 111.916 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.16 94.39 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.627 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 13' ' ' ASP . 73.9 mt -127.17 162.74 31.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.445 ' N ' HG22 ' A' ' 12' ' ' ILE . 57.2 p30 -58.78 -20.58 51.04 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 122.986 0.179 . . . . 0.0 111.467 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 42.63 -167.28 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 122.473 0.309 . . . . 0.0 111.757 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.01 -175.51 54.79 Favored Glycine 0 C--N 1.35 1.33 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -100.16 120.23 39.56 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.678 0.275 . . . . 0.0 110.629 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -65.28 -39.96 93.25 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.072 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.48 144.14 53.31 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.94 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.54 138.27 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.502 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 54.5 p-80 -134.25 162.6 31.72 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.707 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 96.9 m -72.31 159.9 33.28 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.802 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -61.67 136.68 58.1 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.197 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -69.82 -23.37 63.3 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.601 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.64 -29.12 14.01 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.752 178.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -128.51 53.8 12.09 Favored Pre-proline 0 CA--C 1.56 1.358 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.208 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.69 -21.86 24.77 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.054 1.836 . . . . 0.0 112.942 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -85.95 -10.3 55.41 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.9 t -131.6 19.53 4.71 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 30.5 p -62.75 152.14 36.58 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -119.32 -47.06 2.47 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -176.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? 61.18 176.84 0.11 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.669 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -138.49 149.96 45.93 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 123.208 0.317 . . . . 0.0 111.042 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.3 pm0 -159.21 167.72 28.34 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.16 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 59.64 166.9 0.07 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.556 178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -71.67 153.23 93.47 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.665 179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.14 -27.9 13.31 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.116 1.877 . . . . 0.0 111.874 -178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -76.42 135.1 39.43 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.536 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 77.0 ttt-85 -132.35 142.77 49.46 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.617 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 42.4 ttm105 -139.82 134.39 31.68 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.979 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -107.14 140.59 15.36 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 48.8 t -88.7 114.63 25.53 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -134.76 18.72 4.04 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.702 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.8 m -64.43 -34.66 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.958 0.379 . . . . 0.0 110.959 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 70.0 mt 63.28 2.22 1.09 Allowed 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.377 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -69.08 -36.48 77.66 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-O 121.053 0.454 . . . . 0.0 111.134 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.64 49.47 0.02 OUTLIER Glycine 0 C--O 1.234 0.109 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 18.3 t -60.87 -45.04 96.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.747 -0.726 . . . . 0.0 110.73 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -159.96 40.99 0.19 Allowed 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.434 0.635 . . . . 0.0 110.162 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 75.34 -48.12 0.61 Allowed 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.509 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 80.61 -87.57 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.3 0.64 . . . . 0.0 111.217 178.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.7 m -163.19 -50.09 0.04 OUTLIER 'General case' 0 C--N 1.346 0.444 0 CA-C-O 120.771 0.32 . . . . 0.0 110.62 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -172.97 171.85 44.71 Favored Glycine 0 CA--C 1.545 1.959 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.18 148.44 56.01 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.025 1.817 . . . . 0.0 112.49 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -140.37 82.39 16.55 Favored Pre-proline 0 CA--C 1.549 0.941 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.028 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -65.52 -16.57 54.47 Favored 'Trans proline' 0 N--CA 1.501 1.968 0 C-N-CA 121.977 1.785 . . . . 0.0 111.794 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.6 m . . . . . 0 C--N 1.349 0.564 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.997 -178.541 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.53 0.681 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.48 -37.64 84.38 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.212 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.0 m -58.9 -38.9 79.94 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.692 -177.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 64.9 t -111.52 126.49 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 121.03 0.443 . . . . 0.0 111.111 -178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 -72.03 162.78 28.96 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.71 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -155.65 102.54 2.22 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.3 pt -139.75 170.22 15.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.53 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 7.7 t -108.99 156.9 19.19 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.146 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -68.07 159.09 81.74 Favored Pre-proline 0 CA--C 1.55 0.949 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.632 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.59 124.5 12.91 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.437 1.425 . . . . 0.0 110.942 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.28 -39.77 95.51 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.811 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.485 ' O ' HG22 ' A' ' 12' ' ' ILE . 33.0 mm -69.78 -2.19 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.001 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.73 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.3 t0 61.82 49.21 4.92 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 122.082 0.944 . . . . 0.0 109.018 -177.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -66.2 142.54 57.68 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.694 -177.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -170.96 165.96 39.15 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.2 t70 57.16 39.8 28.66 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 120.856 0.36 . . . . 0.0 111.47 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -108.02 116.9 32.8 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.315 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.31 136.13 46.13 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.12 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.7 p -152.13 127.24 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.179 178.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -133.26 143.28 48.99 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.406 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 80.1 m -95.39 138.56 32.9 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.315 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -66.28 130.64 43.91 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 123.228 0.33 . . . . 0.0 110.111 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -66.31 -24.01 66.47 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.924 179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.2 -27.68 14.43 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.761 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -127.48 53.92 11.49 Favored Pre-proline 0 CA--C 1.559 1.297 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.115 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -72.71 -22.48 20.51 Favored 'Trans proline' 0 N--CA 1.5 1.91 0 C-N-CA 122.143 1.896 . . . . 0.0 111.812 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 42.4 p-10 -74.67 -14.12 60.71 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.876 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 68.1 p -107.62 9.85 29.22 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.803 -0.18 . . . . 0.0 111.314 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 53.5 t -70.7 132.57 45.59 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 122.693 0.397 . . . . 0.0 110.545 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -131.0 152.14 50.64 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.309 -175.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -85.44 149.69 25.24 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.37 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -133.91 149.4 51.29 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.623 0.577 . . . . 0.0 111.568 -174.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.0 pm0 -154.84 166.89 32.06 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.942 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.87 138.96 58.4 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.364 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -72.28 153.81 92.17 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.432 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.94 -25.47 11.96 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 122.365 2.043 . . . . 0.0 111.909 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -66.76 129.53 40.17 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.169 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 -160.0 152.91 21.54 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.085 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -125.14 111.02 14.82 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -133.0 -173.34 13.26 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -178.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.4 p -70.78 152.98 43.19 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.587 0.232 . . . . 0.0 110.856 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -124.54 7.14 8.47 Favored Glycine 0 CA--C 1.54 1.62 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.438 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.1 m -65.72 -30.14 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 116.899 0.35 . . . . 0.0 111.262 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.4 mt 59.38 9.92 1.62 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.364 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -65.31 -36.17 83.22 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-O 120.9 0.381 . . . . 0.0 110.882 178.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.27 -34.31 0.2 Allowed Glycine 0 CA--C 1.531 1.058 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 47.24 22.95 0.28 Allowed 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -149.17 120.74 7.99 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.128 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -170.5 17.12 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -147.93 -71.04 0.22 Allowed 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.0 t -161.93 160.71 28.19 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.313 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -147.69 148.03 19.23 Favored Glycine 0 CA--C 1.545 1.966 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -71.34 147.21 52.45 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 122.047 1.831 . . . . 0.0 112.188 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -136.33 60.39 32.42 Favored Pre-proline 0 CA--C 1.562 1.438 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.5 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -65.15 -22.29 61.59 Favored 'Trans proline' 0 N--CA 1.507 2.311 0 C-N-CA 122.029 1.819 . . . . 0.0 111.931 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.931 -179.179 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.54 152.9 38.76 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.52 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.3 p -70.2 157.48 37.56 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.978 -179.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 81.1 t -65.52 -44.85 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.693 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -76.49 146.78 38.26 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.535 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -109.92 -29.12 8.41 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.846 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mp -123.26 125.8 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.773 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.9 m -112.83 35.93 3.68 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.931 0.396 . . . . 0.0 111.338 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 59.35 155.03 0.1 OUTLIER Pre-proline 0 CA--C 1.552 1.038 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.34 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.61 152.72 48.59 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 122.305 2.003 . . . . 0.0 112.016 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -150.88 146.94 26.65 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.674 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 42.0 mm -98.05 -53.21 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.24 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -143.18 -61.17 0.42 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.078 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 50.02 -86.35 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.406 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.99 -174.69 39.24 Favored Glycine 0 C--N 1.351 1.363 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -85.78 100.32 11.96 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.888 0.375 . . . . 0.0 110.793 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -157.39 165.05 36.79 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.635 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -151.66 154.51 36.52 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.421 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.8 p -136.02 150.5 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.585 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -120.18 152.9 37.01 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.203 0.525 . . . . 0.0 112.074 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.2 m -83.27 162.81 21.04 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.154 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -68.35 136.5 53.48 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.32 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.0 mttm -72.03 -25.4 61.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.142 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.39 -27.55 14.04 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.606 178.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -127.88 54.39 13.0 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.057 177.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -70.44 -30.57 18.92 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.838 1.692 . . . . 0.0 111.808 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -70.54 -29.34 65.79 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.385 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 63.9 p -116.17 20.96 14.03 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.798 -178.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 19.2 p -67.15 161.92 23.57 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.922 -179.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm 55.01 85.69 0.06 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.188 178.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -121.45 -42.94 2.42 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.807 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.6 mmtt 66.09 35.22 6.36 Favored 'General case' 0 C--O 1.252 1.217 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.42 177.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -143.56 -44.38 0.28 Allowed 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.802 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 59.99 115.38 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.119 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 30.8 p30 -69.75 156.29 91.98 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.552 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -83.87 -23.77 3.02 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.605 2.204 . . . . 0.0 113.17 -177.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -60.48 -50.4 73.72 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.62 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 62.6 ttt-85 57.62 154.02 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.261 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -162.8 131.27 3.95 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.264 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.66 177.3 45.09 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 178.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 53.5 t -91.24 114.39 26.9 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 120.781 0.324 . . . . 0.0 110.561 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -141.07 38.23 1.57 Allowed Glycine 0 N--CA 1.466 0.671 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.424 HG12 ' H ' ' A' ' 45' ' ' GLU . 67.1 t -63.43 -41.18 91.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 73.2 mt 77.93 -13.14 0.99 Allowed 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.007 0.923 . . . . 0.0 112.103 -176.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.424 ' H ' HG12 ' A' ' 43' ' ' VAL . 71.2 mm-40 -65.04 -36.84 85.65 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-O 120.826 0.346 . . . . 0.0 111.638 176.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 151.5 78.55 0.02 OUTLIER Glycine 0 C--O 1.237 0.302 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 12.5 t -90.23 83.74 6.02 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.163 0.506 . . . . 0.0 110.748 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -127.71 -41.64 1.66 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.439 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 63.2 140.03 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.855 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -67.78 -35.8 79.31 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.79 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 84.0 m -103.17 -67.37 0.89 Allowed 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.203 -177.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.32 95.24 0.91 Allowed Glycine 0 CA--C 1.546 1.981 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -71.26 151.23 60.26 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 121.97 1.78 . . . . 0.0 112.081 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.426 ' HD2' HG22 ' A' ' 56' ' ' THR . 1.0 OUTLIER -142.5 61.4 11.41 Favored Pre-proline 0 CA--C 1.564 1.499 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.793 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -71.12 -23.17 25.05 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 122.211 1.941 . . . . 0.0 112.043 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.426 HG22 ' HD2' ' A' ' 54' ' ' LYS . 8.9 t . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.96 -1.019 . . . . 0.0 111.385 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.29 75.3 0.35 Allowed 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.099 0.476 . . . . 0.0 110.967 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.6 m -94.26 137.91 32.87 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.977 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.6 p -64.9 -32.44 58.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.389 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 23.9 tpp180 -62.3 130.22 44.29 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.308 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -148.27 99.95 3.1 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.318 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.0 mm -125.41 125.87 69.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.653 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.2 t -150.0 153.08 35.93 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.956 0.407 . . . . 0.0 111.921 -178.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.807 ' CE1' ' HB2' ' A' ' 11' ' ' ALA . 46.1 p90 -133.7 154.08 80.42 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.402 178.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.56 -29.87 70.67 Favored 'Trans proline' 0 N--CA 1.507 2.285 0 C-N-CA 122.081 1.854 . . . . 0.0 113.415 -175.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.807 ' HB2' ' CE1' ' A' ' 9' ' ' TYR . . . 48.48 63.43 2.08 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.262 0.553 . . . . 0.0 110.788 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 46.2 mm -61.04 -47.12 95.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.342 -177.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -163.08 39.1 0.1 Allowed 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.154 0.502 . . . . 0.0 110.774 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 70.3 mtp85 -100.97 114.23 27.95 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.499 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -138.99 141.18 11.62 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -137.08 152.15 49.7 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 120.595 0.236 . . . . 0.0 111.006 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 -155.22 160.09 40.59 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.25 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -156.25 152.92 28.35 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.968 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.1 m -71.3 -18.37 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.775 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -65.63 148.46 51.71 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.698 0.285 . . . . 0.0 110.926 -178.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 77.0 m -80.0 143.77 33.82 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.328 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -71.33 130.29 41.01 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -67.06 -23.65 65.9 Favored 'General case' 0 N--CA 1.472 0.674 0 O-C-N 123.129 0.268 . . . . 0.0 110.949 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.07 -28.55 14.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.762 178.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -128.31 54.81 14.53 Favored Pre-proline 0 CA--C 1.555 1.17 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.3 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.19 -23.24 29.07 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.675 1.584 . . . . 0.0 111.338 177.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -63.35 -35.98 82.2 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.166 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.3 p -85.0 -7.68 59.04 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.601 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 52.4 t -61.61 132.5 53.51 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 123.136 0.272 . . . . 0.0 110.552 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -128.11 151.9 48.65 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.967 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -126.8 153.08 46.07 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.326 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -129.79 151.11 50.72 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.972 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -153.81 171.49 18.84 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.158 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.5 29.02 5.36 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.495 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 61.11 154.46 0.11 Allowed Pre-proline 0 CA--C 1.546 0.795 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.0 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.98 -24.34 15.23 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.376 2.051 . . . . 0.0 112.01 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -63.05 131.7 49.47 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.0 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 60.0 ttt85 -136.43 138.23 41.28 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.709 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 73.3 ttt-85 -156.07 140.67 16.92 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.9 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -127.98 162.64 21.78 Favored Glycine 0 N--CA 1.467 0.76 0 N-CA-C 111.613 -0.595 . . . . 0.0 111.613 -178.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 53.8 t -90.21 114.36 26.34 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.1 20.44 3.02 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.165 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 35.8 m -65.22 -32.57 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.777 0.322 . . . . 0.0 111.309 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.4 mt 64.37 2.28 1.5 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -66.59 -36.7 83.25 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.012 0.434 . . . . 0.0 110.84 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.14 55.94 0.02 OUTLIER Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 10.3 t -75.33 125.2 28.5 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.238 -0.481 . . . . 0.0 110.272 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -155.29 142.47 19.33 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.875 0.369 . . . . 0.0 111.537 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -63.58 -39.32 94.08 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.691 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -103.15 152.17 21.75 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 120.809 0.337 . . . . 0.0 110.685 -176.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.1 m -64.52 -43.8 92.89 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.49 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -164.85 163.67 36.51 Favored Glycine 0 CA--C 1.543 1.811 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -73.01 -30.32 10.99 Favored 'Trans proline' 0 N--CA 1.5 1.901 0 C-N-CA 122.223 1.949 . . . . 0.0 112.588 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -130.62 67.51 80.48 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.989 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -61.56 -20.7 69.71 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 122.599 2.199 . . . . 0.0 111.657 175.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.4 m . . . . . 0 C--O 1.219 -0.513 0 CA-C-O 117.952 -1.023 . . . . 0.0 111.27 -178.629 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.69 140.01 58.69 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.147 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.8 p -70.6 154.4 41.9 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.101 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.452 HG13 ' O ' ' A' ' 4' ' ' VAL . 11.1 p -176.9 117.27 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.907 178.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 72.0 mtp85 -139.84 151.25 45.55 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.296 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -132.01 148.89 52.53 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.603 178.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.7 tt -134.28 145.47 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 O-C-N 123.233 0.333 . . . . 0.0 111.416 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.8 p -128.49 160.41 32.4 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.152 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -69.21 148.67 97.55 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.863 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.46 ' CG ' HD11 ' A' ' 12' ' ' ILE . 55.8 Cg_endo -69.24 -31.98 21.71 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 122.087 1.858 . . . . 0.0 112.926 -178.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 54.88 82.1 0.1 Allowed 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.095 0.474 . . . . 0.0 110.282 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.46 HD11 ' CG ' ' A' ' 10' ' ' PRO . 0.8 OUTLIER -121.44 41.21 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.261 -178.3 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.9 t0 77.69 -14.44 0.85 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.267 -175.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 51.64 31.3 7.65 Favored 'General case' 0 C--N 1.352 0.693 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 174.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.93 -170.78 41.67 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -88.87 104.07 16.59 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -98.44 133.9 42.18 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.628 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.0 137.49 58.23 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.923 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.8 t -126.44 128.01 70.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.64 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 68.0 m170 -108.92 130.03 55.43 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.061 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.8 m -72.28 156.26 39.3 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.814 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -66.9 131.58 46.19 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.086 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.03 -23.58 65.91 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.948 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.05 -28.63 14.06 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.733 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -128.01 54.76 14.07 Favored Pre-proline 0 CA--C 1.556 1.2 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.149 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.26 -26.01 25.68 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.897 1.731 . . . . 0.0 112.011 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -70.83 -27.42 63.85 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.137 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.7 p -113.1 12.65 19.19 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -175.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 21.9 p -68.19 149.43 49.55 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 121.014 -0.274 . . . . 0.0 110.942 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -142.19 -68.99 0.36 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.841 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -139.94 155.13 47.3 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.804 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -129.28 149.58 51.02 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.453 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -151.5 170.7 18.98 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.165 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.11 175.93 7.85 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.618 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -64.19 152.52 87.98 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.052 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -79.41 -19.88 9.99 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.599 2.199 . . . . 0.0 112.528 -177.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -59.28 -50.13 75.17 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.199 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -62.7 -48.16 80.46 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -172.08 142.05 1.38 Allowed 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.436 -178.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -107.77 141.62 15.73 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 5.7 p -76.14 155.03 35.0 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.856 0.36 . . . . 0.0 111.638 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -145.37 13.09 1.82 Allowed Glycine 0 CA--C 1.541 1.667 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.22 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 27.6 m -62.59 -27.2 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 116.794 0.297 . . . . 0.0 111.174 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.5 mt 70.06 -4.74 1.44 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.51 0.724 . . . . 0.0 112.823 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -66.19 -36.75 83.89 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.008 0.432 . . . . 0.0 110.539 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -167.66 53.3 0.23 Allowed Glycine 0 C--N 1.332 0.357 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.5 t -132.78 118.24 18.77 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.164 -0.518 . . . . 0.0 111.065 -177.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -160.69 97.86 1.2 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.606 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 67.1 ttt-85 -166.85 142.26 4.27 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.29 178.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -149.27 159.88 43.88 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.813 0.34 . . . . 0.0 111.744 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.2 t -152.94 150.68 29.51 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.45 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -141.64 64.45 0.51 Allowed Glycine 0 CA--C 1.545 1.925 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -70.54 153.54 65.27 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 122.256 1.97 . . . . 0.0 111.741 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -131.49 83.93 57.28 Favored Pre-proline 0 CA--C 1.554 1.111 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.708 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.62 -22.35 38.09 Favored 'Trans proline' 0 N--CA 1.503 2.047 0 C-N-CA 122.097 1.865 . . . . 0.0 111.947 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.4 m . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 117.992 -1.004 . . . . 0.0 111.009 -179.101 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.76 142.55 58.12 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.875 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.4 m -64.19 139.52 58.77 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.86 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.97 128.56 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.94 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -105.36 108.22 19.62 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.933 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -175.59 79.88 0.02 OUTLIER 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.383 178.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 mp -124.43 122.15 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.402 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 77.5 p -134.46 160.04 39.23 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.856 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -62.55 135.37 95.5 Favored Pre-proline 0 CA--C 1.557 1.214 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.46 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -70.7 153.8 64.41 Favored 'Trans proline' 0 N--CA 1.505 2.154 0 C-N-CA 122.174 1.916 . . . . 0.0 112.656 -178.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -114.03 138.4 50.43 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.429 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 90.6 mt -61.43 -47.21 94.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.106 -179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.0 p-10 -176.91 -36.34 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.122 179.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 48.74 -176.13 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.615 179.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.1 158.93 34.58 Favored Glycine 0 C--N 1.344 1.012 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -103.18 138.75 39.57 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.801 -0.2 . . . . 0.0 110.558 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -63.24 -40.68 98.12 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.818 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.32 142.0 50.45 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.854 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.0 p -142.32 145.21 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.16 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -115.94 134.36 55.05 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.205 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 99.0 m -75.59 156.37 35.03 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.075 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -67.64 134.14 50.62 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.268 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -69.07 -23.86 64.09 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.116 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.99 -27.55 14.19 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.672 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -128.5 55.14 15.95 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.895 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -69.91 -27.7 25.44 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.912 1.741 . . . . 0.0 111.951 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -70.67 -27.66 64.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.964 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 75.7 p -115.62 16.43 16.49 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 23.7 p -64.61 159.64 21.44 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.448 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -117.97 138.66 52.02 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.904 -178.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -87.52 -42.0 13.08 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.638 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -139.52 148.07 42.12 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.49 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -159.46 176.2 12.38 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.873 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -113.26 130.41 56.25 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.399 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.4 p30 -72.85 158.16 87.65 Favored Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.718 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -81.67 -19.77 7.18 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.464 2.109 . . . . 0.0 112.743 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -89.34 119.52 29.88 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.314 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -137.09 141.96 42.34 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.788 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 68.9 ttp85 -130.18 -44.71 1.14 Allowed 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.715 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.46 150.81 47.4 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 31.2 p -74.97 153.43 38.55 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.801 0.334 . . . . 0.0 111.081 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -145.87 4.12 1.18 Allowed Glycine 0 CA--C 1.541 1.702 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.429 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 30.2 m -64.8 -28.92 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-N 116.934 0.367 . . . . 0.0 111.279 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.8 mt 58.7 12.6 2.26 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.098 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -64.02 -36.6 84.53 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-O 120.98 0.419 . . . . 0.0 110.321 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.5 43.12 0.02 OUTLIER Glycine 0 C--N 1.333 0.399 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.8 t -62.74 -61.56 2.33 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.429 -0.386 . . . . 0.0 110.339 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 50.37 176.75 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.908 176.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -63.47 -45.2 91.9 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 177.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 173.18 86.8 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.658 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.5 m 62.86 104.49 0.03 OUTLIER 'General case' 0 C--N 1.344 0.365 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.061 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -122.5 140.74 13.6 Favored Glycine 0 CA--C 1.541 1.684 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -74.06 157.59 46.53 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.762 1.642 . . . . 0.0 112.143 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -130.78 81.25 67.88 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.612 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.35 -13.49 40.09 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 122.224 1.949 . . . . 0.0 111.977 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 C--N 1.35 0.603 0 CA-C-O 117.921 -1.037 . . . . 0.0 111.358 -178.401 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.79 146.15 55.23 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.868 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.1 t 59.63 109.0 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.927 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.2 m -129.09 157.75 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.145 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 89.9 mmt-85 -76.08 159.55 30.66 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.058 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -126.61 129.76 49.16 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.5 tt -114.74 130.02 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.657 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 73.3 p -79.84 163.7 24.19 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.953 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -132.09 155.81 80.88 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.529 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -69.6 148.8 66.88 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 121.933 1.755 . . . . 0.0 111.996 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -154.06 156.46 37.35 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.853 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 77.4 mt -86.01 -66.81 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.529 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -127.88 17.07 6.81 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.6 mtt85 -62.24 -38.45 89.27 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.389 0.138 . . . . 0.0 111.363 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.02 20.16 37.97 Favored Glycine 0 N--CA 1.475 1.281 0 CA-C-N 116.361 -0.382 . . . . 0.0 112.614 -178.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 53.79 -178.96 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 122.321 0.248 . . . . 0.0 111.213 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -158.42 165.97 33.36 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.382 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.0 144.1 48.53 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.202 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.3 t -84.73 -70.93 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.712 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -133.83 112.84 11.65 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.208 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.6 m -95.61 157.58 15.83 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.375 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -66.83 138.56 57.43 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 123.256 0.348 . . . . 0.0 110.869 -179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -73.87 -24.35 59.72 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.736 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.44 -27.01 14.26 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.586 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -129.06 54.31 13.92 Favored Pre-proline 0 CA--C 1.556 1.193 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.154 177.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.42 -30.61 18.94 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 121.834 1.69 . . . . 0.0 111.694 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -71.11 -28.74 64.52 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.362 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 70.3 p -117.38 20.2 13.71 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.706 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 19.4 p -62.78 161.26 12.84 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.814 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt 63.72 143.61 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.513 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -135.2 154.53 51.57 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.15 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -129.93 152.05 49.82 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.733 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.2 pm0 -148.01 163.93 35.35 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.074 0.464 . . . . 0.0 111.88 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 65.02 -79.39 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.456 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.28 140.92 0.04 OUTLIER Pre-proline 0 CA--C 1.565 1.543 0 C-N-CA 122.918 0.487 . . . . 0.0 112.299 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -79.52 -21.52 8.69 Favored 'Trans proline' 0 N--CA 1.5 1.892 0 C-N-CA 122.245 1.963 . . . . 0.0 112.196 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -60.17 -49.69 76.61 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.103 -178.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 58.7 ttt85 -162.49 140.64 8.62 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.223 0.327 . . . . 0.0 111.178 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.5 ttp-105 -145.32 -10.95 0.55 Allowed 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.289 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -164.33 169.69 39.24 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 25.3 p -78.89 159.91 27.54 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.839 0.352 . . . . 0.0 111.646 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -141.03 14.19 2.83 Favored Glycine 0 CA--C 1.544 1.86 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.139 179.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.4 m -65.08 -32.58 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 116.809 0.304 . . . . 0.0 111.423 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.5 mt 64.12 2.71 1.51 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -65.27 -36.51 84.32 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.002 0.43 . . . . 0.0 110.562 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -177.62 -58.5 0.07 OUTLIER Glycine 0 C--N 1.332 0.338 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.9 t 45.39 94.15 0.01 OUTLIER 'General case' 0 C--O 1.239 0.503 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 80.8 m80 -98.23 114.21 26.39 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.377 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 70.2 ttp85 -138.32 131.69 30.44 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.834 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -129.77 153.69 47.96 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.928 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 t -151.94 150.46 30.06 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 123.34 0.4 . . . . 0.0 111.684 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.75 57.27 0.05 OUTLIER Glycine 0 CA--C 1.545 1.936 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.66 155.46 66.2 Favored 'Trans proline' 0 N--CA 1.504 2.142 0 C-N-CA 122.438 2.092 . . . . 0.0 112.09 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.6 mmmm -129.5 69.8 81.53 Favored Pre-proline 0 CA--C 1.561 1.381 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.538 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.21 -22.46 40.42 Favored 'Trans proline' 0 N--CA 1.505 2.179 0 C-N-CA 122.172 1.915 . . . . 0.0 112.001 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 117.973 -1.013 . . . . 0.0 111.665 -179.178 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.66 146.53 54.69 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.11 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.561 ' O ' HG22 ' A' ' 4' ' ' VAL . 68.7 m -66.04 158.19 29.01 Favored 'General case' 0 C--O 1.226 -0.181 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.458 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 3' ' ' SER . 12.8 m 55.73 141.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.476 1.11 . . . . 0.0 112.285 -178.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -59.96 -50.2 74.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.147 -175.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.1 t80 178.37 85.04 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.84 0.352 . . . . 0.0 110.42 178.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 43.4 pt -138.0 135.02 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.157 0.503 . . . . 0.0 111.524 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 28.8 m -149.89 136.86 19.49 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.006 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -110.96 144.0 29.46 Favored Pre-proline 0 CA--C 1.551 0.981 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.993 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.53 157.72 22.08 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.407 2.071 . . . . 0.0 112.217 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -106.65 79.41 1.35 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.087 178.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.445 ' C ' HD12 ' A' ' 12' ' ' ILE . 2.9 pp -44.62 -15.75 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -176.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -65.9 -4.86 7.62 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 121.23 -0.188 . . . . 0.0 110.978 175.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 11' ' ' ALA . 63.0 mtp180 -33.33 128.63 0.3 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.027 0.931 . . . . 0.0 111.779 -178.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.08 -168.16 53.8 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -141.24 89.93 2.27 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 120.918 0.39 . . . . 0.0 110.425 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -82.0 -11.45 58.83 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.94 115.27 23.44 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.741 0.305 . . . . 0.0 111.11 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.0 p -152.07 136.89 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.834 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -86.58 152.44 22.61 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.502 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 82.1 m -67.65 139.34 56.8 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.036 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -69.06 132.83 47.25 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.92 -22.92 64.12 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 123.182 0.301 . . . . 0.0 110.969 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.94 -28.68 14.08 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.636 178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -128.58 54.93 15.15 Favored Pre-proline 0 CA--C 1.557 1.247 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.326 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.85 -23.3 25.98 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 121.825 1.684 . . . . 0.0 111.432 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -63.23 -36.35 83.35 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.964 178.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.1 p -91.22 4.49 52.15 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.918 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.7 t -57.32 142.83 42.01 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.074 0.464 . . . . 0.0 110.959 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -55.4 129.24 37.85 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.722 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -70.23 -39.81 74.88 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.98 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -137.44 150.19 47.43 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.295 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -149.26 -44.02 0.14 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.054 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.74 140.16 58.84 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.983 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -80.89 152.54 71.96 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.735 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.47 -23.91 14.56 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.324 2.016 . . . . 0.0 111.995 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -65.95 131.89 47.31 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.067 -178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 80.2 ttt-85 -138.05 139.76 39.73 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.194 177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -153.82 142.88 21.27 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.771 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -105.01 147.31 16.25 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 51.2 t -64.43 128.01 33.96 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.607 0.241 . . . . 0.0 110.77 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.09 17.34 1.36 Allowed Glycine 0 CA--C 1.539 1.554 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.308 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 28.5 m -66.01 -30.73 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 116.837 0.319 . . . . 0.0 111.437 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 87.3 mt 64.45 2.72 1.65 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -66.31 -36.11 82.1 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.921 0.391 . . . . 0.0 110.711 177.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.44 -48.12 0.11 Allowed Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 t 46.84 59.12 4.16 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.43 0.634 . . . . 0.0 111.376 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -154.4 162.37 41.2 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.197 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.0 ttt85 -91.4 -56.5 3.11 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.664 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -146.25 -174.27 4.4 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.97 178.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.9 m -125.05 121.98 35.91 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 108.26 129.22 5.95 Favored Glycine 0 CA--C 1.552 2.355 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.87 153.7 53.2 Favored 'Trans proline' 0 N--CA 1.498 1.736 0 C-N-CA 121.983 1.789 . . . . 0.0 112.082 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -130.1 70.41 82.16 Favored Pre-proline 0 CA--C 1.56 1.332 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.5 178.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.75 -23.67 35.57 Favored 'Trans proline' 0 N--CA 1.505 2.182 0 C-N-CA 122.317 2.011 . . . . 0.0 112.4 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.8 m . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 117.904 -1.046 . . . . 0.0 111.08 -178.967 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 18.0 pm0 . . . . . 0 N--CA 1.495 1.795 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.45 152.05 31.51 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-O 120.591 0.234 . . . . 0.0 110.92 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.2 p -155.8 161.73 40.6 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.127 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.14 157.56 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.917 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -137.36 129.63 29.49 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.202 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -141.87 132.14 24.96 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.3 tt -126.72 134.65 65.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.205 -178.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 8' ' ' THR . 5.2 t -157.87 88.27 0.96 Allowed 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.496 178.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -72.58 134.19 82.15 Favored Pre-proline 0 CA--C 1.557 1.221 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.893 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -90.5 -76.61 0.0 OUTLIER 'Trans proline' 0 CA--C 1.555 1.544 0 C-N-CA 122.018 1.812 . . . . 0.0 112.056 177.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.606 ' O ' HG23 ' A' ' 12' ' ' ILE . . . 51.62 18.57 0.73 Allowed 'General case' 0 C--N 1.347 0.488 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 11' ' ' ALA . 1.2 pt -165.59 -83.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 178.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -60.58 -40.91 93.44 Favored 'General case' 0 C--N 1.345 0.379 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -178.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 70.7 mtp85 49.41 27.88 2.16 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.132 177.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.7 164.21 44.81 Favored Glycine 0 C--N 1.34 0.801 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.343 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.47 -33.82 75.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.11 -0.545 . . . . 0.0 111.101 178.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 78.13 -58.34 0.46 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.384 0.674 . . . . 0.0 110.919 -178.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -104.29 99.03 8.74 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.696 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.6 p -150.63 142.13 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.929 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -132.2 150.26 52.2 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.652 179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.3 m -72.03 151.9 42.82 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.913 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -74.17 134.43 42.78 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.035 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -71.36 -26.37 62.78 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.12 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -95.72 -28.37 14.82 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.58 177.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 65.1 m170 -127.83 53.46 10.66 Favored Pre-proline 0 CA--C 1.558 1.266 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.521 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.04 -25.6 19.24 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.903 1.735 . . . . 0.0 111.488 177.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -64.42 -35.57 81.34 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.142 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.8 p -82.59 -19.6 38.11 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.892 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.5 t -62.21 142.13 57.84 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.652 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -61.57 143.94 55.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.566 -177.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -129.82 153.34 48.35 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.718 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -129.7 150.37 51.05 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.741 -177.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -150.96 171.52 17.15 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.495 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.07 131.68 34.21 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 123.444 0.465 . . . . 0.0 110.946 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -73.52 154.17 89.75 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.817 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.1 -25.25 16.24 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.194 1.929 . . . . 0.0 111.686 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -64.57 129.82 41.28 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.35 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 56.3 ttt85 61.63 141.43 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.203 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -159.87 127.52 4.69 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.484 179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -107.25 150.86 16.86 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 51.2 t -63.67 124.85 22.48 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -143.88 16.59 2.18 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.363 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.9 m -63.6 -30.61 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.832 0.349 . . . . 0.0 111.331 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 85.2 mt 65.27 1.71 1.68 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -65.1 -36.77 85.36 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.976 0.417 . . . . 0.0 110.702 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.65 -52.09 0.11 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.4 t 45.52 66.25 0.96 Allowed 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.201 0.524 . . . . 0.0 111.307 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 71.6 t60 58.76 99.88 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.198 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 40.0 ptt85 -53.86 149.81 8.36 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.784 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -146.54 149.03 32.81 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.593 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.2 t -158.26 159.38 35.94 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.551 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -149.68 162.65 29.16 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -71.42 149.75 56.97 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 122.057 1.838 . . . . 0.0 112.593 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -130.45 74.81 79.88 Favored Pre-proline 0 CA--C 1.558 1.254 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.904 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -66.17 -22.97 53.35 Favored 'Trans proline' 0 N--CA 1.506 2.211 0 C-N-CA 122.306 2.004 . . . . 0.0 112.113 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.1 m . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.077 -0.963 . . . . 0.0 111.055 -179.194 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.72 140.69 50.79 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.123 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 96.3 p -149.94 160.56 43.51 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.027 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 92.7 t -66.31 -41.68 89.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.193 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -125.89 151.43 46.92 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.1 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -130.29 148.19 52.09 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.594 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.8 tp -131.44 129.6 62.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.11 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.6 m -122.32 129.09 51.82 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.733 -178.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -72.71 155.73 90.6 Favored Pre-proline 0 CA--C 1.545 0.772 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.309 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.85 140.18 45.5 Favored 'Trans proline' 0 N--CA 1.5 1.895 0 C-N-CA 121.815 1.676 . . . . 0.0 111.749 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -162.82 153.53 16.85 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.861 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.579 HD12 ' H ' ' A' ' 12' ' ' ILE . 3.7 mp -93.4 -48.28 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.325 178.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -169.79 -53.41 0.02 OUTLIER 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.78 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 84.4 mtp180 54.22 177.64 0.03 OUTLIER 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.708 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -106.46 117.11 5.29 Favored Glycine 0 C--N 1.341 0.839 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.12 -40.51 97.82 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.59 0.233 . . . . 0.0 111.298 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -155.68 -91.81 0.04 OUTLIER 'General case' 0 CA--C 1.561 1.385 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.607 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -162.57 147.75 12.26 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 120.598 0.237 . . . . 0.0 111.072 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.496 HG22 ' HA3' ' A' ' 52' ' ' GLY . 36.0 m -136.11 157.53 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.174 178.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -127.96 161.96 27.89 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.372 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 84.8 m -85.02 138.89 32.17 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.739 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -66.63 128.78 37.57 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -66.05 -23.02 66.46 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 123.108 0.255 . . . . 0.0 110.945 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.31 -25.12 14.95 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.893 178.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.477 ' O ' HG22 ' A' ' 28' ' ' THR . 69.4 m80 -129.48 54.27 13.93 Favored Pre-proline 0 CA--C 1.558 1.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.92 178.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.9 -19.84 26.53 Favored 'Trans proline' 0 N--CA 1.5 1.898 0 C-N-CA 121.946 1.764 . . . . 0.0 111.632 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -62.32 -35.96 80.7 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.777 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 25' ' ' HIS . 8.1 t -82.25 -25.88 33.69 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 120.997 -0.281 . . . . 0.0 111.125 -179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 51.3 t -62.28 138.78 58.49 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.006 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -97.57 129.0 44.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.1 -176.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.7 mmmm -138.22 153.13 49.14 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.197 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -123.67 -33.04 3.25 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.266 -177.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -139.26 167.14 22.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.125 -177.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -161.77 162.4 29.56 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.858 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -125.71 152.65 72.55 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.358 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.18 -24.29 12.68 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.224 1.949 . . . . 0.0 112.384 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -82.76 -67.0 0.82 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.377 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 56.72 160.91 0.02 OUTLIER 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.298 178.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -150.19 140.12 21.92 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.902 179.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.08 117.52 4.86 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.706 -0.558 . . . . 0.0 111.706 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 38.8 t -91.59 161.67 14.84 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.677 -0.262 . . . . 0.0 110.563 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.78 -9.85 57.07 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 111.461 -0.655 . . . . 0.0 111.461 -176.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.432 HG23 ' H ' ' A' ' 45' ' ' GLU . 25.0 m -63.01 -24.17 35.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 120.805 0.336 . . . . 0.0 110.353 175.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.9 mt 67.83 1.28 2.61 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.452 0.701 . . . . 0.0 112.633 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.432 ' H ' HG23 ' A' ' 43' ' ' VAL . 95.5 mt-10 -66.46 -36.6 83.18 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-O 120.915 0.388 . . . . 0.0 110.505 175.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 169.68 88.95 0.07 OUTLIER Glycine 0 C--N 1.336 0.577 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.7 t -138.25 129.7 27.68 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.747 0.308 . . . . 0.0 110.825 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -154.96 163.53 40.18 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.232 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 57.1 ttt85 56.6 100.41 0.02 OUTLIER 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.206 -178.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -116.68 173.23 6.74 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.363 -178.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.5 m -114.26 127.7 56.01 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.206 178.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.496 ' HA3' HG22 ' A' ' 19' ' ' VAL . . . -160.53 73.77 0.21 Allowed Glycine 0 CA--C 1.544 1.899 0 CA-C-O 119.649 -0.528 . . . . 0.0 111.952 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -71.12 151.23 61.1 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.054 1.836 . . . . 0.0 111.754 179.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -130.22 69.92 82.08 Favored Pre-proline 0 CA--C 1.563 1.471 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.688 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.11 -24.68 38.32 Favored 'Trans proline' 0 N--CA 1.505 2.169 0 C-N-CA 122.352 2.035 . . . . 0.0 112.351 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.2 m . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.74 -179.04 . . . . . . . . 0 0 . 1 stop_ save_